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Abbreviations 
aa amino acid 
ABD actin-binding domain 
ABP actin-binding protein 
ADMIDAS adjacent to metal-ion-dependent 
adhesion site 
Ala alanine 
Alk activin-receptor-like kinase 
ANK ankyrin 
aPKC atypical protein kinase C 
Arg arginine 
Arp2/3 complex actin-related protein 2/3 complex 
Asp asparagine 
ATP adenosine triphosphate 
ATPase adenosine triphosphatase 
bFGF basic fibroblast growth factor 
BM basement membrane 
Ca2+ calcium-ion 
Cdc42 Cell division control protein 42 homolog 
CH calponin homology domain 
CH-ILKBP CH domain-containing ILK-binding protein 
Col collagen 
Crk v-crk sarcoma virus CT10 oncogene homolog 
DLL4 Delta-like-4 
DNA deoxyribonucleic acid 
Dock180 180-kDa protein downstream of CRK 
DRF diaphanous-related formin 
E embryonic day 
EB embryoid bodies 
EC endothelial cell 
ECM extracellular matrix 
Ena/Vasp enabled/vasodilator-stimulated 
phosphoprotein 
EPC endothelial precursor cell 
EST expressed sequence tag 
FA focal adhesion 
F-actin filamentous actin 
FAK focal adhesion kinase 
FC focal complexes 
FERM 4.1, ezrin, radixin, moesin 
FN fibronectin 
FRET fluorescence energy transfer 
G-actin globular actin 
GAP GTPase activating protein 
GEF guanine nucleotide exchange factor 
GDI guanine nucleotide dissociation inhibitor 
GDP guanosine diphosphate 
GIT G-protein-coupled receptor kinase interacting 
protein 
GSK3β glycogen-synthase kinase-3β 
GTP guanosine triphosphate 
GTPase guanosine triphosphatase 
HeLa Henrietta Lacks 
ICAM1 intercellular adhesion molecule-1 
Ig immunoglobulin 
IL interleukin 
ILK integrin linked kinase 
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ILKAP ILK-associated phosphatase 
IPP complex ILK-PINCH-Parvin complex 
JNK c-Jun N-terminal kinase 
kDa kilodalton 
LAD-III leukocyte-adhesion deficiency type III 
LDV leucine-aspartic acid-valine 
LLC Lewis lung carcinoma 
LIM Lin11, Isl1, Mec3 
LIMBS ligand-induced metal ion binding site 
LIMK LIM kinase 
LN laminin 
LTBP latent TGFβ-binding protein 
MAdCAM-1 mucosal addressin cell adhesion 
molecule-1 
MC Mesangial cell 
MCP-1 monocyte chemotactic protein 1 
Mg2+ magnesium-ion 
MHC myosin heavy chain 
MIDAS metal-ion-dependent adhesion site 
MLC myosin regulatory light chain 
MLCK MLC kinase 
MLCP MLC phosphatase 
MMP matrix metalloproteinase 
μm micrometer 
Mn2+ manganese-ion 
mRNA messenger RNA 
MTOC microtubule organizing centre 
MYPT1 myosin phosphatase-targeting subunit 1 
NLS nuclear localization signals 
P postnatal day 
PAK p21-activated kinase 
PAR6 polarity-protein-partitioning-defective-6 
PAT paralyzed and arrested at the twofold stage 
PDGF platelet-derived growth factor 
PDGFRβ PDGF receptor β 
PH Pleckstrin Homology 
PINCH particularly interesting Cys-His-rich protein 
PIX PAK-interacting exchange factor 
PKB protein kinase B/Akt 
PKL paxillin-kinase linker 
PLGF placental growth factor 
PSI plexin-semaphorin-integrin 
PTB phospho-tyrosine binding 
PtdIns(3,4,5)P3 phosphatidylinositol-3,4,5-
trisphosphate 
Rac1 Ras-related C3 botulinum toxin substrate 1 
Ras rat sarcoma 
RGD arginine-glycine-aspartic acid 
RhoA Ras homologous 
Rif Rho in filopodia/RhoF 
RNA ribonucleic acid 
RNAi RNA interference 
ROCK Rho-associated kinase 
s second 
S1P sphingosine-1-phosphate 
Ser serine 
SFK Src family of tyrosine kinases 
SH2 Src-homology 2 
SH3 Src homology 3 
SRF serum response factor 
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TESK1 testicular protein kinase 1 
TGFβ transforming growth factor β 
THD talin head domain 
Thr Threonine 
TM transmembrane 
TNFα tumor necrosis factor α 
UB ureteric bud 
UC Ureter smooth muscle cell 
UNC uncoordinated 
VCAM1 vascular cell adhesion molecule 1 
VN Vitronectin 
vSMC vascular smooth muscle cell 
vWFA von Willebrand factor A 
WASP Wiskott-Aldrich syndrome protein 
WAVE WASP-family verprolin-homologous protein 
WIP WASP-interacting protein 
Y2H yeast two hybrid 
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Summary 
Migration on and adhesion of cells to extracellular matrix (ECM) componentss or neighboring cells is 
crucial for development and homeostasis of multicellular organisms. The binding to the ECM is mainly 
mediated by integrins, a class of α/β heterodimeric transmembrane receptors. Integrins possess only a 
short cytoplasmatic tail and lack enzymatic activity or actin binding ability. Thus, they rely on adaptor 
and signaling molecules to transmit extracellular signals into the cell or vice versa and thereby control 
proliferation, survival and differentiation. The precise function of integrin associated proteins is still not 
fully known, but in most cases a missregulation of one member of this protein cluster results in severe 
abnormalities in embryonic development or leads to disease.  
First we investigated the impact of plasma derived fibronectin (pFN) on the development of 
atherosclerosis in mice. It was known, that atherosclerotic plaques develop preferentially at areas of 
turbulent blood flow in the aorta, at vessel branches and bifurcations. FN depositions were observed at 
these areas, even before plaques developed, but the source and concrete function of FN remained 
unknown. In vitro experiments suggested that FN deposits at the vessel endothelium enforce and 
maintain a pro-atherogenic milieu through integrin binding and signaling. We used a conditional 
knockout approach to delete the FN gene in either hepatocytes and/or haematopoietic cells of 
atherosclerosis-prone (ApoE)-null mice. These mice are commonly used for atherosclerosis studies, since 
they develop all stages of lesions throughout their lifespan when being fed a high fat containing diet. 
While deleting FN in haematopoietic cells did not affect plaque formation, loss of pFN resulted in 
reduced FN deposits in the subendothelial space of atherosclerosis-prone regions and diminished the 
number and size of atherosclerotic lesions. Without these FN deposits we observed a downegulation of 
inflammatory and adhesion markers for monocytes at the endothelium. In addition pFN deletion 
blocked the migration of vSMC and led to a strongly diminished fibrous cap formation. We could show 
with our experiments, that pFN has two opposing roles in disease initiation and progression. It promotes 
disease by enhancing inflammation and monocyte adhesion but also stabilizes developing plaques by 
promoting fibrous cap formation. 
Second, we investigated the in vivo function of α-parvin (αpv) in vascular smooth muscle cells (vSMC). 
αpv is a focal adhesion (FA) protein and forms together with its binding partners integrin linked kinase 
(ILK) and particularly interesting Cysteine-Histidin-rich-protein (PINCH) a ternary protein complex, the 
IPP complex. Constitutive deletion of αpv has been shown to result in embryonic lethality due to severe 
cardiovascular defects. vSMC, crucial for stabilizing vessels, were not properly recruited to their 
destination on the endothelial layer of vessels and adherent cells remained round and not properly 
spread. In vitro isolated cells were round, with multiple retraction fibers and elevated levels of phospho-
Myosin light chain 2 (pMLC2) and RhoA indicated hypercontraction after αpv deletion. Comparable 
results were obtained after ILK and integrin β1 deletion conditional from vSMC. The conditional αpv 
deletion from vSMC results in vascular defects, similar to αpv null mice, but mice survive until 4 weeks of 
age. As expected we could detect elevated pMLC2 levels in αpv null vSMC but also higher matrix 
degradation in the absence of αpv, which is further weakening vascular structures. The proposed role 
for αpv in regulating contraction is also applying to intestinal SMC (iSMC), but not to ureter SMC (UC) 
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and mesangial cells (MC), which in vivo results in the formation of a paralytic ileus and subsequent death 
of mice.  
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Introduction 
The Integrin family of adhesion receptors 
In almost all tissues, cells are surrounded by a three-dimensional crosslinked network of 
macromolecules that form the extracellular matrix (ECM). This network is secreted and constantly 
remodeled by the cells themselves. The ECM provides the cell with environmental information, but also 
acts as signaling platform and is capable of binding growth factors and chemokines. There are multiple 
cellular receptors, which enable the cell to bind to the ECM and transmit signals into the cell. Integrins 
belong to the family of type I transmembrane adhesion receptors, and are the major receptor family in 
all metazoans for mediating cell adhesion to proteins of the ECM. In vertebrates they can additionally 
interact with cellular counter receptors and thus mediate cell-cell interaction. Integrins are 
heterodimeric proteins, consisting of one α- and one β-subunit, which form with their head domains a 
shared binding platform for different ECM molecules. Their name “integrins” refers to their ability to act 
as a bridge between the ECM and the intracellular cytoskeleton. This linkage to various intracellular 
binding proteins enables integrins not only to act as simple adhesion molecules, but additionally induces 
signaling events in the cell mediating cell shape, contraction but also proliferation, survival and 
differentiation. Because of this central role they are of great importance for development and immune 
response. Not surprisingly therefore, that misregulations in integrin signaling can lead to cancer and 
other diseases. In line with their importance for the organism, they are evolutionary conserved and the 
number of integrin subunits rises with the complexity of the organism. In the nematode Caenorhabditis 
elegans only two integrins are known, formed by two α- and one β-subunits. In the fruit fly Drosophila 
melanogaster already five different integrins can be assembled out of five α-subunits and two β-
subunits (Hynes et al. 2000). In all mammals 24 integrins are known, made up by combining 18 α- and 8 
β-subunits. These different integrins heterodimers are subdivided into 4 distinct categories, grouped by 
specificity to a specific ligand and also cell-specific expression patterns. (Fig. 1) 
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Figure 1: The Integrin receptor family 
Depicted are the 24 mammalian integrin heterodimers arranged to their main ligands (RGD containing ligands, 
Collagen and Laminin) and a 4
th
 group containing integrins specifically expressed on leucocytes only. Gray 
hatchings indicate the presence of an inserted I/A domain. (taken from Hynes, 2002) 
Class 1) These integrins bind preferentially to ligands containing the RGD (arginine-glycine-aspartic acid) 
tripepdide sequence. All αV containing heterodimers (αvβ1, αvβ3, αvβ5, αvβ6 and αvβ8) belong to this 
group and in addition α5β1, α8β1 as well as αIIbβ3, an integrin specific for platelets. Ligands, which 
contain RGD are fibronectin (FN), vitronectin (VN), thrombospondin, osteopontin, tenascin and many 
other proteins. Although this subset of integrins shares a large number of ligands, there is a variance of 
affinity to the receptor, most likely regulated by how precise the RGD conformation fits to the integrin 
binding pocket.  
Class 2) Collagen (Col) binding integrins are the β1 heterodimers α1β1, α2β1, α10β1 and α11β1. All of 
these α-subunits contain a special αA/I domain, critical for ligand binding. The different heterodimers 
vary in their preference to different Col types. 
Class 3) The β1 heterodimers α3β1, α6β1, α7β1 together with α6β4 integrin are highly specific receptors 
for laminin (LN). It has been demonstrated with LN fragments, that different binding regions exist for 
distinct integrin dimers (Nishiuchi et al. 2006). In addition the Col-receptors α1β1, α2β1 and α10β1 can 
also bind LN (Humphries et al., 2006). 
Class 4) The α4β7 and αEβ7 heterodimers as well as the β2 heterodimers αLβ2, αMβ2, αXβ2, αDβ2 are 
specific for leucocytes. They recognize the tripeptide motif LDV (leucine-aspartic acidvaline) or 
structurally related motifs. Besides FN, this sequence is found in VCAM1 (vascular cell adhesion 
molecule 1), mucosal addressin cell adhesion molecule-1 (MAdCAM-1) and intercellular adhesion 
molecule 1 (ICAM1). The latter three are surface proteins expressed by endothelial cells enabling 
leucocytes to bind to the EC layer and transmigrate into the tissue. The related integrins α9β1 and α4β1 
can bind both: ECM such as FN and additionally recognize Ig-superfamily counter receptors like VCAM1. 
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Integrin structure, activation and ligand binding 
Both Integrin subunits, α as well as β, consist of very large extracellular domains of up to 1104 amino 
acids (aa) for α- and 778 aa for β-subunits, that contribute to ligand binding, a helical transmembrane 
(TM) domain of 25-29 aa and only a very short C-terminal cytoplasmic segment of about 20-50 aa. The 
only exception is the β4 subunit which contains a long cytoplasmatic segment of around 1000 aa. β4 is - 
as integrin α6β4 the only heterodimer that is connected to intermediate filaments instead of the actin 
cytoskeleton.  
 
 
 
 
 
 
 
 
 
Figure 2: Integrin structure 
Integrin domain structure and rearrangements during activation are shown. The leg region of β subunits separate 
during activation. The picture shows what may be the predominant (solid representation) and less predominant 
(dashed lines) orientations. (modified from Luo et al. 2007). 
The extracellular head domain of α subunits is folded into 7-bladed β propellers, followed by the stalk 
consisting of an Ig-like (thigh) and two calf (1 & 2) domains (β sandwich domains) (Fig. 2). The head 
domain of the β subunit is organized in a βI/A domain, which is inserted into an immunoglobulin (Ig)-like 
“hybrid” domain. The stalk consists of a PSI (plexin, semaphorins, and integrins) domain, four tandem 
cysteine-rich EGF-like repeats and a β-tail domain. The βI/A domain together with the β propellers of the 
α-subunits forms the integrin head domain, with the ligand binding pocket, where ligand binding itself is 
taking place. It is commonly accepted, that integrins can exist in a low-, intermediate- and high affinity 
state. Based on electron microscopy studies it is believed, that a bent head domain represents the low 
affinity state, while integrins with an extended ectodomain are on high affinity for ligands. There are 
two models proposed for this change in affinity: The “deadbolt model” describes a scenario where the 
head is still bent in an activated integrin. The TM regions perform a piston-like movement that results in 
sliding of the extracellular stalks of the α and β subunits, and the interaction between headpiece β stalk 
is disrupted just beyond the membrane (Luo et al. 2007). Until now no experimental evidence for this 
theory could be found (Luo et al. 2006). In the “switchblade model”, first the α and β cytoplasmic and 
TM regions dissociate, which then results in a dislocation of an epidermal growth factor (EGF)-like 
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repeat in the β stalk and causes the head region to extend in a switchblade-like movement. Additionally, 
the Hybrid domain of the β-subunit performs a “swing-out” movement, that results in a shift from a 
closed (low affinity) to an open (high affinity) conformation of the βA/I domain. The Col-binding and the 
leukocyte specific α-subunits have in addition an N-terminal von Willebrand factor A (vWFA) domain 
inserted into their β-propeller, referred to as the αA/I domain. It has a strong similarity to the βA/I 
domain and can as well change from a closed and low affinity to an open and high affinity state. The 
βA/I domain and also the αA/I domain contain a central Mg2+ binding site (MIDAS - metal-ion-
dependent adhesion site), which is regulating the switch between the affinity conformations. Only on 
the βA/I domain two flanking additional Ca2+ binding sites are present: one called SyMBS (synergistic 
metal ion binding site) and the other AdMIDAS (adjacent to MIDAS). At integrins lacking the αA/I 
domain, the βA/I domain is mainly mediating ligand binding, but for these 9 integrins with αA/I domain, 
this domain is stronger contributing to ligand binding. Concerning the cytoplasmatic domain (integrin 
tail) of β-subunits, a strong sequence homology was described, whereas the α-subunit tails show more 
variance in sequence apart from the conserved GFFKR motif. It was shown by mutation studies that this 
motif is important for the association with the β-tail (Takada et al. 2007), since any changes in this motif 
activates integrins by destabilizing the association of α- and β-TM domain (O’Toole et al. 1994, Lu et al. 
2001). A recognition sequence for phosphotyrosine-binding (PTB) domains is found on most integrin β 
tails:a membrane proximal NPxY motif and a membrane distal NxxY motif. These protein sequences can 
be found in a large variety of cytoskeleton adaptors and signaling proteins, that are necessary to 
transmit signals from the ECM to the cytoskeleton or are critical for integrin activation (Hynes 2002). 
 
Bidirectional signaling 
Integrins have the ability to signal in both directions (bidirectionally) across the plasma membrane. In 
general this means that ligand binding to the integrin head triggers signaling within the cell through 
recruitment of different integrin tail binding proteins (outside-in signaling). This then induces changes in 
the cytoskeleton or various signal transduction pathways and can lead to cell spreading, contraction or 
migration. In the other direction, inside-out signaling describes a process where intracellular signals 
induce the conformational changes in integrins, necessary for ligand binding. 
 
Inside-Out signaling 
The affinity for integrins to bind their corresponding ligand is a tightly regulated process. The best 
example for inside-out signaling is the activation of integrins themselves. Especially for cells of the 
hematopoietic system it is important to keep their integrins in the inactive conformation and to prevent 
unwanted strong cell-cell/ECM interactions. Leukocytes travel through the blood stream and do not 
adhere to the endothelial cell (EC) layer, until inflammatory stimuli like T-cell receptor activation or 
ligation of selectins on neutrophils emerge. This induces a signal cascade, resulting in the translocation 
of the adaptor proteins talin and kindlin to the cytoplasmatic tail of β-subunit and subsequent tail 
separation, switching the integrin into a high affinity state. Only then, firm leucocyte adhesion to EC 
surface proteins like ICAM1 and VCAM1 by the LDV-binding class of integrins will occur and lead to the 
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transmigration into the tissue. Also for platelets, where integrin activation leads to clot formation, an 
intracellular stimulus is required for ligand binding. Here the binding of glycoprotein VI on platelets to 
exposed Col is preceding the activation of their integrin αIIbβ3 and fibrinogen binding. 
The two cytoplasmatic integrin adaptor molecules talin and more recently also kindlin have emerged as 
critical regulators of integrin activity. Orthologs of talin were identified in all multicellular eukaryotes 
studied. Whereas lower eukaryotes only have one talin, vertebrates encode two talin isoforms (talin1 
and talin2). Talin is 270 kDa protein, composed of a 50 kDa N-terminal globular head domain (THD) and 
a 220 kDa C-terminal rod domain. The THD contains three FERM (protein 4.1, ezrin, radixin, moesin) 
subdomains: F1, F2, and F3, and a non-homologous F0 domain. Binding to the conserved membrane-
proximal NPxY (x can be any aa) motif of β integrin cytoplasmic tail occurs via a PTB (phosphotyrosine 
binding) domain that is located in the F3 subdomain. Talin binding was abolished after mutating the 
NPxY motif in β1 or β3 integrins, or mutating the PTB domain resulting in decreased integrin affinity 
(Moser et al. 2009). FRET (Fluorescence energy transfer) studies suggested that talin head binding 
induces separation of the two integrin tails and TM domains, a final step in integrin activation (Kim et al. 
2003). But still, the head domain of talin is not enough to trigger also clustering of integrins after ligand 
binding and the formation of focal adhesions (FA). This was shown with reexpression of THD in talin 
deficient cells and proposes an independent function of the talin tail (Zhang et al. 2008a). The talin rod 
domain is composed of a series of helical bundles that contain binding sites for vinculin and actin and it 
is therefore regarded as an important linker between the ECM and the cytoskeleton. Its ability to also 
bind integrins along with the presence of a homodimerization motif suggests that the tail of talin is 
necessary for integrin clustering and FA-Formation.  
Although talin is essential for integrin activation it is not enough and further co-factors are required. It 
was for example shown, that mutations and truncations of the β3 integrin tail C-terminal to the talin 
binding site results in decreased ligand affinity of the integrin, suggesting that also other proteins can 
modulate the affinity state (Ma et al. 2006). More recent studies showed that kindlin is one of these 
proteins, also binding to integrins and controlling integrin activation (Ussar et al. 2008, Montanez et al. 
2008, Moser et al. 2008,). The kindlin family consists of three members: kindlin1/Unc-112-Related 
Protein 1 (URP1), which is expressed in epithelial cells; kindlin2/Mig-2, which is ubiquitously expressed; 
and Kindlin3/URP2, whose expression is restricted to hematopoietic cells. Like talin, kindlins have a C-
terminal FERM domain, but the F2 subdomain is split by an inserted pleckstrin homology (PH) domain. 
Binding to the integrin tail again works via the PTB domain in the F3 subdomain in kindlin. Unlike talin 
that interacts with the membrane proximal NPxY motif, the F3 subdomain of kindlin interacts with the 
more distal NxxY motif. Interestingly, kindlin2 is not able to activate integrins like the THD does, but 
further enhances activation when co-expressed with THD (Montanez et al. 2008). Studies further 
showed that both proteins critically depend on the presence of each other, because THD domain cannot 
achieve integrin activation in kindlin2 knockdown cells (Ma et al. 2008). It is not yet fully understood, 
how this synergistical effect is achieved and if both proteins bind simultaneously or subsequently to the 
tail of β integrin. Mutations in kindlin1 cause a skin-blistering disease in humans called Kindler 
syndrome. A knockout model of the ubiquitously expressed kindlin2, led to peri-implantion lethality due 
to a severely decreased function of β1 and β3 integrin. Kindlin3 was shown to be required for leukocyte 
adhesion and extravasation and in humans. Mutations in kindlin3 leads to a rare disease known as 
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leukocyte-adhesion deficiency type III (LAD-III) characterized by severe bleedings, leukocyte adhesion 
and extravasation defects (Kuijpers et al., 2009, Svensson et al., 2009). 
 
Integrin clustering and FA formation 
After being activated, integrins are able to bind their corresponding ligand and thus form a link between 
the cell and the ECM. Nevertheless, the adhesion force of one integrin is too weak to realize firm 
adhesion of the cell to the matrix. Lateral association of integrins to the point of adhesion unites 
numerous weak links to the ECM in a synergistic manner, also called “avidity”. It has been shown, that 
activation of integrins as well as their clustering is required for transmitting signals from the ECM into 
the cell (Zhu et al. 2007), but how this integrin clustering is mechanistically executed, is not known yet. 
On 2D cultured cells, several distinct types of adhesive structures can be observed: nascent adhesions 
appear at the leading edge of cells, where new interactions to the ECM are formed (Choi et al. 2011). 
These small adhesions can mature in a Rac1 driven manner into focal complexes (found at the 
lamellopodiums edge). Under the influence of RhoA activity and tension, focal complexes grow in size to 
become FAs (localized at the cell periphery) and finally mature into fibrillar adhesions (center of cells) 
(Geiger et al. 2001). The mechanism of this maturation process is still not perfectly clear, but several 
proteins have been identified, which serve as a marker for some of these subtypes. Talin and also 
paxillin are already found in nascent focal adhesions and focal complexes, whereas the LIM-domain 
protein zyxin is first present in large FAs. While αv integrin is more associated to FA, α5 integrin and 
tensin are typical components of fibrillar adhesions (Zamir et al. 1999). Although these defined 
structures are only observed in vitro on solid surfaces, comparable adhesive units were observed in vivo, 
for example the adhesions to the basement membrane (BM) formed by aortic EC (Kano et al. 1996), or 
the adhesive structures of SMC (Turner et al. 1991). A large number of proteins in recruited to the place 
of FA formation, actin linkers as well as signaling proteins, in a process named outside-in signaling. 
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Outside-In signaling 
 
 
 
 
 
 
 
 
Figure 3: Outside-in signaling.  
Depicted are the major signal pathways and key players. They often act in concert with G protein-coupled or kinase 
receptors. The major integrin associated proteins are highlighted with a pink-purple pentagon beneath the 
clustered integrins. (modified from Hynes et al. 2002) 
Integrins have a central role for adhesion and signaling in all cells and are therefore crucial for the 
survival of the organism (Fig. 3). However their short cytoplasmatic tail lacks catalytic activity of its own. 
Instead integrins bind a huge number of proteins either directly or via adaptor molecules. So far over 
700 molecules, associated to integrin mediated adhesion were identified (Zaidel-Bar et al. 2007 and 
2010, Schiller et al. 2011), also called the integrin “adhesome”. Out of them more than 40 proteins were 
shown to bind directly to β integrin cytoplasmic tails (Legate et al. 2009). Interestingly much fewer 
proteins interact directly with the tails of α-subunits. Since not all of these proteins bind simultaneously 
there is a spatiotemporal control of assembly/disassembly of the molecular composition of the FA 
adhesome (Legate et al. 2009). Integrin activation results in downstream signaling events that can be 
divided into three temporal stages The first effects of integrin activation is the up-regulation of lipid 
kinase activity that then increases the concentrations of PtdIns-4,5-P2 and PtdIns-3,4,5-P3 as well as the 
induction of rapid phosphorylation of specific protein substrates. Among them are the important kinases 
FAK and src. Their phosphorylation leads to FAK/src activation and several minutes after the first stage 
to phosphorylation of more FA proteins like paxillin and activation of signaling pathways like Ras/MAPK. 
Also Rho family GTPases and other actin regulatory proteins are activated, resulting in the 
reorganization of the actin cytoskeleton. The last stage represents the long-term consequences of 
integrin outside-in signaling, like proliferation and survival as well as alterations in cell morphology.  
Actin binding and regulation via Integrins 
The link of integrins to the actin cytoskeleton is one of the key functions of the adhesome proteins. 
Integrins are unable to bind directly to actin but proteins of the adhesome serve as a mechanical link 
between actin and the ECM and also regulate actin remodeling. According to Legate et al. 2009 they can 
be roughly divided into 4 classes: 
1) integrin-bound proteins that directly bind actin, such as talin, α-actinin, and filamin; 
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2) integrin-bound proteins that indirectly associate with the cytoskeleton or in its regulation such as 
kindlin, integrin-linked kinase (ILK), paxillin, and FAK;  
3) non-integrin-bound actin binding proteins, like vinculin;  
4) adaptor and signaling molecules that regulate the interactions of the proteins from the groups 
mentioned above. 
The first linkage to the cytoskeleton after integrin-ligand-binding is the recruitment of talin to the NPxY 
motiv of β-integrin tails. A 2-pN slip bond is established, providing the initial force from the cytoskeleton 
to the ECM (Jiang et al. 2003). As a next step, vinculin is recruited to nascent adhesions, which is binding 
to several sites in the talin rod domain. Interestingly these binding sites are normally not exposed and 
probably mechanical stretch is required for binding. Along with this finding, expression of the THD in 
talin null cells, which is not able to bind vinculin, activates integrins but fails to form detectable focal 
contacts (Zhang et al. 2008a). This suggests that talin is required for the initial contact, but vinculin, 
which can bind to both actin and talin is critical for maintaining and strengthening this connection. α-
actinin is a protein, able to bind to vinculin, as well as talin and even to β-integrin itself. It was shown, 
that α-actinin incorporation into FAs is increasing in a force-dependent manner (Laukaitis et al 2001) and 
matching to this theory α-actinin has been shown to have an essential role in adhesion strengthening in 
vivo: In mammals, which express four isoforms of α-actinin, α-actinin2 and α-actinin3 can cross-link actin 
filaments in the region of Z discs in striated muscles where they regulate force coupling of muscle fibers 
(MacArthur et al. 2007). α-actinin 4 was shown to be essential for kidney function by strengthening the 
adhesion of podocytes to the glomerular basement membrane (Kos et al. 2004). Another FA protein, 
being able to bind to the tail of β-integrin is the adaptor protein ILK. Through binding to its main binding 
partner parvin, ILK is also acting as a link between ECM and actin. This link is additionally working via ILK 
binding to paxillin, which is also an actin binding protein. Since the main focus of the second publication 
is on parvin and the IPP complex, these proteins will be presented in more detail in an own paragraph. 
Actin dynamics and Rho / Rac signaling  
The attachment of integrins to F-actin not only critical for the force dependent formation of FA, it is also 
needed for the precise control of cell protrusion and retraction during cell migration, cell shape 
regulation, wound healing or cell contraction. Although actin dynamics are highly dependent on Rho-
GTPase signaling, which will be further discussed below, there are many actin binding proteins (ABP), 
which regulate actin assembly and disassembly during cell migration. The lamellopodium forms at the 
leading edge of cells, a dendritic actin network in a thin membrane leaflet. There, nascent adhesions are 
formed between integrins and the ECM and membrane protrusions are formed by the polymerization of 
actin. This assembly of new actin fibers requires the polymerization of G-actin into F-actin. As short 
dimeric or trimeric actin intermediates are very unstable, this process is highly dependent on the 
presence of actin nucleators. 
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Figure 4: Link between actin polymerization and integrins:  
 
The activated Arp2/3 complex binds directly to vinculin, an adhesion molecule, recruited to integrins by interaction 
with talin. Binding of the Arp2/3 complex to vinculin localizes polymerization to new sites of integrin adhesion. 
(modified from DeMali et al., 2003) 
 
The heptameric actin-related protein 2/3 (Arp2/3) complex is one of the best characterized actin 
nucleators. This complex promotes the branching of new actin filaments out of existing ones and thus 
forms the branched actin network in lamellopodia. However, the isolated Arp2/3 complex has no 
endogenous actin nucleating activity and must be activated by the Wiskott-Aldrich Syndrome protein 
(WASP) family (WASP, N-WASP, WAVE, and WASH proteins) of activator proteins. WASP binding leads to 
a conformational change in Arp2/3 that allows Arp2/3 to form a template for actin filament elongation. 
Arp2/3 is recruited to nascent integrin adhesions through interactions with FAK as well as vinculin to 
promote actin polymerization directly at the site of adhesion. This generates the protrusive force for the 
lamellopodium (Fig. 4). In the lamellum, the area directly behind the lamellopodium, actin is organized 
into parallel bundles to establish directional persistence of cell motility. Here actin assembly is mediated 
by the diaphanous-related formin (DRF) protein family, including mDia or Ena/Vasp. These proteins 
prevent the binding of ABP named “capping proteins”, which bind to the “barbed ends” of actin and 
thus inhibit further polymerization(Zigmond et al. 2004). 
Rho GTPases (Rho family of small (~21kDa) GTPases) are key regulators of the actin cytoskeleton and its 
dynamics. They control the processes listed above in a spatiotemporal manner. The Rho family is a 
subfamily of the Ras (Rat sarcoma) protein family and in mammals consists of 20 signaling proteins. They 
cycle between an active GTP-bound state and an inactive GDP-bound state and they hydrolyze GTP to 
GDP (Fig. 5).  
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Figure 5: The Rho-GTPase activation cycle.  
 
This model depicts  how Rho-GTPases are regulated. Rho-GDP dissociation inhibitors (Rho-GDIs) sequester inactive 
GDP-bound Rho-GTPases (Rho) in the cytoplasm. After being released Rho-GTPases are targeted to the plasma 
membrane. Their activation is regulated by GEFs that promote GTP loading, whileinactivation of Rho-GTPases is 
mediated by GAPs that promote GTP hydrolysis to GDP. (taken from Huveneers et al., 2009) 
 
This cycling is regulated by three sets of proteins, guanine nucleotide exchange factors (GEFs), GTPase-
activating proteins (GAPs), and guanine nucleotide dissociation inhibitors (GDIs). GEFs exchange GDP for 
GTP and thus are required for the activation of Rho GTPases. In contrast, GAPs inactivate Rho GTPases 
by enhancing their intrinsically inefficient GTPase activity. While in humans a large number of GEFs and 
GAPs are known (over 70 GEFs and around 80 GAPs), only 3 GDIs are identified. GDIs inhibit the guanine 
nucleotide exchange and retain Rho GTPases in an inactive state in the cytosol. After dissociation from 
the inhibitory GDIs, Rho GTPases can relocate to plasma membranes. The best characterized Rho 
GTPases for the regulation of actin dynamics at FAs are Rac, Cdc42, and RhoA. (Fig. 6). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Downstream effector targets of Rho family of GTP ases. (taken from Spiering et al. 2011) 
 
Rac - regulator of lamellopodium formation 
Because of their similarity in sequence, RAC1, RAC2, RAC3 and the more distinctly related RhoG form a 
subfamily within the Rho GTPases. Rac proteins stimulate lamellopodium formation at the leading edge 
of cells, which was proven experimentally by inhibition of Rac1 or in Rac1 null epiblasts (Ridley et al. 
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2001). Both approaches led to severe migration defects. The effect of constitutively active Rac1 is not 
consistent in all cell lines. In macrophages overexpression of constitutively active Rac1 resulted in 
polarization defects due to lamellopodium formation all around the cell and therefore impaired 
migration (Allen et al. 1998). In Boyden chamber assays a positive or a negative effect of constitutively 
active Rac1 on the transmigration rate of cells was observed (Banyard et al. 1999, Leng et al. 1999) . 
Rac1, the best studied member of this family is ubiquitously expressed, while Rac2 expression restricted 
to hematopoietic cells and Rac3 is mostly found in brain. RhoG also stimulates lamellopodium 
formation, probably by activating RacGEFs, which activate Rac (Heasman et al. 2009). It was shown that 
integrin activation and clustering lead to membrane recruitment of Rac as well as recruitment of several 
GEFs via signaling modules such as the FAK–p130Cas–CrkII–DOCK180 (Cary et al. 1998, Kiyokawa et al. 
1998) pathway, or the paxillin–GIT–PIX pathway (Nayal et al. 2006). The critical importance of integrin-
Rac signaling could be demonstrated by knockout studies of either of these proteins in Schwann cells. β1 
integrin-deficient Schwann cells display decreased Rac1 activity and are deficient in the extension of 
lamellopodia. This defect can be partly rescued by expressing constitutively active Rac (Nodari et al. 
2007). In the opposite experiment, deletion of Rac1 in Schwann cells, or treating these cells with Rac 
inhibitor, results in loss of lamellopodia in vitro (Benninger et al. 2007). Rac proteins can regulate actin 
polymerization at lamella in different ways: first, they are able to activate actin nucleating proteins, 
including the ARP2/3 complex (through Scar/WAVE proteins) and formins like mDia. Second, Rac 
proteins can remove the barbed end capping proteins of actin. Third, Rac-mediated activation of the 
Ser/Thr kinase PAK (p21-activated kinase) phosphorylates LIM (Lin11, Isl1, Mec3) kinase (LIMK). The 
actin depolymerizing protein cofilin is one target of this kinase and the phosphorylation and thereby 
inactivation of cofilin is resulting in decreased depolymerization of F-actin (Heasman et al. 2009). Cofilin 
severs actin filaments, leading to an increase in uncapped barbed ends, thus creating new sites for actin 
polymerization and filament elongation (Ghosh et al. 2004). 
 
Cdc42: regulator of cell polarity and filopodia formation 
Cdc42 has a conserved role in regulating cell polarity in many eukaryotic organisms and was first 
discovered in Saccharomyces cerevisiae, where loss of Cdc42 results in budding deficiencies (Etienne-
Manneville et al. 2004). The constitutive deletion of Cdc42 in mice results in early embryonic lethality 
before E7.5 (Chen et al. 2000), but deletion studies in mammalian cell lines have demonstrated a critical 
role for Cdc42 in the regulation of cell polarity and filopodia formation, like in embryonic stem cells and 
neurons (Chen et al. 2000, Garvalov et al. 2007). Cdc42 regulates cell polarity by activating Arp2/3 
through N-WASP or WASP, which establishes sites for lamellopodium formation and by orienting the 
microtubule-organizing center and Golgi apparatus in front of the nucleus where the leading edge is 
forming or maintained (Jaffe et al. 2005). This regulation process CDC42 seems to function via two 
distinct pathways: first, through PAR6 (polarity-protein-partitioning-defective-6) and thus with PAR3 
and/or aPKC (atypical protein kinase C). This complex has been suggested to mediate organization of 
microtubules at the front of the cell and to orientate the Golgi and MTOC (microtubule organizing 
centre) during the establishment of cell polarity (Etienne-Manneville et al. 2003). Second, Cdc42 
functions through its target, myotonic-dystrophy-kinase-related Cdc42-binding kinase, to move the 
nucleus behind the MTOC (Gomes et al. 2005). Additionally, Cdc42 can activate PAK1, like it was shown 
for Rac (Edwards et al. 1999). Activation of PAK1 leads in turn to the activation of LIMK and thereby 
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inactivation of cofilin. Although both proteins, Rac1 and Cdc42 activate similar downstream pathways to 
regulate the actin cytoskeleton, they are associated with distinct actin-containing structures. Rac1 is 
connected to lamellopodia formation, as it was discussed above, and Cdc42 is thought to be the main 
mediator of the parallel linear actin filaments constituting filopodia. Filopodia are thin cytoplasmic 
projections that extend beyond the leading edge of lamellopodia in migrating cells. In many cell types, 
both constitutively active Cdc42 and dominant negative Cdc42 affect the formation of filopodia (Gupton 
et al. 2007). In mouse embryonic fibroblasts (MEF) deletion of Cdc42 results in the total absence of 
filopodia while a CDC42GAPnull mouse with increased Cdc42 activity has a strong increase in filopodia 
formation (Yang et al. 2006). Different cellular processes have been described that require filopodia 
formation, including the establishment of the neural circuitry during development and the formation of 
“adhesion zippers” between endothelial cells that lead to the tight linkage between single cells (Gupton 
et al. 2007).  
 
RhoA: regulator of cell contractility 
Rho activity in migrating cells is associated with FA assembly and cell contractility and is responsible for 
cell body contraction and rear end retraction. RhoA GTPase promotes cell contractility through two key 
effector pathways: the Rho kinase (ROCK), which promotes contractility by increasing phosphorylation 
of the regulatory light chain of myosin II (MLC2), and DRFs, which regulate actin bundling and 
microtubule stability. A recent study discovered that calpain cleavage of β3 integrin at Tyr759 serves as 
a molecular switch that changes the outcome of the integrin outside-in signals from mediating cell 
spreading to promoting cell retraction. This switch from cell spreading to retraction is mediated by 
calpain cleavage of the c-Src binding site at the integrin C-terminus. This relieves the c-Src–dependent 
inhibition of RhoA, and facilitates integrin-mediated, RhoA-dependent contractile signaling (Flevaris et 
al. 2007). It is not yet clear, if also other integrin β subunits are able to modulate RhoA activity. There 
are studies demonstrating that integrins αvβ3 and α5β1 differentially regulate RhoA activity after 
binding to FN, which suggests, that there are different ways to modulate RhoA activity (Danen et al. 
2002). If this process is indeed dependent on c-Src binding, it may be explained with the high ability of 
β3 tail to bind c-Src, which has not been demonstrated for β1 tails (Arias-Salgado et al. 2005). 
ROCK is one of the best characterized Rho effectors, which exists in two isoforms: ROCK1 (also known as 
ROKβ or p160ROCK) and ROCK2 (also called ROKα), which are both ubiquitously expressed with 
redundant functions and are both able to bind to RhoA in a GTP-dependent manner (Nakagawa et al. 
1996). Since ROCK is a main candidate for regulating contractility and actin reorganization in vascular 
smooth muscle cells (vSMC), it is often associated to vascular disorders like hypertension, 
atherosclerosis and stroke. The major regulatory mechanism of cell contraction in smooth muscle and 
non-muscle cells is not regulated via troponin and tropomyosin but through 
phosphorylation/dephosphorylation of myosin light chain (MLC). The myosin superfamily consists of 
more than 25 members. Myosin II is one subfamily which includes skeletal, cardiac, smooth muscle 
myosin and nonmuslce myosin II and is the only known myosin so far, able to form filaments. Myosin II 
is a hexameric molecule that can reversibly bind to actin and is composed of a myosin heavy chain 
(MHC) dimer that also form the actin binding head domains and α-helical coiled-coils at the tail, as well 
as two pairs of MLC. Actin filaments have a plus end (“barbed end”) and a minus end (“pointed end”) 
and like most other myosins, myosin II moves towards the barbed ends of actin. In mammals there are 
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three different MHC known: A, B and C, that lead to the formation of myosin IIA, IIB and IIC (De La Cruz 
et al. 2004, Krendel et al. 2005). Interestingly myosin IIA and IIB strongly differ in their duty ratio, which 
is the proportion of the ATPase cycle that a motor spends strongly attached to its track. While myosin IIB 
is a high duty ratio motor, that is necessary for continuous movement and most likely the maintenance 
of cortical tension, myosin IIA is a low duty ratio motor, more suited for rapid contractile movements. 
The MLCs are non-covalently bound to the MHC and are required for stabilization and regulation of 
myosin II (Conti et al. 2008). MLC2 can be phosphorylated by the Ca2+-calmodulin–activated MLC kinase 
(MLCK) specifically at Ser19, which induces the separation of the head domains of myosin II that possess 
an ATP-binding site as well as an actin-binding site (Walsh 2011). Cell contraction is performed via the 
“sliding filament” mode of action. Contraction is induced by bipolar myosin II filaments that force two 
actin filaments of opposing polarity to slide towards each other and thereby shortening the fiber. At the 
rear of a migrating cell, myosin II is localized to stress fibers (Saitoh et al. 2001) and contraction 
promotes movement of the cell body and facilitates detachment of the cell rear. Dephosphorylation is 
mediated only by the Ca2-independent MLC phosphatase (MLCP) (Murthy 2006). MLCP is a heterotrimer 
composed of a catalytic subunit of type 1 phosphatase δ isoform and two regulatory subunits: a 
target/regulatory subunit (myosin phosphatase target subunit 1; MYPT1) containing 7 ankyrin repeats 
followed by a PP1c-binding motif and a smaller regulatory subunit (M20) (Ito et al. 2004). It was shown, 
that RhoA/ROCK can modulate the phosphorylation state of MLC2 in two independent ways: by 
phosphorylation of the regulatory subunit of MLCP (MYPT1), which attenuates binding to pMLC2 and 
therefore stabilization of pMLC levels, or by directly phosphorylating MLC2 (Kimura 1996). ROCK not 
only controls MLC phosphorylation, but it also activates LIMK by phosphorylation at Thr508 (Ohashi et 
al. 2000). LIMK can in turn phosphorylate cofilin at Ser3, which inactivates cofilin and thereby promotes 
stress fiber stability (Jaffe et al. 2005). RhoA can also directly bind to the formin mDia1 which leads to 
the exposition of an FH2 domain on mDia that then binds to the barbed end of actin filaments and 
additionally prevents binding of other capping proteins (Zigmond et al. 2004). The affinity of the FH2 
domain for G-actin is low but formin-induced filaments turn over fast, suggesting that other proteins are 
required for actin polymerization. One of these co-factors is the actin binder profilin, which can bind to 
the FH1 domain of mDia.The fact that G-actin-profilin complex is present at higher concentrations than 
G-actin alone makes it very likely the primary substrate for nucleation. 
 
ILK – PINCH – Parvin, the IPP complex 
As described above the cytoplasmatic tail of integrins has no intrinsic enzymatic activity and signaling is 
dependent on the recruitment of intracellular adaptor, linker and signaling proteins. A ternary protein 
complex consisting of ILK, PINCH and parvin is one key component of this integrin-mediated signaling, at 
least for β1 and β3 and will here be discussed in more detail (Fig. 7). 
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Figure 7: The IPP complex and its binding partners.  
The scheme depicts the protein structure of the IPP complex members ILK, PINCH and parvin as well as some of its 
binding partners. (modified from Legate 2006) 
The composition and assembly of the IPP complex 
ILK was the first of the three IPP components that was identified. In 1996 ILK was found as a binding 
partner for β1 integrin tails in a yeast two hybrid (Y2H) screen (Hannigan et al. 1996). Subsequently, ILK 
binding to β3 integrin was shown (Yamaji et al. 2002). The ubiquitously expressed protein is composed 
of five N-terminal ankyrin (ANK) repeats and a C-terminal kinase-like domain. Additionally, ILK has a 
central PH domain, which may bind phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3). The ANK 
repeats of ILK mediate the interaction between ILK and PINCH, a family of LIM domain only containing 
proteins, while the kinase-like domain is serving as binding site for parvin and thus linking ILK to the 
cytoskeletion. ILK has been mostly shown to function as adaptor protein, but there were studies 
demonstrating a catalytic activity of ILK. The initial study that identified ILK showed that bacterially 
expressed recombinant ILK possesses kinase activity and phosphorylates serine and threonine residues 
in the cytoplasmic tail of β1 integrin (Hannigan et al. 1996). Since then, more and more substrates for 
ILK, found by in vitro experiments, were published. Among them were the kinase Akt, a regulater of key 
functions like survival and differentiation of cells and MLC (Legate et al. 2006), which upon 
phosphorylation is mediating cell contraction. The first evidence, that ILK may have no kinase activity 
came from in vivo studies in C. elegans and D. melanogaster. The kinase dead ILK mutants used in their 
assays could fully rescue the severe phenotypes of ILK deletion in both species (Zervas et al. 2001, 
Mackinnon et al. 2002). They suggested that ILK might be an adaptor and scaffolding protein rather than 
a kinase. While in later years more and more studies demonstrated an important role for ILK in actin 
organization, the final evidence for ILK being a kinase was still lacking. Interestingly even opposite 
functions of ILK were published. The vSMC specific ILK deletion is resulting in hyperphosphorylation of 
MLC2 rather than decreased phosphorylation, suggesting that ILK may not act as a kinase for MLC in vivo 
(Kogata et al. 2009). The analysis of knock-in mice with ILK point mutations, which were reported to 
affect kinase activity, was a breakthrough in this discussion. Mice with mutations in the PH domain 
(R211A) or in the autophosphorylation site (S343A or S343D) are normal and do not show changes in Akt 
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or Gsk-3b phosphorylation and actin organization downstream of integrins (Lange et al. 2009). When the 
potential ATP-binding site (K220A/M) was destroyed mice died shortly after birth from kidney agenesis. 
But this phenotype is not the result of an impaired kinase activity, since no changes in phospho-levels of 
reported ILK substrates could be detected. Finally, in 2009 also the crystal structure of ILK bound to α-
parvin was solved (Fukuda et al. 2009). The structure revealed a distinct pseudo-active site in ILK thus, 
defining it as a pseudokinase. A more detailed analysis demonstrated that this kinase-like domain is 
necessary to recognize α-parvin and for targeting of IPP to FAs. 
PINCH1 (particularly interesting new cysteine-histidine-rich protein) also known as LIMS1 was originally 
identified in 1994 as a marker for senescent erythrocytes (Rearden 1994). As a binding partner to ILK it 
was found in a Y2H screen, using ILK as bait (Tu 1999). PINCH1 is a widely expressed FA protein 
consisting of five LIM domains, of which the second zinc finger of the most N-terminal LIM domain 
(LIM1) is binding to the N-terminal ANK domain of ILK. Beside PINCH1 a second highly homologous 
isoform (92% sequence identity in mice) was identified in vertebrates only and named PINCH2 (Braun et 
al. 2003). Like PINCH1 also PINCH2 is localizing to FAs. Interestingly both proteins have mostly 
overlapping expression patterns in different cells and tissues, but only in the adult organism. During 
embryogenesis, only PINCH1 was detectable until E14.5. Expression of PINCH2 starts shortly after 
midgestation and is then only partially overlapping with PINCH1 expression. PINCH1 for example is 
expressed exclusively in spleen and thymus as well as megakaryocytes during fetal liver hematopoiesis.   
Parvin was the last identified member of the IPP complex. It was identified in 2000 in a screen for 
paxillin leucine-rich sequence domain (LD1) binding proteins (Nikolopoulos 2000). It was initially named 
actopaxin, because of its ability to bind both, actin and paxillin. In 2001 Olski et al. detected a new 
member of the α-actinin superfamily, while searching for new proteins containing an actin binding 
domain (ABD) and named it α-parvin While lower organisms like C.elegans and D.melanogaster only 
have one parvin-like protein, in vertebrates three different isoforms were identified: α-parvin and the 
paralogues β- (also known as affixin) and γ-parvin. Like other members of the α-actinin superfamily, α-
parvin contains at its C-terminus two in tandem arranged calponin homology (CH) domains. Based on 
the low sequence similarity to CH-domains of other ABD-containing proteins the parvins built up their 
own family among the α-actinin superfamily. In α-parvin and β-parvin, but not in γ-parvin, two putative 
N-terminal nuclear localization signals (NLSs) as well as three potential SH3-binding sites (Src homology 
3) were identified. Also in 2001 Tu et al. found a new calponin homology (CH) domain-containing ILK 
binding protein that is widely expressed and highly conserved among different organisms and named it 
therefore CH-ILKBP. It was further shown that this protein forms a ternary complex consisting of ILK-
PINCH and CH-ILKBP. The binding to ILK is mediated via the second of the two CH-domains of CH-ILKBP. 
Interestingly, while all three parvin isoforms share a high sequence homology, they display a distinct 
expression pattern with α-parvin being ubiquitously expressed, β-parvin expression is enriched in heart 
and skeletal muscle, and γ-Parvin expression is restricted to the haematopoietic system (Korenbaum et 
al. 2001). 
 
The ILK-PINCH-parvin (IPP) complex is formed prior to cell adhesion, suggesting that IPP complex 
formation is happening in the cytoplasm and is then recruited to FAs (Zhang et al. 2002b). The stability 
and also recruitment to FAs of the IPP complex is critically dependent on the presence of all three 
members of the complex (Fukuda et al. 2003b). If one IPP member is missing, the remaining two 
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proteins are to a large extend degraded by the proteasome, which makes deletion studies and assigning 
specific functions to distinct IPP members challenging. But since that degradation is not complete, it may 
be that there are IPP complex independent functions for ILK, PINCH and parvin. Many cell types express 
both isoforms of PINCH as well as both, α- and β-parvin. It was shown that binding of PINCH and parvin 
isoforms to ILK is mutually exclusive (Fukuda et al, 2003; Montanez et al, 2009), allowing cells to form 
distinct IPP complexes that could compensate for each other. It could be shown that the loss of β-parvin 
in vSMC could be fully compensated by α-parvin, while compensation by β-parvin in α-parvin null vSMC 
is not fully working. When α-parvin is deleted from these cells, an upregulation of β-parvin was observed 
that could compensate protein levels and FA targeting of ILK and PINCH but was unable to functionally 
rescue the loss of α-parvin (Montanez et al. 2009). Comparable results were obtained for PINCH1 and 2. 
Fukuda et al. 2003 showed that depletion of PINCH2 can be fully rescued by PINCH1 overexpression in 
HeLa cells. On the other hand PINCH2 is not rescuing PINCH1 functions, although protein levels of ILK 
and parvin were stabilized. A different result was obtained for cardiomyocytes, where a cardiac 
phenotype only arises after deletion of PINCH1 and 2, while the single knockout in both cases showed 
no overt phenotype in vivo and in vitro (Liang et al. 2005 and 2009.  
ILK binding partners 
ILK was first identified as a binding partner for β1 integrin, but over the years, a large number of 
proteins has been shown to bind to ILK apart from parvins and PINCHs (all reviewed in Wickström et al. 
2009). Interestingly the evidence of ILK binding directly to the β1 integrin tail is still missing and it is 
more likely that this interaction is indirectly mediated by kindlins (Montanez et al. 2008, Chen et al. 
2008). Since there is no additional ILK isoform all direct ILK binding partners in theory all direct ILK 
partners could be detected at all IPP complexes, regardless of which subset of parvins and PINCHs are 
present. But it is more likely that protein binding to ILK is requiring a certain isoform of parvin and PINCH 
or even simultaneously binding by both proteins, if there are binding sites for more than one IPP 
complex component. Paxillin for example, can bind directly to ILK, but also simultaneously to α- and γ-
parvin but not to β-parvin (Nikolopoulos et al. 2000 and 2001, Yoshimi et al. 2006). Direct ILK binding 
partners, either shown by Y2H experiments, interaction of recombinant proteins or co-crystallization 
studies, include β1 and β3 integrins, PINCH and parvin, paxillin, thymosin β4, ELMO-2, EphA1, kAE1 
(kidney anion exchanger), the serine/threonine phosphatase ILKAP (ILK-associated phosphatase), PKB 
(protein kinase B)/Akt, Rictor, Src, the muscle LIM protein (MLP/CRP3) and IQGAP (Wickström et al. 
2010). A SILAC-based approach in 2008 revealed further possible binding partners of ILK including RuvB-
like 1 and α-tubulin (Dobreva et al. 2008). In 2002 it was additionally shown by immunofluorescence in 
C.elegans that UNC-112 (Kindlin2) localization to pat3 (β-integrin) requires the presence of pat4 / ILK 
(Mackinnon et al. 2002). In a Y2H experiment full-length UNC-112 and pat4 strongly interact with each 
other and further studies with deleted constructs mapped the binding site the kinase-like domain of 
pat4 / ILK. Moreover ILK localization to FAs failed in mammalian cells in the absence of kindlin2. Further 
immunoprecipitation assays with fibroblast lysates showed that Kindlin-2 interacts with ILK (Montanez 
et al. 2008).  
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PINCH binding partners 
Although PINCH is an essential part of the IPP complex and its binding to ILK facilitates the localization of 
IPP to the FAs, not many direct PINCH binding partners are known so far. Interestingly all binding 
partners have only been verified for PINCH1 and no specific interactors for PINCH2 have been identified 
yet.. Besides binding to ILK with the first LIM domain, PINCH1 is also able to bind to Nck-2, a Src 
homology (SH) adaptor protein (Tu et al. 1998). The PINCH–Nck-2 interactions are mediated through the 
4th LIM domain of PINCH and the third SH3 domain of Nck-2. Point mutations of LIM4 residues in the 
SH3-binding interface disrupted the PINCH-Nck-2 interaction leading to impaired localization of PINCH to 
FAs (Velyvis et al., 2003). Nck-2 can bind to IRS-1, to growth factor receptors such as PDGFRβ (platelet 
derived growth factor receptor β) and EGF-receptors, as well as PAK, WASP and DOCK180. This suggests 
that Nck-2 functions as an adaptor protein that serves as a connection between growth factor receptor-
signaling pathways and integrin-signaling pathways. The in vivo relevance for this binding was not shown 
so far. PINCH1 but not PINCH2 can bind to the Ras-suppressor protein RSU1 through the LIM5 domain, 
which might explain why PINCH2 is unable to rescue PINCH1 deletion (Kadrmas et al. 2004, Dougherty et 
al. 2005). RSU1 functions as a negative regulator of JNK (Jun N-terminal kinase) activation, inhibits Rho 
(ROCK) kinase activity and can alter the actin cytoskeleton organization. Additional binding partners of 
PINCH are the G-actin binding and sequestering protein thymosin-β4 that binds to LIM4 andLIM5 of 
PINCH1 and is able to simultaniously bind ILK (Bock-Marquette et al. 2004). The formation of a complex 
between ILK / PINCH1 and thymosin-β4 promotes myocyte survival and motiliy. Another binding partner 
is the phosphatase PP1α, whose binding depends on the KFVEF-motif in the LIM5-domain of PINCH1 
(Eke et al. 2010). Binding of PP1α to PINCH1 inhibits PP1α in dephosphorylation of Akt and thereby 
PINCH1 acts as a survival factor for cells. This explains why PINCH1 was found to be overexpressed in 
human tumors and was contributing to radiation cell survival in vitro and in vivo. Since most of the 
studies mentioned focused only on PINCH1 it was not determined if these binding partners, apart from 
RSU1 are also capable of binding PINCH2.  
Parvin binding partners 
The structure of parvin is characterized by two in tandem arranged CH-domains, which serve as ABD 
also in a variety of other actin binding proteins like α-actinin, filamin and smoothelin. α-parvin binds 
directly to F-actin through this domain (Olski et al. 2001), but also via the interaction with paxillin. If β- 
and γ-parvin also directly interact with F-actin has not been shown yet, but indirectly through their 
interaction with the actin binding protein α-actinin (Yamaji et al., 2004, Yoshimi et al., 2006), to which α-
parvin does not bind (Nikolopoulos et al. 2002). Therefore one of parvins most important functions is 
the linkage of the actin cytoskeleton to FAs and integrins. α-parvin can additionally bind the paxillin-
homologue Hic-5 highly expressed in SMC. Hic-5 has many binding partners similar to paxillin but they 
have a distinct role and distribution in cells. Paxillin regulates cell morphology through Rac1 signaling, 
while Hic-5 is acting through RhoA signaling (Deakin et al. 2012). For β-parvin an interaction with the 
GEF αPIX and βPIX (Matsuda et al. 2008) could be shown. While overexpression of β-parvin resulted in 
high Rac1 levels, this could be counterbalanced by expressing mutant versions of αPIX or βPIX lacking 
the GEF-activity. This suggests a role for β-parvin in Rac1 mediated signaling. Furthermore, α-parvin was 
recently shown to also interact with αPIX in vitro (Pignatelli et al 2012) Other binding partners are 
CdGAP, a Cdc42- and Rac-specific GAP that concentrates at the ends of actin stress fibers (LaLonde et al. 
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2006), and TESK1 (testicular protein kinase 1), a Ser/Thr kinase closely related to LIMK that 
phosphorylates and activates the actin-regulating protein cofilin (LaLonde et al. 2005). The interaction 
between α-parvin and TESK1 is negatively regulating TESK1 kinase activity. Normally in cells spreading 
on FN, this interaction is strongly reduced but cells, expressing a shortend α-parvin construct where α-
parvin / TESK1 interaction is not reduced upon binding, display a spreading defect. 
 
In vivo functions of the IPP complex 
To understand the in vivo function of the IPP complex and the specific role of each protein and its 
isoforms, several deletion studies have been performed in C. elegans, D. melanogaster and mice. In 
general all of these studies confirm a critical role for IPP as an adaptor between actin and the ECM as 
well as in actin remodelling. However, as not all deletions result in the same phenotype each IPP 
member also has distinct functions.  
Invertebrates represent a relative simple model to study these functions, because of their low number 
of integrin subunits and single isoforms of ILK, PINCH and parvin. In C. elegans deletion of pat-4 (ILK), 
unc-97 (PINCH), or pat-6 (parvin), as well as βpat-3, the only β-integrin, result in a PAT (paralyzed and 
arrested elongation at twofold) phenotype (Mackinnon et al. 2002, Norman et al. 2007, Lin et al. 2003). 
This broad class of lethal mutations affects muscle formation caused by cell attachment defects. Similar 
observations were made in D. melanogaster, where deletions of βPS, the orthologue of β1 integrin, or 
the orthologues of ILK and PINCH result in abnormal muscle attachments. In βPS null flies, the link 
between cell and ECM is impaired, whereas loss of ILK or PINCH leads to the detachment of actin 
filaments from the plasma-membrane (Zervas et al. 2001, Clark et al. 2003). Interestingly, only the 
deletion of βPS and PINCH, not of ILK, results in dorsal-closure defects (Brown et al. 1994, Kadrmas et al. 
2004), hinting at an additional cell migration defect and a specific role for βPS and PINCH in this process. 
In mice genetic ablations of β1 integrin, ILK, PINCH1 or α-parvin result in embryonic lethality at different 
stages (Fässler et al. 1995, Sakai et al. 2003, Li et al. 2005, Montanez et al. 2008). In contrast, mice 
deficient of PINCH2, or β- and/ or γ-parvin (Montanez et. al. 2008, Chu et al. 2006, Stanchi et al. 2005) 
are without phenotype, most likely due to compensation by PINCH1 or α-parvin. β1 integrin -/-, ILK -/- and 
PINCH -/- embryos arrest their development at the peri-implantation stage, but while β1 integrin–/– and 
ILK–/– embryos die at E5.5–E6.5, PINCH null mice survive one day longer until E6.5–E7.5. Functional 
analysis at this early stage is difficult, but could be overcome by generating embryoid bodies (EB) from 
embryonic stem cells (ES cells), or by creating tissue specific deletions. Studies on EB revealed that β1 
integrin is required for LN1 secretion and formation of a BM (Aumailley et al. 2000). While this process 
was unaffected in ILK- or PINCH1-null EB, their loss led to abnormal epiblast polarity, impaired cavitation 
and detachment of primitive endoderm from the BM and abnormal actin reorganization (Li et al. 2005a, 
Sakai et al. 2003). These defects were worse in ILK mutants, but PINCH1 mutants additionally displayed 
cell-cell adhesion defects and impaired endoderm survival. In contrast to the early lethality described for 
β1 integin, ILK and PINCH1, constitutive α-parvin knockout mice survive until E10.5 to E14.5 (Montanez 
et al. 2008). Here, defects are prevalent to the cardiovascular system and were especially severe for 
vSMC. Additionally, these embryos show kidney agenesis/dysgenesis due to impaired ureteric bud 
invasion into the metanephric mesenchyme (Lange et al. 2009). It could be observed that in α-parvin-
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null cells isolated from these mice β-parvin is upregulated, which suggests a compensatory function of 
β-parvin during development and explains the longer survival of α-parvin-/- animals. Although β-parvin 
can stabilize ILK and PINCH protein levels and FA localization, is not able to fully compensate loss of α-
parvin in vSMC. These cells display a strong hypercontractility, due to elevated RhoA and ROCK levels, 
suggesting that this regulation might be a specific function of α-parvin. Comparable results were 
obtained in the microvasculature of ILK deficient vSMC as shown by Kogota et al. 2009. In contrast Shen 
et al. showed in 2011 a downregulation of contractility markers in the aorta of mice with a conditional 
deletion of ILK in SMC. Conditional deletion of β1 integin in vSMC also results in a severe vascular 
phenotype while no hypercontractility could be detected in these cells (Abraham et al. 2008). Over the 
past years different conditional deletion studies have been performed on IPP and their corresponding 
integrins, like in keratinocytes, endothelial cells, Schwann cells, chondrocytes, etc. A detailed list of 
phenotypes can be found in Wickström et al. 2009. 
 
Extracellular matrix 
The extracellular matrix (ECM), which is surrounding most cells, plays an important role during 
development and tissue homeostasis, but also in disease. The ECM is a heterogeneous meshwork of 
fibrillar and non-fibrillar components and is assembled in complex structures like BMs: it provides 
structural support for organs and tissues, serves as substrate for cell motility, and plays a role in 
signaling to cells through adhesion receptors and growth factor storage and presentation. Thus, ECM 
proteins and structures play vital roles in the determination, differentiation, proliferation, survival, 
polarity and migration of cells (Hynes 2009). A major fraction of the ECM is composed of Col, LN and 
other glycoproteins such as FN, which are secreted by the cells themselves and function as substrates 
for different adhesion molecules including integrins. Not all integrin heterodimers are able to bind to all 
glycoproteins as described above, and different integrin/ECM pairings are able to start distinct signaling 
pathways within the cell. It is therefore easy to understand that changing the ECM environment of a cell, 
for example in an inflamed tissue, also changes cell behavior.   
The following paragraph will shortly introduce the most important ECM components and their function. 
 
Collagens are triple helical proteins that occur in the ECM and at the cell–ECM interface. There are more 
than 30 Cols and Col-related proteins known so far. Cols can be roughly divided into two classes; the 
fibril forming Col (Col I, II, III, V and XI) and the more heterogeneous class of non-fibrillar Col, (Col IV, VIII 
and X). All Col family members are characterized by containing domains with repetitions of the proline-
rich tripeptide Gly-X-Y that is important in the formation of the Col triple-helices. Some Cols are almost 
ubiquitously expressed, while others are found only in distinct tissues. The most abundant and 
widespread family of Col with about 90% of the total Col is represented by the fibril-forming Col. Col I 
contributes to the structural backbone of bone, tendons, skin, ligaments, cornea, and many interstitial 
connective tissues, while Col II and XI contribute to the fibrillar matrix of articular cartilage. Col VI form 
microfilaments found in almost all connective tissues. Col IV has a more flexible triple helix and its 
presence in the BM of glomeruli and arteries is important for their proper function. (Gelse et al. 2003 
and Kadler et al. 2008) 
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LNs are heterotrimers constituted by the association of 3 different gene products, the α, β and γ chains. 
Mammals possess at least 15 LNs formed through the combinations of several α, β, and γ subunits with 
additional variation resulting from mRNA splicing. LNs polymerize into sheet-like supramolecular 
structures which interact with the Col network via entactin/nidogen or perlecan and with receptors on 
the cell surface such as integrins and dystroglycans. LN is a ubiquitous component of BM appearing at a 
very early developmental stage of mouse embryos, even before Col can be detected. They have a critical 
function in organ development as well as in organ homeostasis in adult organisms. (Miner et al. 2004) 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Schematic depiction of the modular structure of FN.  
 
FN consists of three different domains (type I: blue; type II: brown; type III: green). The alternatively spliced 
extradomains B, A, and variable region (V) are shown in ochre. Two sulfide bonds at the C-terminus are necessary 
for dimerization.The dimer forms via two disulfide bonds at the C-terminus. Integrin binding sites and binding 
domains for FN, collagen, fibrin, heparin and bacteria are indicated. (modified from Leiss et al. 2008) 
 
FN is a modular protein, consisting of repetitions of type I, II and III domains. It is secreted as a disulfide-
bonded dimer, and the dimerization seems to be required to assemble FN into a fibrillar matrix (Fig. 8). 
The FN gene can be alternatively spliced which leads to the expression of up to 12 isoforms in mouse, 
which may result in an even larger variety of FN dimers. FN exists in two versions: one form is cellular FN 
(cFN), which contains, depending on the tissue, variable proportions of the alternatively spliced exons 
coding for the extra domains A and B (EDA, EDB). The other form is plasma FN (pFN), which lacks EDA 
and EDB and is synthesized by hepatocytes and released into the circulation where it remains soluble. 
Assembly of FN into insoluble and biologically active fibrils critically depends on the interaction with 
integrins. This is resulting in the unmasking of cryptic FN binding sites, association with other FN 
proteins and finally crosslinking by tissue transglutaminases into a fibrillar matrix. FN fibrils possess 
binding sites for multiple ECM components, which are used to orchestrate the assembly of several other 
ECM proteins like Col and Fibrin. In developing mouse embryos, FN is first expressed in blastocysts and 
in vitro experiments demonstrated a role for FN in mouse embryo attachment and outgrowth (Armant 
et al. 1986). Therefore it has been suggested that FN may promote migration of parietal endoderm and 
trophoblast outgrowth during implantation. Interestingly FN-null mice blastocysts are normal and 
knockout embryos survive until E 8.5 (George et al. 1993). They show a clear quantitative deficit in 
mesoderm and it was suggested, that the lack of FN impairs the migration of mesodermal cells.   
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Vasculature  
In vertebrates distribution of gases, liquids, nutrients and signaling molecules into organs and cells is no 
longer efficient just by diffusion. This important transportation task is performed by the cardiovascular 
system, the first functional organ that forms during embryonic development. It consists of the heart and 
two highly branched, tree-like tubular networks: the blood vessels and the lymphatic vessels, which are 
organized in a hierarchical structure. Both vessels tubes are formed by endothelial cells (EC) and covered 
by mural cells and ECM. Both endothelial networks are essential for homeostasis in the healthy 
organism and their malformation or dysfunction contributes to the pathogenesis of many diseases 
(Carmeliet 2003). Insufficient blood vessel supply can lead to tissue ischaemia in cardiovascular diseases, 
while abnormal or excessive angiogenesis is often found in tumor tissue or inflammatory diseases.  
Development of the vasculature 
During embryonic development, the vasculature forms by two processes: vasculogenesis (de novo 
formation of vessels from endothelial precursors) and angiogenesis (sprouting from new vessels out of 
existing vessels) (Fig. 9). The processes that lead to the formation of a mature vascular network will be 
closer discussed in the next paragraphs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Origin of endothelial cells and assembly of the vasculature.  
 
Vasculogenesis describes the formation of blood islands out of endothelial precursors and the formation of a 
primary capillary plexus. During Angiogenesis this plexus is highly remodeled and new vessels are formed by 
sprouting leading to the hierarchical network of arterioles and arteries (red), capillaries (grey), and venules and 
veins (blue). Vascular smooth-muscle cells (vSMCs) are associated with arteries and veins, whereas capillaries are 
covered by pericytes (yellow). (taken from Adams et al. 2007) 
 
Vasculogenesis 
Vasculogenesis, the de novo formation of blood vessels, occurs at two different locations within the 
embryo: the extraembryonic yolk sac tissue and the intraembryonic tissue. In both cases, endothelial 
cells have to differentiate from endothelial precursor cells (angioblasts) from the mesenchyme. Drake et 
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al. 2003 defines 5 distinct steps necessary in the formation of the first vascular plexus: 1) the formation 
of angioblasts; 2) angioblast aggregation; 3) angioblast elongation into cord-like structures; 4) the 
organization of isolated vascular segments into networks; 5) endothelialization and lumen formation. 
The dorsal aorta, the cardinal vein and the yolk-sac vasculature are generated by this process (Adams et 
al. 2007).   
Angiogenesis  
Angiogenesis describes the remodeling process taking place after the formation of the first primitive 
vascular plexus that finally leads to the hirarchical structuring of major arteries and veins, smaller (pre-
capillary) arterioles and (post-capillary) venules, and a branched network of fine capillaries Therefore 
more ECs are generated to form new vessels by either sprouting out of a preexisting vessel, splitting, or 
by intussusception (Risau, 1997). Hypoxia is an important stimulus for expansion of the vascular bed. In 
the beginning the few cells of the embryo are oxygenated by simple diffusion, but when tissues grow 
beyond the limit of oxygen diffusion, hypoxia triggers vessel growth. This happens through signaling via 
hypoxia-inducible transcription factors (HIFs). HIFs upregulate many pro-angiogenic genes, especially 
VEGF (Pugh et al. 2003). How essential VEGF is for sprouting can be observed in heterozygous VEGF null 
mice, where vessels display a strongly reduced sprouting (Carmeliet et al. 1996). It is important that for 
the sprouting process only some ECs are selected. These ECs are known as tip cells, which lead the 
growing sprout and are characterized by the formation of multiple filopodia that enables the cell to 
sense their environemt and follow attractive cues. To prevent that all ECs become tip cells this process is 
tightly regulated via Notch receptors and their endothelial specific ligand Delta-like-4 (DLL4). DLL4 is 
expressed on endothelial tip cells as a response to VEGFR2 signalling and presented at their cell surface. 
DLL4 will then ligate the Notch receptor expressed by neighbouring cells and induce its activation. 
Ligand binding to Notch facilitates the proteolytic procession of its intracellular domain, subsequent 
translocation to the nucleus and transcriptional regulation of target genes. This induces the 
downregulation of VEGFR2 expression on ECs adjacent to tip cells and abolishes their responsiveness to 
VEGF-A (Mettouchi 2012). Recent publications have demonstrated that integrins and the BM 
component LN play a critical role in the selected expression of DLL4 and Notch signalling. Vascular LNs 
are LN 511 which displays prominent expression in the nascent vascular plexus and LN 411 that shows a 
restricted expression at the vascular front and even stronger in tip cells. These LNs are bound by 
differents subsets of integrins, with LN 411 being bound by α2β1, α3β1 and α6β1, while LN 511 is a 
ligand for α3β1 and α6β1 only. In in vitro experiments only ECs cultured on LN 411 showed increased 
levels of DLL4 expression and studies with LN 111, which can bind to α2β1 and α6β1 integrins as does LN 
411, demonstrate a cooperating mechanism by these two integrins is required for DLL4 upregulation. 
Interestingly this observation was specific for LN 411 and DLL4, since no other endothelial Notch ligand 
showed an integrin dependent regulation and also no other ECM protein like Col I or FN was able to 
regulate DLL4 / Notch- signaling (Estrach et al. 2011, Stenzel et al. 2011). These selected ECs have then 
to flip their apical–basal polarity, dissolve their connection to neighboring cells, induce motile and 
invasive activity, and start to degrade the local matrix (through matrix metalloproteinase (MMP) 2, 3 
and 9 mainly). Tip cells, while migrating, leave a trail of platelet-derived growth factor B (PDGF-B). This 
promotes the following recruitment of pericytes and smooth muscle cells (SMA), which are necessary 
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for later vessel stabilization. The tip cells are followed by other ECs – the stalk cells, which migrate 
behind the leading tip cell and with their high proliferative capacity build up the new vessel lumen. Once 
they encounter their target, like other sprouts or capillaries, tip cells have to change again into a non-
motile resting phenotype and reestablish their strong cell-cell contacts, which prevent leakiness of the 
vessels. In addition the formation of arteriovenous shunts has to be prevented, most likely by repellant 
signaling events (Adams et al. 2007). For proper blood flow, these newly formed vessel structures have 
to establish a lumen. Two different ways of lumen formation have been discussed: cord hollowing and 
cell hollowing. Cell hollowing is based on the observation of large intracellular vacuoles in ECs, which 
would build up a vascular lumen out of each central lumen in a single EC. However it is more likely that 
cord hollowing is the mechanism of lumen formation. In this model the opposing ECs separate from 
each other, they elongate in parallel and flatten and thus form the new vessel lumen (Axnick et al. 
2012). 
 
Vessel maturation  
 
The maturation step is required to transform the immature vascular network, formed by vasculogenesis 
and / or angiogenesis into the steady hirarchical structure found in higher organism. Maturation of the 
wall involves according to Jain et al. 2003 the recruitment of mural cells, development of the 
surrounding matrix and elastic laminae, cell specialization like inter-endothelial junctions, fenestrations, 
apical-basal polarity and expression of specific surface receptors. Also arteries and veins are formed in a 
process that is known as arteriovenous differentiation.  
Mural cells can be subdivided into two different cell types: SMC and pericytes (Fig. 10).  
 
 
 
 
 
 
 
 
 
 
Figure 10: Wall composition of nascent versus mature vessels. 
 
(a) Nascent vessels consist of a tube of ECs. They mature into the specialized structures of capillaries, arteries and 
veins. (b) Capillaries consist of ECs surrounded by a BM and pericytes which are in direct contact to the EC layer. (c) 
Arterioles and venules are more strongly covered by mural cells compared with capillaries. (d) The walls of larger 
vessels consists of three layers: an intima out of EC, a media out of layers of vSMCs, separated by elastic laminae 
and an adventitia of fibroblasts. ECs and vSMC are separated by a BM. VSMCs and elastic laminae contribute to the 
vessel tone and mediate the control of vessel diameter and blood flow. (taken from Jain et al. 2003) 
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Capillaries and immature blood vessels are covered by pericytes, which are embedded in the BM and 
establish direct connections with ECs through cell-cell contacts. Larger vessels are covered by one or 
multiple layers of vSMCs, which are separated from the endothelium by the vascular BM and also have 
an active function in regulating the vascular tone. The origin of these cells is not completely clear and 
seems to be very heterogeneous. Some mural cells are derived from neural crest cells that delaminate 
from the neural tube early in embryogenesis, while others are derived from undifferentiated 
mesenchymal cells or vascular stem cells (Adams et al. 2007). Mural cell recruitment is essentially 
required for vessel stabilization, which enables them to withstand the increasing blood pressure during 
development. Additionally, mural cells also keep ECs in a resting state, since a loss of pericytes leads to 
endothelial hyperplasia, abnormal junctions, and excessive luminal membranefolds (Hellström et al. 
2001). It is thought that this recruitment process is depending on 4 different molecular pathways: 
PDGFB − PDGF receptor β(PDGFRβ); endothelial differentiation sphingolipid G-protein-coupled receptor-
1 (EDG1)); Ang1-Tie2; and transforming growth factor β(TGFβ). 
 
Endothelial tip cells secrete PDGF-BB, while mural cells express the corresponing PDGFRβ. Receptor 
activation is resulting in proliferation and migration of mural cells during vessel maturation. The 
knockout of PDGF-BB and PDGFRβ in mice leads to similar phenotypes and perinatal death caused by 
vascular dysfunction (Levéen et al. 1994, Soriano et al. 1994). The primary cause of the phenotype is the 
lack of pericytes and most likely further endothelial dysfunction due to upregulated VEGF-A levels, 
observed in these mice.  
Sphingosine-1-phosphate (S1P) is a secreted sphingolipid engaged in cell communication through G-
protein coupled receptors named as S1P1 (also called edg1). Mice deficient in S1P1 display mid/ late-
gestational lethality with vascular abnormalities and defective vSMC/pericyte coverage of vessels (Liu et 
al. 2000). Interestingly, although S1P1 is expressed on both – mural cells and ECs – only the EC-specific 
knockout of S1P1 could show the same phenotype than the full knockout (Allende et al. 2003). It was 
suggested that S1P1 signaling through Rac results in the location of N-cadherin to the plasma membrane 
in endothelial cells and thereby strengthening their contact with mural cells. (Armulik et al. 2005)  
Tie-2 is a tyrosine receptor kinase that binds both angiopoietins (Ang-1 and Ang-2). Unlike Ang-2, which 
activates Tie-2 on some cells but blocks Tie-2 on others, Ang-1 consistently activates Tie-2. Genetic 
experiments in mice have shown that binding of Ang-1 (which is expressed by mural cells) to Tie2 
promotes angiogenesis and pericyte association to the endothelium, reduces vascular leakage and has 
anti-inflammatory properties. Ang-2 on the other side can antagonize that signaling. Ang1- or Tie2 
knockout mice die at mid-gestation from cardiovascular failure. Angiogenesis is defective and vessels 
display a badly organized BM as well as reduced mural cell coverage (Armulik et al. 2005). However, 
Ang2 may also promote angiogenesis depending on the tissue and context. 
TGF-β (transforming growth factor β) is a multifunctional cytokine that is critically for de novo formation 
of mural cells by differentiation of mesenchymal cells. The bioavailability of TGF-β is regulated through 
its storage into the ECM, especially FN, anchored by the latent TGFβ-binding protein (LTBP). Knockout 
studies in mice of TGF-β as well as its receptors TGFβ receptor-2 (Tgfbr2) or activin-receptor-like kinase-
1 and -5 (Alk1 and Alk5) and also deletion of the downstream target SMAD5 have demonstrated severe 
vascular defects and embryonic lethality (Adams et al. 2007).   
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Cell – ECM interaction in the vasculature 
Vascular development as well as vessel homeostasis requires correct interactions between different cell 
types (EC-EC and EC-pericyte) and between these cell types and their BM. Interactions of EC and 
pericytes / SMC with their ECM involve various ECM molecules, which differ to some degree among 
vessels, and are dependent on the state of the vessel (quiescent or angiogenic). In quiescent vessels ECs 
and pericytes are adhering to a BM consisting of mostly of LN (mainly laminin-8/ laminin411 and 
laminin-10/ laminin511), Col IV, perlecan, nidogens, Col XVIII and vWFA (Hynes 2007b). Likewise the BM 
of contractile vSMC, which are unlike perycites separated from the EC layer, is mostly containing LN and 
Col IV. This structure changes dramatically in angiogenesis or wound healing, when cells, ECs as well as 
pericytes / SMC have to proliferate and migrate again. FN is one of these ECM proteins predominantly 
found in vessels during development, diseased vessels and tumor vasculature and it is believed that FN 
triggers an active phenotype of ECs and pericytes / SMC. This was further strengthened by knockout 
studies in mice of FN or its receptors which lead to severe vascular defects and reduced somite 
formation during embryonic development (George et al. 1993, Francis et al. 2002). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Integrins involved in angiogenesis. 
(a) A quiescent capillary comprises ECs,pericytes and a shared BM. These cell types express partly overlapping 
integrin profiles. (b) In sprouting angiogenesis a proliferating endothelial stalk with a single guiding migratory tip 
cell at its end is formed. This process requires changes in cell adhesion and therefore changes in the integrin 
profile, including the upregulation of , αvβ3, αvβ5, α1β1, α2β1, α4β1, and α5β1, whose expression appears to be 
upregulated during this process. (taken from Silva et al. 2008) 
 
ECs and pericytes both express a broad range of different integrin receptors (Fig. 11): the FN receptors 
α4β1, α5β1; the Col receptors, α1β1, α2β1; the LN receptors, α3β1, α6β1, and α6β4; and the 
osteopontin receptor, α9β1. ECs additionally express αvβ3 and αvβ5, two VN binding integrins. Pericytes 
and vSMC exclusively express integrin α7β1, which is a LN receptor and α8β1, an osteopontin receptor 
(Silva et al. 2008). αvβ8 on glial cells also regulates brain blood vessel development (Avraamides et. al. 
2008). Most insight into the specific function of the different integrins in vascular development and 
disease has been gained by constitutive or conditional gene deletions in mice. 
FN as one of the key proteins in vessel development is bound by α5β1, αvβ5 and αvβ3 integrin on its 
RGD site, or by integrins α4β1 and α9β1 that bind to the alternatively spliced EDA, EDB and IIICS 
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domains. The β1 integrin subunit builds three of the most important integrins required for angiogenesis: 
α5β1, α4β1 and α9β1. Genetic ablation of β1 results in impaired EC proliferation and defective 
branching of blood vessels in EBs. Similar, only host derived blood vessels are forming in β1-deficient 
teratomas (Bloch et al. 1997). Furthermore, the EC specific deletion of β1 integrin leads to severe 
angiogenic sprouting defects at E9.5 and death of homozygous mice before E10.5 (Tanjore et al. 2008). 
Whereas the large vessels develop normally, branching and sprouting is strongly reduced, resulting in 
hypoxia in the embryos. Absence of β1 integrin on mural cells also results in a lethal phenotype in mice, 
but later than for EC (Abraham et al. 2008). Vessels of these mice were often dilated; the mural cells had 
a severe spreading phenotype and could not support the vasculature sufficiently. Interestingly an almost 
similar phenotype was observed for the mural cell specific loss of α-parvin and ILK, two downstream 
proteins of integrin signaling. Here the defects in spreading and polarity of mural cells was explained by 
overactive RhoA / ROCK signaling and hypercontractility, that could not be seen when β1 integrin was 
deleted (Kogata et al. 2009, Montanez et al. 2009). Instead, the proliferation of mural cells was 
increased along with a loss of differentiation in the absence of β1 integrin. Genetic ablation of α5 
integrin results embryonic lethality at E10 to E11 and showed severe neural tube and mesodermal 
defects in the posterior trunk region (Yang et al. 1993). At E9.5 defects in blood vessel formation and 
leaking of vessels in the embryo and extraembyonic tissue were visible along with a reduced number of 
blood cells within vessels and heart. As a properly assembled FN matrix was detectable it was suggested 
that other FN binding integrins could partly rescue the phenotype and thus explain the longer survival of 
embryos compared to FN null and also β1 integrin null mice. The α4 null embryos show defects in two 
cell-cell adhesion events; allantois-chorion fusion during placental development (death at E11) or 
epicardium-myocardium attachment during cardiac development (death at E13.5 to E14.5) (Yang et al. 
1996). Importantly, α4β1 is not only binding to FN but additionally to VCAM1. α4 integrin is expressed in 
the chorion, whereas VCAM1 is expressed in the allantois, suggesting that the phenotype is a result of 
the lost interaction between these two proteins. This is further supported by the VCAM1 knockout, 
which leads to comparable defects to the α4 knockout (Gurtner et al. 1995). A second study with α4 
knockout mice could demonstrate the exclusive expression of α4β1 integrin on mural cells but not on EC 
(Grazioli et al. 2006). Pericytes on cranial microvessels were severely reduced in number as well as 
mislocalized and their migration speed impaired. Integrin α9β1 can bind to FN but also to a number of 
other ligands. α9β1 null mice die P8 to P12 due to defects in development of the lymphatic system, but 
they do not show any obvious defects in the cardiovascular system (Huang et al. 2000). However it was 
shown that α9β1 binds to VEGF-A and thrombospondin and thus promotes angiogenesis (Avraamides et 
al. 2008). 
The genetic ablation of the two Col binding integrins expressed on ECs α1β1 and α2β1 leads to opposing 
results. Deletion of α1 did not affect embryonic development but tumor angiogenesis is reduced in mice 
lacking α1β1 (Pozzi et al. 2000). In the absence of α2β1, tumor angiogenesis was increased in 
melanomas and in Lewis lung carcinomas (LLC), although only upon PLGF (placental growth factor) 
treatment (Zhang et al. 2008b). This shows that both integrins are dispensable for vascular 
development, they can modulate pathological angiogenesis, but in different directions. 
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α3β1, α6β1, and α6β4 integrin all bind to LN. For α3β1 also thrombospondin is acting as a ligand and is 
able to interact with tetraspanin, CD151, the metalloproteinase inhibitor TIMP2 and the α3-
noncollagenous (α3NC1) domain of Col IV, all of which have been implicated in either promoting or 
inhibiting angiogenesis (Silva et al. 2008). The knockout of α3, although lethal hours after birth due to 
several defects, does not display any signs of vascular malfunctions (Kreidberg et al. 1996). Also the 
ablation of α6, which can dimerize with β1 or β4, is lethal and shows a skin blistering phenotype, but no 
cardiovascular defects are reported. Different in vitro and in vivo studies propose a role for this integrin 
subunit in tumor angiogenesis but with opposing findings (Silva et al. 2008). 
ECs express two different VN binding integrins: αvβ3 and αvβ5 while glial cells express αvβ8. Deletion of 
αv in mice leads to embryonic lethality in most animals around E11.5 due to vascular defects and 
pericardial edema formation. Interestingly around 20% of homozygous mutants survive this stage, but 
then die shortly after birth because of intracranial and intestinal hemorrhages (Bader et al. 1998). In 
mice lacking αv specifically at ECs these bleedings in the brain vasculature could not be detected. In 
contrast specific deletion αv in neuronal cells or total loss β8 displays a similar phenotype to the 
constitutive deletion of αv integrin subunit (McCarty et al. 2005, Zhu et al. 2002). This proposes that the 
observed defect in αv knockout mice was due to the loss of αvβ8 on glial cells not because of lacking 
αvβ3 and αvβ5 on EC. Unlike αv integrin knockout mouse, the β3 and β5 integrin–null mice are viable 
and fertile and their vasculature is without visible defect (Reynolds et al. 2002). While β3 integrin is not 
detectable in quiescent vessels its expression is apparently upregulated on tumor biopsies and therefore 
implicates a role for β3 in tumor angiogenesis (Silva et al. 2008). Its expression on endothelial cells is 
stimulated by angiogenic growth factors such as bFGF, TNFα, and IL-8 (Brooks et al. 1994). Because of 
these findings antibodies blocking αvβ3 like Vitaxin and the RGD-mimetic Cilengitide are used to 
suppress neovascularization and tumor growth. However studies in mice lacking β3 integrins or both β3 
and β5 integrins showed that tumorigenesis is not only supported, but tumor growth was even 
enhanced (Reynolds et al. 2002). Tumors displayed enhanced angiogenesis, strongly suggesting that 
neither β3 nor β5 integrins are essential for neovascularization.  
α7β1 is a LN receptor only expressed on vSMC and not detectable on ECs. While most studies focused 
on the role of α7β1 on skeletal muscle development, the deletion of α7 also results in partial embryonic 
lethality (Flintoff-Dye et al. 2005). Around 70% of the embryos die between E10.5 and E14.5 and 
displayed vascular hemorrhaging and reduced vasculogenesis. In vitro studies have suggested a possible 
crosstalk between α7β1 and PDGF signaling (Chao et al. 2005). VSMC treated with PDGF showed 
increased adhesion to LN, which could be partially abrogated by blocking α7β1.   
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Atherosclerosis  
Atherosclerosis is a progressive inflammatory disease characterized by the accumulation of lipids and 
ECM in the large arteries, especially the aorta. As the disease can result in severe health complications 
like stroke, heart attack and thrombosis it is the major cause of death in the western world.  
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Stages in the development of atherosclerotic lesions.  
(a) The inner layer of the aorta, the tunica intima, is formed by a EC monolayer. The middle layer, the tunica media, 
contains layers of vSMCs separated by elastic laminae. The adventitia, the outer layer of arteries, contains 
fibroblasts, nerve endings and microvessels. (b) The initial steps of atherosclerosis include adhesion and 
transmigration of leukocytes across the injured endothelial monolayer, maturation of monocytes into 
macrophages, and their uptake of lipid that transforms them into foam cells. (c) Lesion progression involves the 
proliferation of vSMC and their migration from the media to the intima along with increased expression of Col that 
leads to the formation of a fibrous cap. Foam cells and vSMCs can die in advancing lesions and form together with 
free lipids the so-called lipid- / necrotic core. (d) Plaque rupture is the result of a thinning fibrous cap and leads to 
thrombus formation. (modified from Libby et al. 2011) 
Atherosclerosis begins with an endothelial injury caused by many different stimuli including diabetes 
mellitus, hypertension, and dyslipidemia (Fig. 12) and weakens the monolayer of EC. This is followed by 
the subendothelial deposition of lipids, especially LDL and VLDL, and the induction of inflammatory 
signaling by EC. This includes the expression of ICAM1 and VCAM1 at the cell surface of ECs and 
promotes the adhesion of monocytes to the EC layer. They subsequently transmigrate to the 
subendothelial space, start to proliferate and differentiate into macrophages. Their scavenger-receptors 
enable them to take up the cell-activating oxidized LDL (oxLDL) and transform into lipid-filled “foam 
cells”. These small lesions, named “fatty streaks” can already be observed during the first decade of life 
(Lusis 2000). They form preferentially at areas with turbulent blood flow in the aorta, found at 
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curvatures and bifurcations. The changes in signaling by ECs as well as signals derived from the 
accumulated immune cells can start a switching in the underlying vSMC layer from a resting and 
contractile phenotype to a proliferative and migrative phenotype. They migrate from the tunica media 
and form a so called fibrous cap out of vSMC and a Col-rich matrix. This cap shields the core region of 
the plaque, which becomes necrotic during progression of atherosclerosis, from the blood stream. In 
most patients, myocardial infarctions occur as a result of erosion or thinning and subsequent rupture of 
the fibrous cap. That often happens at the shoulder regions of the plaque. This event can be the result of 
cell apoptosis in this area or also of elevated MMP expression and matrix degradation by macrophages 
(Gough et al 2005). The consequence of plaque rupture is an immediate platelet activation and 
aggregation due to the contact with cell debris of the necrotic core and a subsequent thrombus 
formation (Lusis 2000, Rudijanto et al. 2007). Over the years on atherosclerosis research most findings 
were derived from patient studies, blood analysis and biopsies but a great breakthrough was the 
development of animal models to study atherosclerosis. These models allowed a new perspective on 
how atherosclerosis develops and that there is more to it, than the accumulation of lipids due to high 
cholesterol levels observed in the patient’s blood. Although mice normally do not develop 
atherosclerosis, there is a large variety of genetically modified mouse models and diets available that 
can induce the disease in mice (Maganto-Garcia et al. 2012). The most commonly used model is the 
ApoE-/- mice which develop lesions resembling all phases of atherosclerosis throughout the arterial tree 
after being fed a high-fat / high-cholesterol containing diet (Nakashima et al. 1994). Unfortunately the 
final stage of atherosclerosis – the rupture of plaques – cannot be studied in this model, but it allows the 
detailed analysis of all preceding stages, especially what modulates the immune response leading to 
leukocyte adhesion to atheroprone areas. It was thereby shown, that VCAM1 is significantly upregulated 
in ApoE-/- mice even before leukocyte recruitment started. Additionally, experiments with hypomorphic 
variants of VCAM1 introduced into ApoE-/- mice show reduced lesion formation. Also deleting other 
proteins mediating leukocyte adhesion like E-selectin and P-selectin appear to play quantitative roles in 
monocyte accumulation based on a 40% to 60% decrease in atherosclerosis in ApoE–deficient mice 
lacking both genes. Similarly, gene deletion of ICAM1 resulted in small but significant reductions in 
monocyte recruitment to atherosclerotic lesions in ApoE–deficient mice. Also the absence of proteins 
required for monocyte transmigration into the vascular wall reduces lesion formation. This was shown 
by the disruption of the MCP-1 (monocyte chemotactic protein 1) or CCR2 genes, which markedly 
reduces the development of atherosclerosis in ApoE−/− mice (Glass et al. 2001, Libby 2002). In vitro 
experiments have demonstrated that upregulation of inflammatory mediators is highly dependent on 
the type of blood flow the ECs experience in the vessel. While high shear force seems to be protective 
against atherosclerosis, turbulent flow results in the activation of NF-κB, c-Jun NH2-terminal kinases 
(JNKs) and p21-activated kinase (PAK) (Funk et al. 2010, Hahn & Schwartz 2008, Hahn et al. 2009, Orr et 
al. 2005, 2007, 2008). These inflammatory mediators induce endothelial permeability, sustain an 
inflammatory state and thereby enforce the consequences of the turbulent blood flow during 
atherogenesis (Hahn et al. 2009, Orr et al. 2005, 2007). Also the composition of the ECM around ECs and 
vSMC modulates initiation and progression of atherosclerosis. It was already shown over 20 years ago, 
that FN expression is higher in atherosclerotic areas, which suggested an involvement of FN in the 
course of atherosclerosis (Glukhova et al. 1989). While binding of fibrillar Col to α2β1 integrin prevents 
pro-inflammatory signals, in vitro experiments found that FN depositions at atheroprone areas leads to a 
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sustained inflammatory response by the EC and thus further stimulating monocyte attraction (Feaver et 
al. 2010). In line with this observation, genetic deletion of the alternatively spliced EDA domain in 
atherosclerosis-prone mice was reported to reduce the number and size of atherosclerotic lesions 
(Babaev et al. 2008). Additionally FN also promotes the synthetic phenotype of vSMC, which is crucial 
for the migration of vSMC through the plaque in order to form the fibrous cap and can act as a 
chemoattractant for vSMC. Interesting results were also obtained for Col in atherosclerosis. The normal 
BM of vSMC consists of LN and Col IV which is important for a contractile phenotype of vSMC. During 
atherogenesis vSMC begin to deposit soluble, non-polymerized Col I and III, elastin and FN. The 
accumulation of collagen is very high and it is estimated that collagens comprise 60% of the protein in 
the plaque. These non-fibrillar forms of Col I promote proliferation and migration (Adiguzel et al.2009). 
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Aim of the thesis 
Adhesion and migration are two key events during vessel development and vessel homeostasis. 
Integrins, as the main receptors for cell adhesion and their binding partners are well known for their 
critical function during this process. Changes in protein content of this adhesion complexes, mostly done 
by knockout studies in mice, often result in embryonic lethality due to severe malformations in 
vasculogenesis or angiogenesis. Inducible knockout strategies demonstrated an equally important role 
for the integrin adhesome in the adult organism, where protein deletions resulted frequently in 
pathological conditions like tumor angiogenesis or other cardiovascular diseases.  
Aim 1 
Fibronectin depositions in these areas of the aorta, where atherosclerotic plaques develop were already 
discovered 20 years ago. They form preferentially at sites of turbulent blood flow like branchings and 
bifurcations. Also in vitro studies demonstrated a critical role for FN in initiating and sustaining the 
inflammatory signaling of the endothelium that leads to leukocyte adhesion. It was not clear however, 
what the source of these FN deposits is. FN is an ECM molecule either secreted and assembled by cells 
into fibrils (cFN) or secreted by hepatocytes in a soluble form into the circulation (pFN). It has been 
shown, that pFN can also be assembled into fibrils after being bound by integrins or after diffusing into 
tissues. Previous studies demonstrated a role for the alternatively spliced EDA and EDB domain of FN in 
formation and progression of atherosclerosis. In some other studies elevated pFN levels were observed 
in patients with atherosclerotic plaques. We therefore wanted to investigate the role of pFN in initiation 
and progression of atherosclerosis in ApoE -/- mice. MxCre mediated deletion of FN was used to 
overcome the problem of early embryonic lethality in FN null mice. Because MxCre also targets 
hematopoietic cells, a second Cre-line (VavCre) was used to distinguish between effects of pFN and 
hematopoietic derived FN in our results. 
Aim 2 
β1 integrin and the members of the IPP complex have been shown to be essential for proper vSMC 
alignment on vessels during vessel maturation. vSMC specific deletion of β1 integrin and ILK lead to 
vessels that are poorly covered by vSMC leading to edemas  and aneurysms. Isolated cells are unable to 
spread, polarize and, in the case of ILK, are hypercontractility due to upregulated RhoA/ROCK signaling. 
The constitutive deletion of α-parvin also results in lethality due to severe cardiovascular defects. vSMC 
remain round and are unable to support the vasculature sufficiently. Consistent with findings in vSMC 
lacking ILK, αpv null vSMC are highly contractile with elevated pMLC2 levels and upregulated active 
RhoA. In a next step we wanted to investigate the specific function of α-parvin in vSMC by performing 
Cre-mediated deletion of αpv in SMC only. This should abolish any possible contributions to the 
phenotype by other αpv deleted cell types in the constitutive knockout model. An cell tape-specific and 
inducible Cre-line were used to investigate the function of α-parvin in late development and in adult 
SMC, where the cells have properly attached to vessels and other SMC containing organs.  
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Short summary of publications 
Publication 1: Plasma fibronectin deficiency impedes atherosclerosis progression and 
fibrous cap formation 
Atherosclerosis is an inflammatory disease of the artery wall that can lead to vascular occlusion 
representing the most common cause of death in the Western world. It is characterized by the 
formation of atherosclerotic plaques which are filled with lipids, leukocytes and ECM and covered by a 
thick layer of vSMC. This cap erodes over time, which then leads to the life threatening condition of 
plaque rupture and subsequent thrombus formation. Plaques do not form randomly in the aorta but 
rather at places of turbulent blood flow like branchings and bifurcations. FN is one of the earliest ECM 
proteins deposited at these atherosclerosis-prone sites, even before leukocyte adhesion is visible. 
Additionally in vitro studies demonstrated enhanced inflammatory signaling of ECs when plated on FN. 
Therefore it was suggested that FN promotes atherosclerotic lesion formation. Until now the source of 
the FN detected at atherosclerosis prone sites was unknown. Here, we report that atherosclerosis-prone 
apolipoprotein E-null mice lacking hepatocyte-derived pFN fed with a pro-atherogenic diet display 
strongly reduced FN depositions at atheroprone sites, which results in significantly smaller and fewer 
atherosclerotic lesions. We show that FN indeed enhances signaling events at the endothelium that 
result in enhanced adhesion of leukocytes and bigger lesions. However, the atherosclerotic lesions from 
pFN-deficient mice displayed an insufficient covering by vSMC. We could show that FN acts as a 
chemoattractant to vSMC in culture, which suggests that FN also promotes vSMC migration towards the 
cap. Thus, our results demonstrate that FN acts in two ways in atherosclerosis. It promotes initiation of 
atherosclerosis by enhancing inflammatory signaling of ECs and leukocyte adhesion. FN also acts as a 
migration stimulus for vSMC and secures fibrous cap formation. Absence of pFN results in smaller and 
fewer plaques but also more vulnerable lesions. 
 
Publication 2: α-Parvin controls contraction and actin organization in smooth muscle 
cells 
α-parvin (αpv) is a focal adhesion (FA) protein that has been shown to be essential for blood vessel 
maturation during mouse development by regulating RhoA/ROCK signaling in vascular smooth muscle 
cells (vSMC). Here we report that a conditional deletion of the αPv gene in SMCs leads to lethality in 
mice around 4 weeks of age. The vasculature of mutant mice displays severe defects in the organization 
of the smooth muscle layer and spreading of single vSMC leading to dilations and aneurysm 
development in the aorta. Vessels are insufficiently covered by vSMCs and elastic fibers are degraded. In 
addition, the mutant mice suffer from intestinal pseudoobstruction and glomerulosclerosis in their 
kidneys. Deleting αpv from adult mice with an inducible knockout strategy leads to the death of 
homozygous mice 4-6 weeks after Cre induction, due to intestinal defects after the loss of αpv in the 
intestinal smooth muscle cell (iSMC) layer. Isolated primary vSMC and iSMC display a hypercontractile 
phenotype and fail to spread and polarize their cytoskeleton. We show that the loss of αpv in vSMC 
leads to higher activation of Myosin II, as well as elevated levels of MMP expression and matrix 
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degradation. Our findings identify αpv as a key component for vessel integrity and a regulator of vSMC 
organization and contractility. 
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 2012 EMBO Molecular MedicineAtherosclerotic lesions are asymmetric focal thickenings of the intima of arteries
that consist of lipids, various cell types and extracellular matrix (ECM). These
lesions lead to vascular occlusion representing the most common cause of death
in the Western world. The main cause of vascular occlusion is rupture of
atheromatous lesions followed by thrombus formation. Fibronectin (FN) is one
of the earliest ECM proteins deposited at atherosclerosis-prone sites and was
suggested to promote atherosclerotic lesion formation. Here, we report that
atherosclerosis-prone apolipoprotein E-null mice lacking hepatocyte-derived
plasma FN (pFN) fed with a pro-atherogenic diet display dramatically reduced
FN depositions at atherosclerosis-prone areas, which results in significantly
smaller and fewer atherosclerotic plaques. However, the atherosclerotic lesions
from pFN-deficient mice lacked vascular smooth muscle cells and failed to
develop a fibrous cap. Thus, our results demonstrate that while FN worsens
the course of atherosclerosis by increasing the atherogenic plaque area, it
promotes the formation of the protective fibrous cap, which in humans prevents
plaques rupture and vascular occlusion.INTRODUCTION
Atherosclerosis is a progressive inflammatory disease of large
arteries characterized by an accumulation of lipids and
extracellular matrix (ECM) proteins in the affected vessel wall
(Lusis, 2000). Atherosclerosis commences with the deposition
of lipoprotein particles into the subendothelial matrix and thenstitute of Biochem-
Ludwig-Maximilians
ersity Hospital, Lund
Ludwig-Maximilians
þ49 89 85782422;
anyrecruitment of monocytes to the luminal surface of the
endothelium. Next, monocytes transmigrate across the endothe-
lial monolayer into the intima, where they proliferate and
differentiate into macrophages that take up the lipoprotein
particles and form foam cells (Woollard & Geissmann, 2010).
Finally, macrophage-derived chemoattractants induce the
migration of vascular smooth muscle cells (vSMC) from the
vessel wall into the lesion, where they secrete ECM proteins
resulting in lesion growth and the formation of the ‘fibrous cap’
that encloses the lipid-rich core (Newby & Zaltsman, 1999). The
rupture of fibrous caps represents an injured vessel surface
and triggers adhesion and activation of platelets, which can
culminate in thrombus formation and eventually myocardial
infarction or stroke (Lusis, 2000). Therefore, the rupture of an
atherosclerotic plaque always represents a life-threatening
event. Plaque rupture depends on many factors including the
composition and vulnerability of plaques (Lusis, 2000).
Vulnerable plaques have thin fibrous caps and contain elevated
numbers of inflammatory cells (Newby, 2007; Newby et al,
2009).EMBO Mol Med 4, 564–576 www.embomolmed.org
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which comprise hypercholesterolemia, hyperglycemia, obesity
and smoking, atherosclerotic lesions develop preferentially at
vessel curvatures, branching points and bifurcations, where the
blood flow is highly turbulent (Hahn & Schwartz, 2009). In vitro
studies suggested that the turbulent blood flow at these
atherosclerotic-prone sites exerts mechanical forces on endothe-
lial cells (EC) leading to the activation of EC integrins, the
secretion and deposition of fibronectin (FN) (Feaver et al, 2010)
and the activation of inflammatorymediators such as NF-kB, the
c-Jun NH2-terminal kinases (JNKs) and p21-activated kinase
(PAK) (Funk et al, 2010; Hahn & Schwartz, 2008; Hahn et al,
2009; Orr et al, 2005, 2007, 2008). These mediators induce
endothelial permeability, sustain an inflammatory state and
thereby enforce the consequences of the turbulent blood flow
during atherogenesis (Hahn et al, 2009; Orr et al, 2005, 2007).
FNs are a family of large ECM proteins that are generated
by alternative splicing from a single gene. FN is found in all
vertebrates where it exists in two different forms; one form is
cellular FN (cFN), which contains, depending on the tissue,
variable proportions of the alternatively spliced exons coding for
the extra domains A and B (EDA, EDB). cFN is synthesized and
secreted by many cells and assembled into an insoluble fibrillar
matrix. The other form is plasma FN (pFN), which lacks EDA
and EDB. pFN is synthesized by hepatocytes and released into
the circulation where it remains soluble (Leiss et al, 2008; White
et al, 2009). Assembly of FN into insoluble and biologically
active fibrils critically depends on the interaction with integrins
resulting in the unmasking of cryptic FN binding sites,
association with other FN proteins and finally crosslinking by
tissue transglutaminases into a fibrillar matrix (Hynes, 2002;
Leiss et al, 2008). Soluble pFN can also be assembled into fibrils,
however, only after it is bound by integrins, e.g. on platelets or
after transfer into tissues (Moretti et al, 2007; Oh et al, 1981).
Studies published more than 20 years ago showed that the
expression of FN is elevated in vessel walls of atherosclerotic
regions and, therefore, suggested a role for FN during the course
of atherosclerosis (Glukhova et al, 1989). Deletion of the FN
gene in mice leads to early embryonic lethality (George et al,
1993), which precludes the analysis of atherosclerosis. How-
ever, a specific ablation of the exon encoding the alternatively
spliced EDA domain in atherosclerosis-prone mice was reported
to reduce the number and size of atherosclerotic lesions,
suggesting that the EDA domain in cFN supports atherogenesis
(Babaev et al, 2008; Tan et al, 2004). In line with this
observation, the expression of FN-EDA is high during athero-
sclerosis (Astrof & Hynes, 2009). A correlation between elevated
pFN levels and increased incidence for atherosclerosis in human
patients has been shown in some studies but also refuted in
others (Orem et al, 2003; Ozcelik et al, 2009; Tzanatos et al,
2009; Vavalle et al, 2007; Zhang et al, 2006).
To elucidate the functions of pFN and monocyte/
macrophage-derived FN in atherosclerosis, we used the Cre
recombinase-loxP sites (Cre-loxP) system to delete the FN
gene in either hepatocytes and/or haematopoietic cells of
atherosclerosis-prone (ApoE)-null mice. While deleting FN in
haematopoietic cells did not affect plaque formation, loss of pFNwww.embomolmed.org EMBO Mol Med 4, 564–576reduced FN deposits in the subendothelial space of athero-
sclerosis-prone regions and diminished the number and size of
atherosclerotic lesions. Importantly, it also blocked the invasion
of vSMCs and the formation of fibrous caps. Thus, pFN plays a
dichotomous role in atherosclerosis: it promotes disease by
supporting initiation and progression of atherosclerotic lesions
but may prevent potential thrombotic events by promoting
fibrous cap formation.RESULTS
FN is deposited at atherosclerosis-prone sites
There are conflicting observations on a correlation of elevated
pFN levels with an increased incidence for atherosclerosis in
human patients (Orem et al, 2003; Ozcelik et al, 2009; Tzanatos
et al, 2009; Vavalle et al, 2007; Zhang et al, 2006). To determine
whether pFN plays a role during the course of the disease, we
manipulated pFN expression in atherosclerosis-prone ApoE/
mice using the Cre-loxP system. ApoE/ mice subjected to a
high-fat diet develop atherosclerotic lesions over the course of
their lifespan (Nakashima et al, 1994). To first test whether FN
accumulates at sites of disturbed flow in our model system, we
induced atherosclerosis in 3-week-old ApoE/mice by feeding
them for 12 weeks with a high-fat diet. Oil Red O staining of
aortas and the vessels branching from the aortic arch (the
innominate, the left common carotid and the left subclavian
arteries) confirmed the formation of large, lipid-rich plaques at
areas of disturbed blood flow in the innominate and subclavian
arteries, and the lesser curvature of the aortic arch (Fig 1A). The
Oil Red O-positive plaques were absent before subjecting
ApoE/ mice to the high-fat diet (Fig 1A). Furthermore, cross-
sections revealed FN depositions in atherosclerosis-prone
regions of aortic arches and innominate arteries, while cross-
sections of regions of the aorta and the carotids protected from
atherosclerosis did not show FN accumulations (Fig 1B).
Mx-Cre-mediated FN gene deletion reduced atherosclerotic
plaque formation in vivo
Since FN depositions are particularly prominent in the
subendothelial space and at the luminal surface of athero-
sclerosis-prone regions (Fig 1B), we hypothesized that soluble
pFN is deposited at these sites and thus might play an important
role in atherosclerosis. To test this hypothesis, we intercrossed
ApoE/mice carrying a loxP-flanked FN gene (ApoE/FNfl/fl)
with mice expressing the Cre recombinase under the control of
the interferon- and polyinosinic-polycytidylic acid (poly-IC)-
inducible Mx promoter (Mx-Cre) to produce ApoE/FNMxCre
mice. Deletion of the FN gene was induced in 2-week-old
ApoE/FNMxCre mice by a single intraperitoneal injection of
poly-IC. Western blot (WB) analysis confirmed loss of pFN
1 week after the poly-IC injection (Fig 2A). Elimination of
pFN was stable for at least 6 months. WB analysis of cell lysates
from ApoE/FNMxCre mice showed loss of FN expression in
haematopoietic cells but neither in ECs nor in vSMCs from the
aorta (Fig 2A and Supporting Information Fig 1A). Together,
these results show thatMx-Cre-mediated deletion of the FN gene 2012 EMBO Molecular Medicine 565
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Figure 1. Fatty streaks and FN depositions at atherosclerosis-prone sites.
A. Whole-mount staining of Oil Red O of an aortic arch from ApoE/ mice
before and after feeding a high fat diet. AA, ascending aorta; BA,
brachiocephalic artery; RSA, right subclavian artery; RCCA, right common
carotid artery; LCCA, left common carotid artery; LSA, left subclavian
artery; DA, descending aorta.
B. Immunostaining of FN of the aortic arch from ApoE/ mice before the
high fat diet. FN stains at the luminal side (arrow heads). Nuclei are
visualized with DAPI. Scale bars represent 75mm.
566was efficient in hepatocytes and haematopoietic cells resulting
in a complete and stable elimination of pFN in ApoE/FNMxCre
mice.
To test whether loss of pFN affects development and/or
progression of atherosclerosis, we subjected ApoE/FNMxCre
and their control (ApoE/FNfl/fl) littermates to high-fat diet and
performed whole-mount staining of longitudinally opened
aortas with Oil Red O to visualize the lipid-rich atherosclerotic
plaques. To avoid possible confounding effects of gender
differences (Goldbourt & Neufeld, 1986), all experiments were
performed with males. After 1 week of high-fat diet, none of the 2012 EMBO Molecular Medicinetest groups displayed signs of atherosclerotic plaque formation.
After 12 weeks of high fat diet, all mice developed athero-
sclerotic lesions with highest incidence at aortic arches and in
the abdominal regions of the aorta (Fig 2B and Supporting
Information Fig 1B). However, ApoE/FNMxCre mice showed
significantly fewer atherosclerotic lesions when compared
to ApoE/FNfl/fl control littermates (Fig 2B–E). Quantitative
analysis of Oil Red O-stained whole mount aortas revealed that
ApoE/FNMxCre aortas displayed a 50% reduction of lesion
areas (Fig 2C), which was due to significantly fewer (Fig 2D)
as well as smaller lesions (Fig 2E). Altogether, these results
indicate that Mx-Cre-mediated deletion of the FN gene protects
against atherosclerosis.
Vav-Cre-mediated FN gene deletion in haematopoietic cells
does not affect atherosclerosis
The Mx-Cre transgene is known to efficiently disrupt floxed
genes in hepatocytes and haematopoietic cells. To determine
whether ablation of the FN gene in haematopoietic cells
including monocytes/macrophages affects the course of athero-
sclerosis, we intercrossed ApoE/FNfl/fl mice with mice
expressing the Cre recombinase under the control of the Vav
promoter (Vav-Cre) to generate ApoE/FNVavCre mice. WB
analysis of cell lysates from ApoE/FNVavCre mice showed loss
of FN expression in haematopoietic cells but neither in
hepatocytes nor in ECs and vSMCs from aorta (Fig 3A and
unpublished observation). Consistent with normal FN gene
activity in hepatocytes, ApoE/FNVavCre mice showed similar
pFN levels as ApoE/FNfl/fl control littermates (Fig 3A and
Supporting Information Fig 1C).
Similar to ApoE/FNfl/fl and ApoE/FNMxCre mice,
ApoE/FNVavCre mice did not develop atherosclerotic lesions
after 1 week of high-fat diet. However, after 12 weeks of a high-
fat diet, ApoE/FNVavCre mice displayed atherosclerotic
plaques at atherosclerosis-prone regions (Fig 3B). The overall
areas covered with lesions as well as the atherosclerotic
plaque sizes and numbers did not differ from those observed in
ApoE/FNfl/fl control littermates (Fig 3C–E). These findings
indicate that FN derived from haematopoietic cells does not
exert a major impact on the development of atherosclerosis.
Loss of pFN reduced FN deposition at atherosclerosis-prone
areas
Lack of pFN significantly reduced the size and number of
atherosclerotic lesions. It has been postulated and confirmed in
this study (Fig 1B) that FN is deposited at atherosclerosis-prone
areas before lesions become visible (Hahn et al, 2009; Orr et al,
2005). To this end, we treated ApoE/FNfl/fl, ApoE/FNVavCre
and ApoE/FNMxCre mice for 1 week with a high-fat diet and
subsequently compared the extent of FN depositions in cross-
sections of the atherosclerosis-prone lesser curvature of aortic
arches.
Neither mouse strain showed evidence of atherosclerotic
plaques after 1 week of high-fat diet. ApoE/FNfl/fl and
ApoE/FNVavCre mice showed continuous FN deposits at
atherosclerosis-prone areas (Fig 4A). In contrast,
ApoE/FNMxCre mice displayed significantly less and oftenEMBO Mol Med 4, 564–576 www.embomolmed.org
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Figure 2. Reduced incidence of atherosclerosis in
ApoE/FNMxCre mice.
A. FN levels in macrophage, EC and vSMC lysates
and plasma from ApoE/FNfl/fl and
ApoE/FNMxCre mice, respectively. Tubulin levels
served as loading control.
B. Whole-mount of longitudinally opened aortas
from ApoE/FNfl/fl and ApoE/FNMxCre mice
stained with Oil Red O after 12 weeks on a high-
fat diet. Scale bar represents 0.5 cm.
C. Quantification of atherosclerotic lesions in aortas
from ApoE/FNfl/fl (n¼26) and ApoE/FNMxCre
(n¼ 18) mice after 12 weeks on a high-fat diet.
Data is presented as a mean of atherosclerotic
plaque area per total aorta area. Values are
mean SD; p¼ 0.000007. n.s.¼ not significant.
D. Quantification of plaque number per aorta. Data
is presented as mean of number of plaques per
aorta from ApoE/FNfl/fl (n¼ 26) and
ApoE/FNMxCre (n¼ 18) mice. Values are
percentage SD; p¼0.03.
E. Quantification of relative size of single lesions.
Values are mean SD; p¼0.024, 0.035, 0.49 and
0.0014. n.s.¼not significant.discontinuous FN staining at the corresponding sites (Fig 4A).
These results indicate that pFN, but not haematopoietic cell-
derived FN, is deposited at atherosclerosis-prone sites prior to
the development of atherosclerotic lesions.
Obesity and hypercholesterolemia are major risk factors for
developing atherosclerosis (Lusis, 2000). Since hepatocytes play
an important role in cholesterol homeostasis and FN is deleted
in these cells, we determined total cholesterol, high-density
lipoprotein (HDL) cholesterol and glucose levels and body
weight in ApoE/FNfl/fl and ApoE/FNMxCre mice treated for
12 weeks with a high-fat diet. We found no differences in either
cholesterol, HDL (Fig 4B) and glucose levels (Fig 4C) or in body
weight (Fig 4D) between ApoE/FNfl/fl and ApoE/FNMxCre
mice. These results exclude an involvement of risk factors in the
differential development of atherosclerosis in ApoE/FNfl/fl
and ApoE/FNMxCre mice.
Expression of inflammatory mediators and recruitment of
monocytes are reduced in ApoE/FNMxCre mice
Integrin-FN interactions are believed to promote monocyte/
macrophage recruitment and to maintain an inflammatorywww.embomolmed.org EMBO Mol Med 4, 564–576milieu at atherosclerosis-prone sites by sustaining shear stress-
induced NF-kB and PAK activation in ECs, which in turn leads to
the expression of downstream genes such as ICAM-1 (Orr et al,
2007) or the activation of signalling molecules such as JNK
(Hahn et al, 2009). To analyze whether pFN modulates NF-kB,
PAK and JNK activity in vivo, we compared the levels of the
phosphorylated NF-kB subunit p65, phospho-PAK, phospho-
JNK and ICAM-1 on cross-sections of the atherosclerosis-prone
lesser curvatures of aortic arches from ApoE/FNfl/fl and
ApoE/FNMxCre mice fed for 1 week with a high-fat diet.
ApoE/FNfl/fl mice had abundant phospho-NF-kB/p65, phos-
pho-PAK throughout ECs, phospho-JNK enriched in nuclei and
ICAM-1 on the luminal surface of the ECs (Fig 5A). In contrast,
ApoE/FNMxCre mice displayed lower levels of phospho-
NF-kBp65, phospho-PAK, phospho-JNK and ICAM-1 in corre-
sponding areas (Fig 5A). Interestingly, atherosclerotic plaques
of ApoE/FNfl/fl and ApoE/FNMxCre mice fed for 10 weeks
with a high-fat diet showed similar expression of all tested
inflammatory markers (Supporting Information Fig 2A). These
results indicate that depositions of pFN facilitate activation of
inflammatory mediators at atherosclerosis-prone sites in vivo. 2012 EMBO Molecular Medicine 567
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Figure 3. Normal incidence of atherosclerosis in
ApoE/FNVavCre mice.
A. FN levels in macrophage, EC and vSMC lysates
and plasma from ApoE/FNfl/fl and
ApoE/FNVavCre mice, respectively. Tubulin
levels served as loading control.
B. Whole-mount of longitudinally opened aortas
from ApoE/FNfl/fl and ApoE/FNVavCre mice
stained with Oil Red O after 12 weeks on a high-
fat diet. Scale bar represents 0.5 cm.
C. Quantification of atherosclerotic lesions in aortas
from ApoE/FNfl/fl (n¼ 9) and ApoE/FNVavCre
(n¼ 9) mice after 12 weeks on a high-fat diet.
Data is presented as a mean of atherosclerotic
plaque area per total aorta area. Values are
mean SD; p¼ 0.96. n.s.¼not significant.
D. Quantification of plaque numbers per aorta. Data
is presented as mean of number of plaques
per aorta from ApoE/FNfl/fl (n¼9) and
ApoE/FNVavCre (n¼ 9) mice. Values are per-
centage SD; p¼ 0.78. n.s.¼ not significant.
E. Quantification of the relative size of single
lesions. Values are mean SD; p¼ 0.27, 0.08,
0.41 and 0.055. n.s.¼ not significant.
568To further confirm these results, we cultured ECs in the presence
and absence of pFN and monitored the expression of ICAM-1 by
WB. In line with our in vivo results, ICAM-1 levels were reduced
in ECs when they were cultured in the absence of pFN (Fig 5B).
Adhesion of monocytes to the endothelium is required for
the initiation of atherosclerosis (Woollard & Geissmann, 2010).
To analyze whether pFN depositions modulate adhesion of
monocytes to ECs, we analyzed leukocyte adhesion on the
endothelium in atherosclerosis-prone regions of the carotid
artery of ApoE/FNfl/fl and ApoE/FNMxCre mice using
intravital microscopy and found that the number of adherent
leukocytes was reduced in ApoE/FNMxCre mice when
compared to ApoE/FNfl/fl control littermates (Fig 5C and
D). Since the number of circulating leukocytes is influencing
their adhesion to the endothelium, we determined their
numbers and found that they were similar in ApoE/FNfl/fl
and ApoE/FNMxCre mice (unpublished observation). The
adhesion of leukocytes to the endothelium is mediated by the
interaction of a4b1 integrins to VCAM-1 (Barringhaus et al,
2004). Immunostaining of cross-sections of aortic arches
with anti-VCAM-1 antibodies and FACS analyses of leukocytes 2012 EMBO Molecular Medicineto quantify a4b1 integrin surface levels revealed normal
levels of both adhesion molecules in ApoE/FNfl/fl and
ApoE/FNMxCre mice fed for 1 week with a high-fat diet
(Supporting Information Fig 2B and 2C).
Next, we measured cell adhesion of Mac-1-positive cells to
monolayers of ECs under static and laminar flow conditions,
both in the presence and absence of pFN. We used bEnd5
endothelioma cells to test adhesion, since they were shown to
promote adhesion of haematopoietic cells equally well as
primary ECs (Steiner et al, 2010). Mac-1-positive cells cultured
in absence of pFN were suspended in pFN-free medium or pFN-
complemented medium (10mg/ml) and then seeded onto a
bEnd5 monolayer. Quantification of adherent cells revealed that
twofold more Mac-1-positive cells adhered to the bEnd5
monolayer when they were cultured in pFN-complemented
medium as compared to pFN-free medium (Fig 5E), indicating
that soluble pFN promotes adhesion of Mac-1-positive cells
to ECs.
During atherosclerosis, low-density lipoprotein (LDL) parti-
cles aggregate and become oxidized in the vascular ECM.
Oxidized LDL will be taken up by macrophages resulting in theEMBO Mol Med 4, 564–576 www.embomolmed.org
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Figure 4. Reduced FN depositions in the aortic arch of ApoE/FNMxCre mice.
A. Immunostaining of FN in the lesser curvature of the aortic arch from ApoE/FNMxCre, ApoE/FNVavCre mice and their respective ApoE/FNfl/fl mice.
Arrowheads point to FN signals at the luminal side of the arch. Nuclei are visualized with DAPI. Scale bar represents 75mm in all images.
B. Fasting cholesterol and HDL cholesterol levels of ApoE/FNfl/fl (n¼ 13) and ApoE/FNMxCre (n¼ 13) mice after 12 weeks on a high-fat diet. Values are
mean SD; p¼0.33. n.s.¼not significant.
C. Fasting glucose levels of ApoE/FNfl/fl (n¼13) and ApoE/FNMxCre (n¼ 13) mice after 12 weeks on a high-fat diet. Values are mean SD; p¼0.15. n.s.¼not
significant.
D. Body weight of ApoE/FNfl/fl (n¼28) and ApoE/FNMxCre (n¼16) mice after 12 weeks on a high fat-diet. Values are mean SD; p¼0.11. n.s.¼not
significant.
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Figure 5. Reduced NF-kB and PAK activation and
macrophage recruitment into atheroprone areas
of ApoE/FNMxCre mice.
A. Immunostaining of phosho-NFkB/p65, phospho-
PAK, phospho-JNK and ICAM-1 in the lesser
curvature of the aortic arch from ApoE/FNfl/fl
and ApoE/FNMxCre mice. Arrowheads point to
immunosignals in ECs.
B. Western blot for ICAM-1 in lysates from ECs
cultured for 36 h in the presence or absence of
pFN.
C. Adhesion of leukocytes and inflammatory
monocytes/neutrophils to carotid arteries of
ApoE/FNfl/fl and ApoE/FNMxCre mice fed with
high-fat diet for 4.5 weeks. Values are mean SD.
D. Representative images of inflammatory mono-
cytes/neutrophils adhering (arrowheads) to the
luminal side of the external carotid artery in
ApoE/FNfl/fl and ApoE/FNMxCre mice.
E. Quantification of adhesion of Mac-1-positive
cells on amonolayer of ECs under static condition
and laminar shear (2.5 dyne/cm2). Values are
mean SD and normalized to adherent cells in
the presence of FN in the culture medium;
p¼ 0.025, 0.023 and 0.029.
570formation of aggregated and oxidized LDL foam cells (Woollard
& Geissmann, 2010). To test whether pFN modulates lipid
accumulation in plaques, we stained cross-sections of athero-
sclerotic plaques from ApoE/FNfl/fl and ApoE/FNMxCre
mice with Oil Red O. Lipids were detected in the core region of
the plaques and a similar lipid accumulation was found in
ApoE/FNfl/fl and ApoE/FNMxCre mice (Fig 6A).
To determine whether FN affects macrophage uptake of
modified LDL, we incubated freshly isolated macrophages from
ApoE/FNfl/fl and ApoE/FNMxCre mice (Supporting Informa-
tion Fig 3) with LDL and acLDL and then stained them with Oil
Red O. The intracellular lipid accumulation was similar in
macrophages from ApoE/FNfl/fl and ApoE/FNMxCre mice
(Fig 6B). Finally, we quantified the acLDL uptake by macro- 2012 EMBO Molecular Medicinephages from ApoE/FNfl/fl and ApoE/FNMxCre mice after
incubating them for 4 and 24 h with acLDL and found that also
the acLDL uptake was normal (Fig 6C). Collectively, these
results indicate that FN is dispensable for foam cell formation.
Atherosclerotic lesions in ApoE/FNMxCre mice lack the
fibrous cap
Advanced atherosclerotic lesions are characterized by a
subendothelial accumulation of vSMCs, which synthesize and
deposit a collagen- and FN-rich matrix into the fibrous cap
(Newby & Zaltsman, 1999). To test whether loss of pFN alters
fibrous cap formation, we immunostained cross-sections of
similarly sized atherosclerotic plaques from ApoE/FNfl/fl and
ApoE/FNMxCre mice for Mac-1 to visualize monocyte/EMBO Mol Med 4, 564–576 www.embomolmed.org
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Figure 6. Normal foam cell formation in
ApoE/FNMxCre mice.
A. Staining atherosclerotic plaques from
ApoE/FNfl/fl and ApoE/FNMxCre mice 12weeks
after a high fat diet with Oil Red O and haema-
toxylin. Scale bar represents 100mm.
B. Staining of macrophages from ApoE/FNfl/fl and
ApoE/FNMxCre mice with Oil Red O and
haematoxylin 24-h after incubating them with
LDL or AcLDL, respectively. Scale bar represents
20mm.
C. Quantification of acLDL uptake by macrophages
from ApoE/FNfl/fl and ApoE/FNMxCre mice.
Values are mean SD; p¼ 0.36 and 0.29.
n.s.¼ not significant.macrophages, Thy-1.2/CD3 to visualize T cells, alpha-smooth
muscle actin (aSMA) to visualize vSMCs and the ECM proteins
FN and collagen type I (Col-I). After 12 weeks of high-fat diet,
atherosclerotic plaques from ApoE/FNfl/fl mice consisted of
macrophage-derived foam cells that were covered at the luminal
side with a FN- and collagen-rich matrix and a continuous layer
of vSMCs (Fig 7A and B and Supporting Information Fig 4A). A
few T cells were detected, mainly at the edges of a few plaques
(Supporting Information Fig 4B). In sharp contrast, athero-
sclerotic plaques from ApoE/FNMxCre mice lacked vSMCs and
a collagen matrix and consisted mainly of macrophage-derived
foam cells (Fig 7 A and B and Supporting Information Fig 4A).
Similarly, atherosclerotic plaques of ApoE/FNMxCre mice fed
for 6 months with a high-fat diet also lacked vSMCs and a
collagen matrix. Distribution and number of T cells were
unaffected in ApoE/FNMxCre mice (Supporting Information
Fig 4B).
To determine whether monocyte/macrophage-derived FN
contributes to vSMCs recruitment and fibrous cap formation, wewww.embomolmed.org EMBO Mol Med 4, 564–576analyzed lesions from ApoE/FNVavCre mice and found that the
cellular composition of their lesions and the FN deposits in their
fibrous caps were similar to ApoE/FNfl/fl control littermates
(Supporting Information Fig 4C). Together, these results
indicate that pFN plays an important role in promoting the
formation of the fibrous cap.
pFN stimulates vSMC migration
Why do vSMCs fail to colonize the fibrous caps in
ApoE/FNMxCre mice? Successful accumulation of vSMCs in
atherosclerotic lesions and subsequent formation of the fibrous
cap depends on a number of factors including vSMC prolifera-
tion and survival rates as well as their ability to migrate into the
lesions (Newby & Zaltsman, 1999). We found no apparent
defects in vSMCs proliferation nor did we observe increased
apoptosis in lesions from ApoE/FNMxCre mice subjected to
high-fat diet. To test whether pFN modulates migration of
vSMCs, we isolated primary vSMCs and performed chemotaxis
assays using transwell motility chambers using pFN as a 2012 EMBO Molecular Medicine 571
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Figure 7. Atherosclerotic lesions from
ApoE/FNMxCre mice lack fibrous caps.
A. Immunostaining of atherosclerotic plaques from
ApoE/FNfl/fl and ApoE/FNMxCre mice after
12 weeks of high fat diet for FN, macrophage
antigen-1 (Mac-1) and aSMA. Arrowheads point
to aSMA immunosignals in the fibrous cap. Nuclei
are visualized with DAPI. Scale bar represents
75mm.
B. Immunostaining of atherosclerotic plaques from
ApoE/FNfl/fl and ApoE/FNMxCre mice after
12 weeks of high fat diet with antibodies against
collagen I and aSMA. White dotted line displays
plaque surface. aSMA stains the luminal side
(arrowheads). Nuclei are visualized with DAPI.
Scale bar represents 75mm.
C. Quantification of vSMC migration against FN in
the lower part of Transwell chambers. Control
medium lacking FN (0) was used to assess
baseline migration.
D. Quantification of vSMCmigration against plasma
from ApoE/FNfl/fl, ApoE/FNMxCre mice with
and without supplementation of FN (12mg/ml).
Values are percentage of migrating cells SD;
p¼ 0.0045 and 0.1. n.s.¼ not significant.
572chemoattractant in the lower part of the chambers. We observed
that pFN increased the migration of vSMCs in a concentration-
dependent manner (Fig 7C). When we added plasma samples
from ApoE/FNfl/fl and ApoE/FNMxCre mice to the lower
part of the migration chamber, we found that plasma from
ApoE/FNfl/fl mice induced twofold higher migration rates
of vSMCs than plasma from ApoE/FNMxCre mice (Fig 7D).
Importantly, the decreased migration rates of vSMCs towards
plasma derived from ApoE/FNMxCre mice could be rescued by
supplementing the plasma with FN (Fig 7D). These results
clearly indicate that pFN is a motility factor for vSMCs.DISCUSSION
FN deposits and atherosclerotic lesions preferentially form at
sites of disturbed blood flow (Hahn & Schwartz, 2009). In vitro
studies with shear-stressed ECs cultured on FN suggest that the
FN deposits enforce and maintain a pro-atherogenic milieu
through integrin binding and signalling (Feaver et al, 2010). It is
not known, however, whether FN serves a similar function 2012 EMBO Molecular Medicinein vivo and whether the FN depositions are derived from the
circulation or from infiltrating monocytes and/or resident ECs.
To address these questions, we generated mice lacking the FN
gene either in hepatocytes and/or haematopoietic cells and
crossed them with atherosclerosis-prone ApoE-null mice and
fed them a high-fat diet. Loss of FN expression in blood cells
modulated neither the development nor progression of athero-
sclerosis in mice. In contrast, loss of pFN abrogated FN
depositions at atherosclerosis-prone sites resulting in the
formation of smaller and fewer atherosclerotic lesions. How-
ever, theywere covered onlywith a thin layer ofmatrix proteins,
which is usually a sign of fragility and increased susceptibility
for ruptures in human atherosclerotic plaques. These findings
suggest a dual function for pFN during atherosclerosis: it
supports plaque initiation by providing an adhesive matrix for
monocytes and at late stages, it protects the lesions by
controlling the formation of the fibrous cap. Thus, targeting
atheroma initiation and growth by modulating FN production
might have the unforeseen consequences of promoting plaque
rupture and arterial occlusions resulting in a significant increase
in vascular morbidity and mortality.EMBO Mol Med 4, 564–576 www.embomolmed.org
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mainly composed of basement membrane (BM) components
including collagen IV and laminins. During pathological
situations such as inflammation, wound healing or athero-
sclerosis transitional matrix proteins such as FN or fibrinogen
are deposited into the subendothelial matrix (Hahn & Schwartz,
2009). In atherosclerosis, FN is deposited at sites of disturbed
flow before fatty streaks are formed (Hahn & Schwartz, 2009;
Hahn et al, 2009; Orr et al, 2005) but the source of the FN
deposits is not known. In vitro studies have shown that
disturbed flow induces the expression and deposition of FN by
ECs (Feaver et al, 2010) suggesting that shear-stressed ECs
deposit FN into the vessel wall. We confirmed these findings
showing that FN is indeed deposited into the subendothelial
space at sites of disturbed blood flow. Since pFN can be
transferred from the plasma into tissues (Moretti et al, 2007; Oh
et al, 1981), we next tested whether pFN contributes to the FN
depositions. To this end, we ablated a conditional FN-null allele
in ApoE-null mice with theMx-Cre transgene (ApoE/FNMxCre)
that deletes efficiently in hepatocytes and haematopoietic cells,
and fed the offspring a high fat diet. The Mx-Cre transgene can
also delete genes at low efficiency in other tissues than liver and
blood cells, which is, however, efficiently compensated by
diffusion of FN from non-deleted neighbouring cells (Sakai et al,
2001). The ApoE/FNMxCre offspring showed very little FN at
atheroprone areas suggesting that pFN represents a major
source for FN depositions at the atherosclerosis-prone areas of
the vasculature. The presence of residual FN in vessel walls
of ApoE/FNMxCre mice indicates that small contributions from
ECs and/or vSMCs may add to the FN depositions at
atherosclerosis-prone areas. Previous reports associating
increased pFN levels with atherosclerosis (Orem et al, 2003)
and ischemic heart disease (Ozcelik et al, 2009; Song et al, 2001;
Taznatos et al, 2009) support a role of pFN as atherosclerosis
promoting factor. On the other hand, however, it has also been
shown that pFN levels were unchanged or even decreased in
cohorts of atherosclerosis patients (Vavalle et al, 2007; Zhang et al,
2006). It is thus possible that other risk factors, which probably
depend on the patient population, are able to either attenuate or
aggravate the effect of pFN on the course of atherosclerosis.
Unfortunately, the nature of these risk factors is not known.
In atherosclerosis, it is believed that binding of fibrillar
collagens to a2b1 prevents pro-inflammatory signals, while FN
sustains a shear-stressed induced inflammatory environment
and therefore is thought to aggravate the course of the disease.
Mechanistically, FN mediates its pro-inflammatory role through
b1-containing integrins, most likely a5b1 (Orr et al, 2006),
which in turn induces phosphorylation of NF-kB through the
activation of the small GTPase Rac1 (Tzima et al, 2002). In
line with these findings we found that ECs of ApoE/FNMxCre
mice contain significantly less of the phosphorylated NF-kB
subunit p65 and less phosphorylated PAK, and develop smaller
plaques than control mice. In line with reduced NF-kB activity
we also observed reduced expression of the downstream
gene ICAM-1 on ECs. Consequently, the adhesion of monocytes
to the endothelium at atherosclerosis-prone regions in
ApoE/FNMxCre mice was also reduced when compared towww.embomolmed.org EMBO Mol Med 4, 564–576control littermates, providing a good explanation for the
reduced recruitment of monocytes to atherosclerosis-prone
sites. Interestingly, we found that the levels of inflammatory
markers in developed lesions of ApoE/FNMxCre mice were
comparable with those of control mice, indicating that pFN is
required for inflammation during plaque initiation, but not
anymore once the plaques have formed. Since the deletion of the
FN gene in monocytes by Vav-Cre did not affect the course of
atherosclerosis, we expected normal monocyte recruitment to
plaques in these mice, although we did not confirm this by
intravital microscopy. In summary, we collected several lines of
evidence suggesting that monocyte recruitment is indeed
impaired in pFN-deficient mice: the expression of ICAM-1 on
ECs was markedly reduced, the adhesion of monocytes to the
endothelium was reduced in pFN-deficient mice, and the
number and size of atherosclerotic plaques was significantly
diminished in ApoE/FNMxCre mice.
The reduced number and size of atherosclerotic plaques in
ApoE/FNMxCre mice corroborate previous observations made
using in vitro systems. In addition, our findings revealed a
previously unknown function for FN in atherosclerosis. Almost all
atherosclerotic lesions in ApoE/FNMxCre mice were devoid of
vSMC, contained reduced levels of collagen I and lacked a fibrous
cap, which points to a role for FN in the reinforcement of
atherosclerotic plaques. Atherosclerotic plaques that are not
stabilized with fibrous caps in humans lead to an increased
likelihood of rupture and subsequent thrombus-mediated vas-
cular occlusion leading to myocardial infarction, stroke and
sudden death (Lusis, 2000). Unfortunately, plaque ruptures with
thrombosis do not occur in mouse models and therefore, the
consequences could not be tested (Glass & Witztum, 2001;
Libby et al, 2011). The formation of a fibrous cap critically
depends on the activation and proliferation of vSMCs in the intima
of the affected vessel and their subsequent migration into the
plaque area where they deposit a collagen-rich matrix. Since we
found normal proliferation and survival rates of vSMCs in
ApoE/FNMxCre mice, we conclude that the vascular FN deposits
represent a trigger for the recruitment of vSMCs. This notion is
supported by our in vitro experiments demonstrating that vSMCs
were less efficient at migrating towards plasma lacking pFN.
These new findings strongly argue against the use of inhibitors
designed to treat atherosclerosis by blocking the function of FN,
such as by using peptides derived from FN. This type of treatment
would inhibit pro-inflammatory signalling and thus reduce the
number and size of atherosclerotic plaques but would also at the
same time destabilize these plaques and increase the danger of
thrombus formation and thrombotic diseases. Furthermore,
reducing pFN levels would also destabilize thrombi and trigger
the shedding of platelet clumps into the circulation (Ni et al, 2003)
resulting in chronic embolism.MATERIALS AND METHODS
Animal procedures
ApoE/ (Jackson Laboratory) and FNfl/fl mice (Sakai et al, 2001) were
intercrossed with Mx-Cre transgenic mice (Kuhn et al, 1995; Schneider 2012 EMBO Molecular Medicine 573
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The paper explained
PROBLEM:
Vascular occlusion of atheromatous arteries is the commonest
cause of death in the western world. The main cause of vascular
occlusions is the rupture of atherosclerotic plaques followed by
thrombus formation. Atherosclerotic plaques are asymmetric
focal thickenings of the artery consisting of lipids, various cell
types and ECM including FN. Expression of FN is elevated in
vessel walls of atherosclerotic regions, however, the source and
functions of FN in atherosclerosis are not clear.
RESULTS:
In our study, we show that atherosclerosis-prone mice lacking
hepatocyte-derived pFN and fed with a pro-atherogenic diet lack
FN deposits and show reduced pro-inflammatory signals at
atherosclerosis-prone areas resulting in significantly smaller and
fewer atherosclerotic plaques. Unexpectedly, the atherosclerotic
lesions were devoid of fibrous caps, which play an important role
for plaque stability and to prevent plaque rupture.
IMPACT:
Our results demonstrate that FN plays a dichotomous role in
atherosclerosis: while FN worsens the course of atherosclerosis
by increasing the atherogenic plaque area, it stabilizes the
plaques with fibrous caps and protects from secondary damage
and vascular occlusion.
574et al, 2003) to produce ApoE/FNMxCre mice, or with Vav-Cre
transgenic mice (Georgiades et al, 2002) to produce ApoE/FNVavCre
mice. Deletion of the floxed FN alleles was induced in 2-week-old mice
by a single intraperitoneal injection of 175mg poly-IC (Sigma).
Atherosclerosis was accelerated by feeding the mice for 12 weeks
with a high fat diet (provided by Altromin, Lage/Lippe, Germany)
containing 21% fat, 0.15% cholesterol but lacking cholate (composi-
tion according to Harlan Teklad TD88137 diet). All experiments with
mice were performed in accordance to German guidelines and
regulations.
Atherosclerotic lesion analysis
Mice were anesthetized with Avertin, hearts were perfused with 15ml
of phosphate-buffered saline (PBS) containing 5mM ethylenediami-
netetracetic acid (EDTA) and then with PBS containing 2% parafor-
maldehyde (PFA), 7.5% sucrose. The adventitia was thoroughly cleaned
under a dissecting microscope, and the aorta was cut open
longitudinally and pinned on to a silicone plate. After 5min
equilibration in 60% isopropanol, aortas were stained with Oil Red
O (Sigma, Germany), plaques were analyzed under the Leica MZ16FA
stereomicroscope, and quantified with Metamorph1 software. The
aortic lesions of each animal are presented as percentage of the total
aortic luminal surface area.
Plasma cholesterol
Total and HDL cholesterol levels in plasma were quantified as
previously described (Dune´r et al, 2011; Fredrikson et al, 2003).
Plasma glucose measurement
Plasma glucose was measured using a commercial kit (Abcam).
Antibodies
The following antibodies were used: biotinylated rat anti-Mac-1
monoclonal antibody (Pharmingen), CD3-PE, Thy-1.2 CD90.2, GM-
130, ICAM-1, PECAM-1 (CD31) (all from Pharmingen), Cy3-coupled
mouse anti-aSMA antibody (Sigma), rabbit anti-FN polyclonal anti-
body (Millipore), rabbit anti-Col-I antibody (Millipore), phospho-NFkB 2012 EMBO Molecular Medicinep65 (Santa Cruz), phospho-PAK1/2 (Cell Signaling), phosphor-JNK (Cell
Signaling). Secondary antibodies were purchased from Jackson
Immuno Research Laboratories, Molecular Probes or Invitrogen.
Histology and immunostaining
Heart and aorta tissues were embedded into a cryo-matrix (Thermo)
and 10 or 12mm sections were prepared using a cryotome. Sections
were blocked with 3% bovine serum albumin (BSA) 0.2% Triton-X in
PBS and incubated with antibodies.
Intravital microscopy
Intravital microscopy of the left carotid artery was performed as
described previously (Drechsler et al, 2010). The left jugular vein was
cannulated with polyethylene tubing (PE50) for the intravenous
administration of anti-Gr1 antibodies (RB6-8C5, 2.5mg/mouse) for
visualizing inflammatory monocytes and neutrophils and rhodamine 6G
to visualize total leukocytes. Intravital microscopy was performed with
an Olympus BX51 microscope equipped with a Hamamatsu 9100-02
EMCCD camera and a 10 saline-immersion objective. For image
acquisition and analysis Olympus cellR software was used.
Isolation of smooth muscle cells
Aortas were dissected, longitudinally opened, washed with PBS, cut
and digested with digestion buffer (2mg/ml collagenase type II and
0.5mg/ml elastase in Dulbecco’s modified Eagle medium (DMEM)) for
30min at 378C. Digestion was terminated with 10% foetal bovine
serum (FBS) in DMEM. Released cells were centrifuged and re-
suspended in DMEM containing 10% FBS, transferred to 6-well dishes
and further expanded for analysis.
Isolation of aortic endothelial cells
Cells were isolated as previously described (Kobayashi et al, 2005).
In vitro foam cell formation assay
Thioglycolate-elicited peritoneal macrophages were plated on 12-well
plates in macrophage serum-free medium (Macrophage-SFM, Invitro-
gen). After 24 h, non-adherent cells were washed off, and macro-EMBO Mol Med 4, 564–576 www.embomolmed.org
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with 50mg/ml native, acetylated human LDL (acLDL) or buffer control
for 24–72h. Cells were stained for 60min with Oil Red O and
counterstained with haematoxylin.
Modified LDL uptake
Thioglycolate-elicited peritoneal macrophages were plated on cover-
slips in macrophage serum-free medium (Invitrogen). After 24 h, non-
adherent cells were washed off and adherent macrophages were
incubated in serum-free medium complemented with 10mg/ml
native, acLDL:Dil for 4 or 24 h. Afterwards cells were washed with
PBS, fixed with 4% PFA and nuclei were stained with 4,6-diamidino-2-
phenylindole (DAPI). Fluorescence was analyzed with ImageJ software.
Five microscopic fields were counted per experiment.
SDS–PAGE and immunoblotting
Plasma samples and cells were incubated in lysis buffer (150mM
NaCl, 50mM Tris pH 7.4, 1mM EDTA, 1% Triton X-100 supplemented
with protease inhibitors (Roche)), homogenized in Laemmli sample
buffer and boiled for 5min. Proteins were resolved by SDS–
polyacrylamide gel electrophoresis (SDS–PAGE) gels and then electro-
phoretically transferred from the gels onto nitrocellulose membranes,
which were subsequently incubation with antibodies. Bound anti-
bodies were detected using enhanced chemiluminescence (Millipore
Corporation, Billerica, USA).
Migration assay
Migration assays were performed in 8mm pore size chamber inserts
(BD Falcon). 4104 vSMCs were seeded into the chambers, which
were then transferred into 24-well plates containing serum-free
medium supplemented with dilutions of pFN or plasma from control
and ApoE/FNMxCre mice, respectively.
After an overnight incubation, the cells in the bottom part of the
chamber were fixed in 4% PFA and stained with 0.2% crystal violet.
Five microscopic fields per chamber were counted. Data are
represented as percentage of reference cell number/field. Three
independent experiments were performed, each of them in triplicate.
Adhesion assays
Adhesion assays of primary peritoneal macrophages to the endothe-
lioma cell line bEnd5 were carried out as follows. bEnd5 cells were
cultured in serum-free medium in 4-well NUNC chamber slides until
confluence, either on 1mg/ml FN or on plastic. Macrophages were
isolated and co-cultured with bEnd5 cells for 6 h, either with
additional FN (10mg/ml) or without in the medium. Cells were
washed with PBS, fixed with 4% PFA and stained for Mac-1. Six
microscopic fields were counted per experiment.
Adhesion assays of primary peritoneal macrophages under flow
conditions were carried out with bEnd5 cells. bEnd5 cells were
cultured in serum-free medium or serum-free medium containing
10mg/ml FN in a m-Slide I 0.4 Luer (Ibidi) over night. Primary
macrophages were isolated and cultured in FN-free medium or
medium containing 10mg/ml FN. Macrophages were perfused at
2.5 dyne/cm2 at 378C over the endothelial monolayer for 10min. Cells
were washed with PBS, fixed with 4% PFA, stained for the Mac-1
antigen and the adherent macrophages were then counted in 10
microscopic fields per experiment.www.embomolmed.org EMBO Mol Med 4, 564–576Statistical analysis
The statistical analysis was performed using the Student’s-t-test. The
values are presented as mean SD.Author contributions
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Supplemental figures 
 
Supplemental figure 1. Reduced incidence of atherosclerosis in ApoE-/-FNMxCre mice 
(A) Quantification of relative FN levels in vSMC lysates from ApoE-/-FNfl/fl and ApoE-/-
FNMxCre mice. Values are percentage + SD; n.s.=not significant. (B) Whole-mount of 
longitudinally opened aortas from ApoE-/-FNfl/fl and ApoE-/-FNMxCre mice stained with Oil red 
O after 12 weeks on a high-fat diet. (C) Quantification of relative FN levels vSMC lysates and 
in plasma from ApoE-/-FNfl/fl and ApoE-/-FNVavCre mice. Values are percentage + SD; n.s.=not 
significant. 
 
Supplemental figure 2. Normal levels of VCAM-1 and α4β1 in ApoE-/-FNMxCre mice 
(A) Immunostaining of phosho-NFκB/p65, phospho-PAK and phospho-JNK in the lesser 
curvature of the aortic arch from ApoE-/-FNfl/fl and ApoE-/-FNMxCre mice fed with high fat diet 
for 10 weeks. (B) Immunostaining of VCAM-1 in the lesser curvature of the aortic arch from 
ApoE-/-FNfl/fl and ApoE-/-FNMxCre mice. Nucleus was visualized with DAPI. (C) Integrin 
surface expression in monocytes from ApoE-/-FNfl/fl (green) and ApoE-/-FNMxCre (blue) mice. 
A background control is shown in red. 
 
Supplemental figure 3. Monocyte/macrophages from ApoE-/-FNMxCre mice 
Immunostaining of freshly isolated peritoneal monocyte/macrophages from control and ApoE-
/-FNMxCre mice for FN, GM-130 and Mac-1. 
 
Supplemental figure 4. Atherosclerotic lesions of ApoE-/-FNMxCre mice lack fibrous caps 
(A) Immunostaining of atherosclerotic plaques of control and ApoE-/-FNMxCre mice 8 weeks 
after a high-fat diet for FN, Mac-1 and αSMA. Arrowheads point to αSMA immunosignals in 
the fibrous cap. Nucleiare visualized with DAPI. (B) Immunostaining of atherosclerotic 
plaques of control and ApoE-/-FNMxCre mice 12 weeks after a high fat diet with Thy-1.2/CD3 
antibodies (white arrowheads). Red dotted line displays plaque surface. Nuclei are visualized 
with DAPI (blue). (C) Immunostaining of atherosclerotic plaques of control and ApoE-/-
FNVavCre mice 12 weeks after a high fat diet with antibodies against FN, Mac-1 and αSMA. 
Arrowheads point to αSMA immunosignals in the fibrous cap. Nuclei are visualized with 
DAPI. Scale bar represents 75µm in all images. 
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ABSTRACT 
α-parvin (αpv) is a focal adhesion (FA) protein that has been shown to be essential for blood vessel 
maturation during mouse development by regulating RhoA/ROCK signaling in vascular smooth muscle 
cells (vSMC). Here we report that a conditional deletion of the αPv gene in SMCs leads to lethality in 
mice around 4 weeks of age. The vasculature of mutant mice displays severe defects in the organization 
of the smooth muscle layer and spreading of single vSMC leading to dilations and aneurysm 
development in the aorta. Vessels are insufficiently covered by vSMCs and elastic fibers are degraded. In 
addition, the mutant mice suffer from intestinal pseudoobstruction and glomerulosclerosis in their 
kidneys. Deleting αpv from adult mice with an inducible knockout strategy leads to the death of 
homozygous mice 4-6 weeks after Cre induction, due to intestinal defects after the loss of αpv in the 
intestinal smooth muscle cell (iSMC) layer. Isolated primary vSMC and iSMC display a hypercontractile 
phenotype and fail to spread and polarize their cytoskeleton. We show that the loss of αpv in vSMC 
leads to higher activation of Myosin II, as well as elevated levels of MMP expression and matrix 
degradation. Our findings identify αpv as a key component for vessel integrity and a regulator of vSMC 
organization and contractility. 
 
 
  
INTRODUCTION 
The contractility of smooth muscle cells is important for maintaining organ function, including the 
regulation of the vascular tone, the motility of the gastrointestinal (GI) tract and the emptying of the 
bladder. Mural cells are one of these highly specialized cells that are associated to vessels, where they 
are of great importance for vascular maturation in development as well as for vessel maintenance in 
adult organism. 
During embryogenesis, the formation of a mature vascular network involves three major steps. During 
vasculogenises the first vascular tubes are built de novo from angioblasts, which differentiate into 
endothelial cells (EC) and form the first primitive vascular plexus. In a second step angiogenesis is 
occurring, which defines the reorganization of this network and involves sprouting of new vessels from 
pre-existing ones (Risau et al. 1997). Vascular maturation as the final step involves the arterio-venous 
determination, the recruitment of mural cells and the development of the surrounding extracellular 
matrix (ECM) and elastic laminae (Jain et al. 2003). Mural cells are mostly derived from the mesenchyme 
(Beck and D’Amore 1997) and can be subdivided into two groups: pericytes (PC) and vascular smooth 
muscle cells (vSMC). PCs cover capillaries, small venules and immature vessels, where they contact the 
EC layer and enclosed by a basement membrane (BM). vSMC are associated with mature and larger 
blood vessels, where concentric layers of vSMC, ECM and elastin fibers are forming around the EC tube 
to resist shear stress and pulsatile flow. Mural cells are essential for blood vessel function, as they 
provide the required stability for the vessels to withstand blood pressure, to control EC proliferation and 
also to control the vascular tone with their ability to contract the vessels (Adams and Alitalo 2007).  
 
PC/vSMCs are attracted to immature vessels by growth factors like PDGF-B (Lindahl et al.1997) and Ang 
1 (Suri et al. 1996) and their migration from the mesenchyme highly dependent on ECM molecules and 
their receptors, the integrins. Integrins are heterodimeric transmembrane receptors, consisting of one α 
and one β subunit. With their extracellular domain, these receptors bind ECM molecules, subsequently 
cluster and form focal adhesions (FA), thereby stabilizing their adhesion to the ECM. With their 
intracellular tail these proteins bind adaptor and signaling proteins, which are important for maintaining 
cell shape (Hynes et al.2002, Legate et al. 2009). It has been shown in several in vitro and in vivo studies, 
that integrin mediated adhesion is crucial for vasculogenesis and vessel maturation. Angiogenesis 
defects and vessel malformations have been observed upon deletion of integrin α4 and α5 and the EC 
specific ablation of integrin β1 (Carlson et al. 2008, Malan et al. 2010, Grazioli et al. 2006, Francis et al. 
2002). Likewise, ablation of extracellular ligands of integrins such as fibronectin (FN) (George et al. 
1993), the laminin (LN) α4 chain (Thyboll et al. 2002) or collagen IV (Col IV) (Pöschl et al. 2004) lead to 
severe vascular phenotypes. Misregulation of ECM composition is associated with phenotypic switching 
of vSMC to a less contractile and more proliferative phenotype (Berk et al. 2001), which is associated 
with vessel abnormalities like aneurysm formation (Cheuk et al. 2004) and atherosclerosis (Owens et al. 
2004). Also other smooth muscle tissues are strongly dependent of integrin signaling. For example, 
laminin α5 seems to be important for the proper development of intestinal musculature (Bolcato-
Bellemin et al. 2003). Various publications also show that integrin-ECM interactions are important for 
the functional properties of mesangial cells (MC) in kidney glomeruli (Pröls et al. 1999). 
The intracellular tail of integrins is short and without enzymatic activity. In order to regulate complex 
actions as adhesion and migration, integrins need to recruit kinases like FAK and Src or adaptor 
molecules like integrin-linked kinase (ILK), which is directly recruited to integrin β1 or β3 tails. ILK has N-
terminal ankyrin repeats through which ILK binds PINCH1 and 2. With the C-terminal kinase-like domain 
ILK can bind to α-, β-, or γ-parvin. ILK, PINCH and parvin forms a protein complex (IPP-complex) that is 
assembled in the cytosol and is recruited to the FA upon assembly (Zhang et al. 2002). Deletion studies 
with each of these proteins have shown that the stability of the IPP complex is critically dependent on 
the presence of all three proteins, as it otherwise results in a proteasomal downregulation of the 
remaining partners (Fukuda et al. 2003). The parvins are a family of adaptor proteins which include an 
actin binding domain (ABD) consisting of two tandemly arranged calponin homology (CH) domains. 
Through this ABD, parvin can link the actin cytoskeleton to FAs and together with additional regulatory 
binding partners like Paxillin, Hic5 and α-actinin regulate cell adhesion, migration and cell survival 
(Legate et al. 2006). The three parvin family members are differently expressed in vertrebrate tissue: α-
parvin/affixin/CH-ILKBP (αpv) is ubiquitously expressed, β-parvin (βpv) is enriched in heart and skeletal 
muscle and the expression of γ-parvin (γpv) is restricted to the hematopoietic system (Chu et al. 2006)].  
The vascular tone, the peristaltic contraction of the intestine and the regulation of ultrafiltration of the 
urine in kidney glomeruli are performed by contracting α-smooth muscle actin (αSMA) filaments, an 
actin isoform which is unique for SMC. This contraction and relaxation of SMCs is regulated by 
phosphorylation of myosin light chain (MLC).This is mainly mediated by the myosin light chain kinase 
(MLCK) and can be reversed by dephosphorylation of MLC, which is achieved by myosin light chain 
phosphatase (MLCP). The RhoA effector ROCK can also directly phosphorylate MLC, but it mainly 
phosphorylates the myosin phosphatase target subunit 1 (MYPT1) and thus prevents the 
dephosphorylation of MLC by dislocating MLCP from MLC (Murthy et al. 2006).While normal 
RhoA/ROCK signaling is crucial for maintaining blood pressure, stabilizing vessels and also intestinal 
peristaltic, misregulation of this signaling in vSMC and other SMC in either direction is often leading to 
pathological conditions like hypertension (Mukai et al. 2001) and gut motility disorders (Rattan et al. 
2010).  
Genetic ablation of β1 integrin and its intracellular binding partner ILK in vSMCs results in late 
embryonic lethality (Abraham et al. 2008, Kogata et al. 2009) with strong vascular phenotypes. In both 
mouse models, vessels were dilated and poorly covered with MCs. Isolated vSMCs displayed spreading 
defects and in the case of ILK depleted vSMC a high RhoA / ROCK activity results in hypercontractility of 
vSMC. It was shown that the constitutive deletion of αpv in mice leads to embryonic lethality due to 
severe cardiovascular defects (Montanez et al. 2009).Homozygous embryos died between E10.5 to 
E14.5 and showed defective vSMC coverage of vessels and heart deformations. While EC were normally 
arranged and showed no abnormalities in culture, vSMC displayed a hypercontractile phenotype, 
increased RhoA /ROCK signaling with higher phosphorylation of MLC2. This suggested a role for αpv in 
vSMC recruitment as a negative regulator of RhoA/ROCK signaling in vSMC. To address the specific role 
of αpv in SMC, we generated αpv fl/fl mice and used tissue-specific (PDGFRβ-Cre) and inducible Cre 
(SMMHC-Cre-ER(T2)) lines to delete apv in SMCs. We show that deletion of αpv at embryonic age 
resulted in lethality of homozygous animals at the age of 4 weeks. Mice had dilated vessels with 
aneurysm formation and defective vSMC coverage. Intestines of these mice showed symptoms of 
intestinal pseudoobstruction and in kidneys defective glomeruli were observed. Tamoxifen induced αpv 
deletion in adult mice led to death 4-6 weeks after induction. Mice developed pseudoobstruction and 
intestinal smooth muscle cell (iSMC) layer showed comparable signs of disorganization as for αpv 
deficient vSMC in vessels. In vitro isolated primary vSMC were hypercontractile, unpolarized and 
displayed elevated levels of pMLC2. Protein levels of ILK and PINCH were markedly reduced. In addition 
we show that αpv deletion in vSMCs resulted in higher expression of MMP9, but not in MMP2 along 
with stronger substrate degradation in in vitro experiments. This indicates that αpv deletion in vSMC 
leads to vessel destabilization in two independent ways: by disturbing vSMC alignement on the vessel 
and by promoting degradation of elastic fibres. 
  
RESULTS 
PDGFRβCre induced loss of αpv results in severe vascular, intestinal and renal defects 
To analyze the specific function of αpv in vSMC we deleted the αPv gene conditionally in vSMC by 
intercrossing αpv fl/fl mice with mice expressing Cre-recombinase under the PDGFRβ promotor 
(PDGFRβCre). PDGFRβCre expressing control mice (αpv fl/+ PDGFRβCre) and knockout (αpv fl/fl 
PDGFRβCre) mice were born with a normal Mendelian ratio (data not shown) and were phenotypically 
normal until postnatal day (P) 21. Strikingly, at P30 αpv fl/fl PDGFRβCre mice became significantly 
smaller and lighter than their αpv fl/+ PDGFRβCre littermates and showed various signs of sickness like 
red skin, cramped posture, diarrhea and a bloated lower abdomen (Fig. 1A, B). First death of mutant 
mice was observed 18 days after birth and only 10% survived until P42 (Fig 1C). Heterozygous αpv fl/+ 
PDGFRβCre mice were vital and fertile. Aortas of αpv fl/fl PDGFRβCre mice displayed abdominal aortic 
aneurysms (AAA), visible already at P1 (Fig. 1D). Although aneurysms gained in diameter over time and 
thrombotic plaques were visible at the common iliac artery, no rupture of the aorta was detected. In 
smaller vessels dilations as well as bleedings were observed (data not shown). Frequently a persistent 
ductus arteriosus could be observed in αpv fl/fl PDGFRβCre mice at P30 (Fig. 1E). Additionally to vascular 
defects, the dissection of the gut of αpv fl/fl PDGFRβCre and αpv fl/+ PDGFRβCre mice revealed an 
extreme dilated food and gas filled caecum and colon after PDGFRβCre induced αpv deletion (Fig 1F), 
which are common symptoms of a paralytic ileus. In this case, symptoms mimic intestinal obstruction 
without physical blockage of the intestine. Interestingly, gross histological examination of kidney 
sections revealed, that PDGFRβCre induced deletion of αpv leads to cyst formation in the collecting 
ducts of the kidney in homozygous mutants (Fig. S1A). 
 
SMC defects in vasculature and intestine of αpv fl/fl PDGFRβCre mice  
To closer examine the vasculature in αpv fl/fl PDGFRβCre mice we performed whole mount 
immunostaining of ear vessels as well as of aorta using antibodies against αSMA and CD31/PECAM to 
visualize endothelial cells. As expected, CD31 staining showed no abnormalities in the EC layer of αpv 
fl/fl PDGFRβCre vessels, but αSMA gave only a punctuate staining and revealed a reduced coverage of 
vessels with vSMC (Fig. 2A). vSMC adherent to the EC layer were round and not stretched around the 
vessel (Fig. 2A middle row). Whole mounts immunostaining of αpv fl/fl PDGFRβCre aortas for αSMA 
showed an equivalent staining pattern for vSMC (Fig. 2A right row). Most vSMC were poorly spread and 
lacked the normal alignment with neighboring cells as observed in αpv fl/+ PDGFRβCre aortas, where 
cells aligned into parallel sheets perpendicular to the blood stream. This inhomogeneous distribution 
and the round cell shape suggest an insufficient support of the vasculature. 
Immunostainings for αpv on aorta sections confirmed the loss of αpv in the vSMC layer of αpv fl/fl 
PDGFRβCre vessels (Fig. 2B). At higher magnification a round morphology of vSMC was detected. 
Interestingly, also HE staining of colon sections showed an unorganized layering of iSMC in the 
muscularis externa of αpv fl/fl PDGFRβCre mice characterized by an insufficient separation of circular 
and longitudinal smooth muscle (Fig. S1B). Immunostaining of these sections for the presence of αpv 
produced a positive signal in the muscularis externa of αpv fl/+ PDGFRβCre mice but not in αpv fl/fl 
PDGFRβCre mice, indicating, that the PDGFRβCre-mediated deletion is also targeting iSMC. 
To analyze the defect in vSMC in vitro we isolated primary vSMC from aorta. Although no differences 
were observed in adhesion of αpv fl/fl PDGFRβCre vSMC to FN-coated dishes (data not shown), these 
cells failed to spread within 4h of plaiting and remained in a round shape compared to the elongated 
αpv fl/+ PDGFRβCre vSMC (Fig. 2C). Immunostaing of primary αpv fl/fl PDGFRβCre vSMC for αpv 
confirmed the absence of αpv protein. αSMA staining revealed a different morphology of the actin 
cytoskeleton, with strong cortical actin fibers and a lack of the characteristic long stress fibers of vSMC 
as seen in αpv fl/+ PDGFRβCre vSMC. In addition, loss of αpv was confirmed by western blot analysis 
(Fig. 2D). Importantly, βpv was neither expressed nor upregulated in vSMC isolated from aorta of αpv 
fl/fl PDGFRβCre mice, and the levels of ILK and PINCH were reduced. Immunostainings of αpv deficient 
vSMC using antibodies against ILK and PINCH1 confirmed the absence of ILK and PINCH1 in FAs (Fig. 2E). 
 
Loss of αpv in the mesangium results in glomerulus breakdown and interstitial fibrosis 
PDGFRβ is strongly expressed on vSMC and therefore commonly used for conditional deletion 
approaches in the SMC layer of vessels. Beside vSMC also MC are highly dependent on PDGF/PDGFRβ 
signaling (Arar et al. 2000). These highly specific αSMA expressing cells are localized in the mesangium of 
kidney glomeruli and regulate the blood flow through the capillaries with their contractile abilities 
(Schlöndorff et al. 1987). A detailed examination of Hematoxilin & Eosin (HE) stained kidney sections 
revealed defective structure of glomeruli in αpv fl/fl PDGFRβCre mice (Fig. S1C). At higher magnification 
areas of hypercellularity as well as acellular areas and ECM accumulation can be seen. Immunostaining 
using antibodies against αpv and αSMA of kidney sections showed absence of αpv from glomeruli of αpv 
fl/fl PDGFRβCre mice in combination with a higher density of αSMA positive cells. αSMA is a widely 
accepted marker for myofibroblast formation in the glomerulus, which is regarded as an indication of 
glomerulosclerosis and nephritis. Further evidence for a decreased function of glomeruli is the secretion 
of protein such as albumin, into the urine of αpv fl/fl PDGFRβCre mice (Fig. S1D). In addition, we show 
areas in the kidney interstitium with high αSMA and colocalizing vimentin expression (Fig. S1E) 
indicating the formation of fibrotic tissue in the collecting ducts as a secondary effect of 
glomerulosclerosis. 
Next, we performed blood sample analysis of αpv fl/fl PDGFRβCre mice and found evidence for acute 
(high levels of neutrophils) and chronic (high monocyte count) inflammation (Fig. S1F). This, together 
with the low red blood cell count and the resulting anemia in αpv fl/fl PDGFRβCre mice (Fig. S1G), is 
indicative for an inflammatory response by the kidney. Taken together we showed that PDGFRβCre 
mediated deletion of αpv is leading to glomerular destabilization resulting in proteinurea, tissue scarring 
and inflammation. 
 
AAA formation in αpv fl/fl PDGFRβCre mice is accompanied by matrix degradation 
We could show that αpv deficiency in vSMC results in the formation of abdomical aortic aneurysms 
(AAA). HE staining of aorta sections displayed dramatic derangements in the structure of the tunica 
media in αpv fl/fl PDGFRβCre aortas compared to αpv fl/+ PDGFRβCre aortas (Fig. S2A). vSMC layers 
were disconnected and gaps suggested areas of cell loss or matrix degradation. In addition, the Verhoeff 
van Gieson (VVG) staining of aorta sections showed a strongly reduced black staining and therefore 
disrupted lamina fibers typical for AAA. Besides an increased vessel wall diameter and a reduced SMC 
density, infiltration of monocytes is a characteristic feature of AAA formation. We therefore immune-
stained aorta sections for the presence of monocytes, using an antibody against Mac-1. While there 
were no Mac-1 positve cells in αpv fl/+ PDGFRβCre sections numerous positive signals, were observed in 
sections of αpv fl/fl PDGFRβCre aortas (Fig. S2B), indicating the presence of monocytes in the vessel wall 
of αpv fl/fl PDGFRβCre mice. Both, monocytes and vSMC are sources of matrix metalloproteinases 
(MMP) that can degrade ECM molecules. To test matrix degradation we performed in situ zymography 
with DQ-Gelatin on fresh aorta cryosections. A positive degradation signal distributed over all cells of 
the tunica media was only obtained in sections from αpv fl/fl PDGFRβCre mice (Fig. S2B). This indicates 
that not only monocytes are a source of MMPs but also αpv-deficient vSMC show high MMP expression. 
In agreement with this finding we also found a slightly stronger degradation signal in αpv fl/fl 
PDGFRβCre vSMC plated on DQ-Gelatin compared to αpv fl/+ PDGFRβCre vSMC (Fig. S2C). Because this 
method does not allow a distinction between the different MMPs that are involved in gelatin 
degradation, we additionally performed gelatin and casein zymography with primary vSMC lysates (Fig. 
S2D). Gelatin as well as casein zymography with vSMC lysates, isolated from αpv fl/fl PDGFRβCre mice 
gave a significantly stronger degradation signal than cells isolated from αpv fl/+ PDGFRβCre mice. A 
prominent band of around 100kDa was detected for MMP9 in gelatin gels and of 57 kDa for MMP12 in 
casein gels. In agreement with these findings we observed an upregulation for MMP9 as well as latent 
MMP1 protein levels in vSMC lysates of αpv fl/fl PDGFRβCre mice (Fig. S2E). Interestingly, MT1-MMP 
levels as well as their target MMP2 were not changed when compared to αpv fl/+ PDGFRβCre vSMC 
lysates. Taken together we show that deletion of αpv in vSMC leads to upregulated MMP expression by 
vSMC, invasion of monocytes and finally results in ECM degradation and AAA formation. 
 
Inducible deletion of αpv results in smooth muscle defects in the GI tract 
It was shown by previous publications (Montanez et al. 2009) and in this study, that αpv is playing a 
critical role in development of a mature vasculature, kidneys and GI tract. The function for αpv in SMC of 
the adult organism is unclear. We therefore intercrossed the αpv fl/fl mice with mice expressing a fusion 
protein of the Cre recombinase with the modified estrogen receptor binding domain (CreERT2) under the 
control of the smooth muscle myosin heavy chain (SMMHC) promoter. Intraperitoneal injection of 
Tamoxifen induced deletion of αpv. Mice, expressing the SMMHC-CreERT2 were phenotypically normal 
until day 30 to 35 after Tamoxifen induction, but then rapidly lost weight, developed a bloated abdomen 
and finally died 32-37 days after induction (Fig. 3A). No changes were observed in αpv fl/fl mice after 
Tamoxifen treatment, excluding Tamoxifen related toxiticity as a reason for lethality. Dissection of the GI 
tract of αpv fl/fl SMMHC-CreERT2 mice revealed an extreme dilation of the small intestine and necrosis, 
suggesting that the loss of αpv in iSMC alters the motility of the GI tract and mice die from starvation 
(Fig. 3B). Whole mount immunostaining of small intestine for αSMA revealed a disorganized SMC layer 
with round iSMCs (Fig. S3A). HE staining of small intestine sections of αpv fl/fl SMMHC-CreERT2 
confirmed the disorganization of the iSMC layer, a closeup revealed mostly round cells (Fig. 3C). 
Immunostainings of these sections confirmed the absence of αpv in the small intestine of αpv fl/fl 
SMMHC-CreERT2 mice after Tamoxifen induction. With immunostaining against Mac-1 we could 
demonstrate the presence of monocytes in the small intestine of αpv fl/fl SMMHC-CreERT2 mice, 
indicative of an inflammatory process taking place in the mutant intestine (Fig. S3B). Comparable to the 
phenotype of the aorta in αpv fl/fl PDGFRβCre mice, also in the intestine of αpv fl/fl SMMHC-CreERT2 
mice a high proteolytic activity could be detected by in situ zymography. Also higher levels of apoptotic 
cells were visible by TUNEL staining compared to αpv fl/fl mice. 
A milder version of the observed intestinal phenotype was also visible in the SMC layer of the stomach 
(Fig. S3C). Although macroscopically no defects could be seen, in HE staining of stomach sections of αpv 
fl/fl SMMHC-CreERT2 mice we observed round and loosely connected SMC in αpv fl/fl mice. 
Interestingly, no abnormalities were visible in the vasculature of αpv fl/fl SMMHC-CreERT2 mice, 
although αpv was absent from vSMC after Tamoxifen induction (data not shown). The vessel diameter of 
the aorta was unchanged and also a closer analysis of HE-stained sections revealed no defects 
comparable to αpv fl/fl PDGFRβCre aortas (Fig. S3D). vSMC were elongated and aligned, the elastic 
fibers were of normal thickness and not interrupted. 
Since the most prominent defect in these mice was found in intestines, we isolated primary iSMC from 
small intestine of αpv fl/fl SMMHC-CreERT2 and αpv fl/fl mice. While αpv fl/fl iSMC had the typical 
stretched and elongated morphology of SMC, cultured iSMC from αpv fl/fl SMMHC-CreERT2 mice 
displayed a round phenotype, similar like in primary vSMC of αpv fl/fl PDGFRβCre mice (Fig. 3D). With 
immunostaining against αpv and αSMA we could confirm the deletion of αpv and an abrerrant 
reorganization of the actin cytoskeleton and the formation of multiple membrane protrusions. Loss of 
αpv was additionally confirmed by western blot analysis of iSMC lysate (Fig. 3E). PINCH1 levels were 
significantly reduced in αpv fl/fl SMMHC-CreERT2 iSMC, while ILK levels remained almost unchanged. 
Taken together we could demonstrate that αpv is of critical importance for the structure and 
functionality of iSMC in adult mice. 
 
αpv deletion leads to hypercontractility in primary vSMC 
 
Deletion of αpv in vSMC was shown to result in a hypercontractile phenotype and elevated RhoA and 
pMLC2 levels (Montanez et al. 2009). Likewise, the vSMC specific ILK-deletion resulted in an increased 
RhoA/ ROCK signaling (Kogata et al. 2009)]. We therefore analyzed the pMLC2 levels and distribution in 
primary vSMC from αpv fl/fl PDGFRβCre mice. Immunostainings against pMLC2 in primary αpv fl/+ 
PDGFRβCre vSMC showed a typical strong colocalization to actin stress fibers, whereas in αpv fl/fl 
PDGFRβCre vSMC pMLC2 localized to thick cortical actin bundles and no colocalization with stress fibers 
could be seen (Fig. 4A). Western blot analysis of pMLC2 protein levels in αpv fl/fl PDGFRβCre vSMC 
lysate showed a strong upregulation of pMLC2 levels compared to αpv fl/+ PDGFRβCre vSMC (Fig. 4B), 
while total MLC2 remained unchanged. This supports earlier findings showing that αpv regulates cell 
contractility in vSMC. Due to the fast dedifferenciation of cultured vSMC, we isolated SMC from the 
ureter (UC) of E14.5 αpv fl/fl animals and performed adenoviral Cre transduction to obtain αpv -/- cells. 
Two morphologically different subclones of αpv -/- cells (361 and 361) were used for further analysis. 
Prior to analyzing contractility we performed immunostainings against αSMA and αpv to characterize 
the phenotype of αpv -/- UC (Fig. S4A upper row). Loss of αpv led in both clones to significantly smaller 
cells and strong cortical actin fibers. αpv -/- 361 UC tend to form colonies, while αpv -/- 369 cells remain 
singular. Along with the loss of αpv, also the localization of ILK and PINCH1 to FAs was lost (Fig. S4A 
lower row). Similarly, Western blot analysis showed a strong decrease of ILK and PINCH1 protein levels 
in the absence of αpv (Fig. S4B). Because of their phenotypic similarity to vSMC, we used immortalized 
UC for further biochemical studies including the analysis of αpv regulated contractility. In αpv fl/fl UC 
immunostainings the pMLC2 signal colocalized to the αSMA signal (Fig. 4C), while in both αpv -/- clones 
pMLC localized stronger to cortical actin bundles. In αpv -/- 361 UC pMLC2 signal orientated towards the 
outer borders of the cell colonies, whereas cell-cell connections remained pMLC2 free. In contrast to 
vSMC, UC did not show an αpv dependent regulation of MLC phosphorylation, since pMLC2 protein 
levels in αpv -/- UC remained unchanged compared to αpv fl/fl UC (Fig. 4D). Another method of 
quantifying pMLC2 intensity is by seeding cells on FN coated micropatterns. As the pattern itself is 
surrounded by PEG, cell spreading is restricted to the FN-coated shape which also reduces the variability 
of pMLC2 signal intensity due to absent size and shape differences between cells. For our assay we used 
umbrella shaped patterns which leads to cell contraction at the two legs of the pattern, while the upper 
part mimics the leading edge of cells and lamellopodia formation. In line with our observation on pMLC2 
protein levels, we could not detect a clear upregulation of pMLC2 intensity in both UC αpv -/- clones 
(Fig. 4E). In αpv -/- 361 UC pMLC2 levels even seemed to be slightly downregulated. This suggests that 
although these cells phenotypically look like primary αpv deleted vSMC, the underlying molecular 
mechanisms leading to cell rounding are different.  
Since the PDGFRβCre induced deletion of αpv is resulting in a destabilization of glomeruli we chose MC 
as a third cellular model for αpv related cell function. Unexpectedly αpv deletion in MC led only to a very 
mild spreading defect (data not shown) and immunostaining on normal 2D culture using antibodies 
against αSMA and pMLC2 showed no differences in cytoskeleton organization or in pMLC2 intensity and 
localization (Fig. S4C). Consistent with our previous findings in vSMC and UC, we could show that protein 
levels of ILK and PINCH1 in αpv -/- MC were significantly downregulated compared to αpv fl/fl MC (Fig. 
S4D). Surprisingly, this loss of the IPP complex was not causing dramatic changes in cell morphology. 
Also more detailed analysis of MC seeded on micropatterns revealed no significant differences in pMLC2 
intensity (Fig. S4E), leading to the conclusion that despite the close relationship with SMC, their 
functionality seems not to be dependent on αpv and defects in glomeruli cannot be explained by 
hypercontractility of MC. 
 
αpv controls cell migration in UC 
 
In the developing embryo, vSMC as well as UC have to migrate from the mesenchyme to their 
destination on vessels or the ureter. We therefore wanted to determine, if this initial migration was 
impaired in the absence of αpv.  To analyze possible migration defects we used an in vitro wound 
healing assay with αpv fl/fl and αpv -/- 361 and αpv -/- 369 UC (Fig. 5A). αpv fl/fl UC closed the wound 
within 24h, while αpv -/- 361 and αpv -/- 369 UC both failed to close the gap properly. Single cell 
tracking revealed two reasons for this observation: speed and directionality of migration. αpv -/- 361 UC 
were strongly impaired in velocity as well as directionality of migration and thus covered only a smaller 
distance during the given time period compared to αpv fl/fl UC.  . αpv -/- 369 UC, although faster in 
migration than αpv fl/fl UC and as a consequence also able to cover a larger distance, had a strong 
decrease in directionality. Therefore they closed the gap more than αpv -/- 361 UC, but even so failed to 
close the cleft completely, as do αpv fl/fl UC. In addition, we also tested the chemotaxis of UC, using FCS 
as attractant in a boyden chamber assay. No strong differences between αpv -/- 369, αpv -/- 361 and 
αpv fl/fl UC were observed (Fig. S5A). Cell migration is a highly regulated process, which involves the 
constant assembly of FAs at the cell front and disassembly at the rear of the cell. It was shown before 
that signaling molecules downstream of integrins, like FAK and ERK are involved in this regulation of 
adhesion formation (Webb et al. 2004). We therefore, analyzed if αpv deletion leads to changes in total 
and phosphorylation levels of FAK, Akt and Erk1/2 in primary vSMC, in UC and MC. No differences in 
phosphorylation of any of these three proteins were detected in primary vSMC lysates from αpv fl/fl 
PDGFRβCre mice (Fig. 5B) and also not in αpv deficient MC (Fig. S5B), consistent with findings in αpv null 
vSMC. In contrast, both αpv -/- UC clones displayed lower pFAK [Y397] levels, while pErk1/2 [T202/ 
Y204] levels were slightly higher(Fig. 5C). The protein level of pAkt [S473] was downregulated only in 
αpv -/- 369 cells. 
Beside migration, also adhesion to the ECM is important for vSMC/PC coverage of vessels. Therefore, we 
tested if αpv deletion is resulting in a defective integrin-mediated adhesion by performing an in vitro 
adhesion assay with different substrates. In line with our in vivo observations on vSMC, αpv -/- 361 and 
αpv -/- 369 UC both display reduced adhesion to LN and especially FN, the two major components of 
vessel BM, compared to αpv fl/fl UC (Fig. 5D). No changes after αpv deletion were detected in adhesion 
to Col I. Interestingly, the αpv -/- 361 UC showed an increased ability over αpv fl/fl UC to adhere to Col 
IV. These changes in adhesion could be due to an altered integrin profile on αpv deleted UC and 
therefore, we tested the surface levels of various integrin subunits by FACS. Surprisingly, we could not 
detect major changes in LN or FN binding integrins (αvβ3 and α5β1) in αpv -/- 361 and αpv -/- 369 UC 
which could explain their reduced adhesion (Fig. 5E) to these substrates. Additionally, also surface levels 
of Col IV binding integrins (α1β1) were normal in αpv -/- 361 UC. This finding suggests that the main 
defects in these cells are probably in intracellular signaling rather than surface expression of integrins. 
 
αpv deletion in MC but not in UC promotes matrix degradation 
 
We could show that absence of αpv in vSMC results in upregulated MMP9 protein expression and as a 
consequence matrix degradation was higher. We wanted to know, if αpv deficient MC also showed 
higher matrix degradation ability, although these cells were not showing any contractility defects in the 
absence of αpv. Interestingly αpv deletion in UC leads to a strong downregulation of MMP9 and MT1-
MMP (Fig. S5C). Consistently also MMP2 protein levels are reduced in αpv -/- 361 and αpv -/- 369 UC. In 
contrast to UC, MC deficient of αpv show upregulated MT1-MMP levels, whereas MMP9 and MMP2 
levels remain unchanged. This tendency was also observed in the DQ-Gelatin degradation assay (Fig. 
S5D). Both, αpv -/- 361 and αpv -/- 369 UC show a strongly decreased ability to cleave Gelatin compared 
to αpv fl/fl UC. No changes were observed for MC in this assay. Overall these findings indicate that αpv 
deficiency is changing cell contractility and matrix degradation in two separate pathways, which are in 
addition cell type specific.  
  
DISCUSSION 
Integrins, their ligands as well as their intracellular binding partners at the FA sites are of critical 
importance for development of heart and vasculature. This was shown by several knockout approaches 
in mice where after deletion of FA proteins severe cardiovascular phenotypes were detected. Our study 
demonstrates a critical role for the FA protein αpv in SMC morphology and function in vivo and in vitro. 
We show that conditional deletion of αpv with PDGFRβCre results in lethality of homozygous mice at 
around 4 weeks of age. In vitro primary vSMC are poorly spread, contracted and show strong matrix 
degrading abilities. Closer analysis of immortalized UC revealed reduced adherence on the two BM 
compontens LN and FN and impaired directional migration in response to αpv deletion. This result 
suggests, although it was not proven experimentally, that intitial vSMC recruitment and attachment to 
the vessel wall is equally impaired. In vivo this leads to reduced coverage of vessels by vSMC and 
insufficient support of the vasculature, a phenotype reminiscent of instable and leaky tumor vasculature 
(Morikawa et al. 2002). Our proposed function for αpv is not exclusive for vSMC, as deletion of αpv 
results in similar defects in many SMC containing organs. iSMC from the intestinal wall also show a 
hypercontractile phenotype and lack the alignment with neighboring cells, which most likely affects 
motility and peristaltic of the intestine and explains the intestinal pseudoobstruction we observed in our 
mouse model. In addition also glomerulus morphology is altered in our αpv deficient mice, which can be 
explained by αpv deleted MC. The critical role for αpv in embryonic and postnatal organ has been shown 
in previous studies. Here we show that αpv has an equally important function for tissue homeostasis in 
an adult organism.  
Vascular maturation describes the process which transforms the unorganized primitive vasculature in 
the early embryo into the hierarchical structure of arteries, veins and capillaries. One hallmark of this 
process is the recruitment of mural cells to the EC layer that forms the vessel lumen. vSMC are covering 
arteries in one or multiple layers and their recruitment involves differentiation, migration and adhesion 
from the surrounding mesenchyme to the vessel. Several mural knockout studies underscored the role 
of these processes for vessel development and especially for vSMC recruitment. The conditional 
knockout of integrin β1 in vSMC resulted in instable vessels, poorly covered by vSMC, similarly like the 
vSMC specific ablation of the IPP component ILK (Abraham et al. 2008, Kogata et al. 2009). Likewise to 
ILK, also the constitutive deletion of αpv primarily results in defective vSMC recruitment and heart 
malformations. Interestingly, while for ILK and β1 a constitutive knockout in mice results in early peri-
implantation lethality (Sakai et al. 2003, Fässler et al. 1995), the constitutive αpv knockout mice survive 
until E10.5 to E14.5. This indicates, that αpv seems to have an important function in vSMC and heart 
development, but is of lesser significance in other cell types, thus allowing the embryo to proper 
develop until the cardiovascular defects become apparent. We therefore chose a conditional αpv 
deletion with PDGFRβ-Cre transgenic mice to investigate the specific role for αpv in SMC. Unexpectedly 
αpv fl/fl PDGFRβCre mice survived until birth and were free of symptoms until P21. Death of 
homozygous mice occurred latest at P30 most likely due to intestinal problems and only 10% of mice 
survived and were free of any phenotype. This discrepancy to the death of constitutive αpv null mice is 
most likely due to the normal heart development in αpv fl/fl PDGFRβCre mice, where the 
cardiomyocytes are not targeted by PDGFRβCre-mediated gene deletion. Furthermore it was postulated 
that PDGFRβ expression and therefore strong vSMC recruitment starts at E11.5 (Hellström et al. 1999) a 
timepoint, where αpv null embryos already developed a strong phenotype. This can explain why the 
vSMC specific deletion of αpv with PDGFRβCre is not leading to perinatal lethality, although the vascular 
defects are comparable. Vessels of αpv fl/fl PDGFRβCre mice displayed only punctuated staining of 
αSMA and vessels were enlarged, which could be also observed in vasculature of αpv null mice. This 
suggests a contractility defect of vessels due to reduced vSMC investment into the vessel wall. Further 
evidence for this is the persistent ductus arteriosus that was frequently observed in αpv fl/fl PDGFRβCre 
mice at P30. This shunt vessel between pulmonary artery and aorta spontaneously closes in small 
rodents rapidly after birth, initially by contraction of the vSMC in the vessel. Thus a patent ductus 
arteriosus can be the result of a contractility defect of vSMC (Feng et al. 2010). In contrast to our 
findings, a study with SM22Cre+Ilk fl/fl conditional mutant mice came to the conclusion that the 
observed aneurysm formation and persistend ductus arteriosus in mutant mice is resulting of a 
downregulated contractility and reduced expression of SMC markers in vSMC after ILK depletion (Shen 
et al. 2011). Unfortunately, their study on RhoA activation was performed with passaged vSMC and 
Adeno virus treatment. It cannot be excluded that this leads to a switch of vSMC to a more synthetic 
phenotype, which probably masks the effects that ILK depletion has on vSMC in vivo.  
We also show that vessel enlargement in αpv fl/fl PDGFRβCre mice is not only due to a defective vSMC 
recruitment and spreading failure of these cells, but they additionally show higher degradation abilities 
of ECM, finally resulting in AAA formation. Sections of AAA displayed invading macrophages, a typical 
observation in aneurysm (Brophy et al. 1991), but in situ zymogram revealed also high degradation in 
the whole tunica media, and thus a participation of vSMC in the degradation process. It was recently 
shown by Pignatelli et al (2012) that matrix degradation is dependent on αpv phosphorylation and 
especially on Rac1 activation which requires αpv phosphorylation, whereas the high RhoA activity 
observed in their non-phosphorylateable αpv is negatively regulating matrix degradation. Although the 
increased pMLC2 levels observed in our αpv null vSMC and the consequential hypercontractility seems 
to support their idea, we report that αpv deficient vSMC show increased secretion of MMPs, especially 
MMP9 along with higher matrix degrading ability compared to wildtype vSMC. Along with our 
observation in MC, which show only slightly higher matrix degradation and UC, where MMP secretion 
and matrix degradation is strongly decreased after αpv deletion, we believe that there is a connection, 
but most likely no direct link between αpv deletion and matrix degradation. The changed MMP 
expression is more likely a secondary effect of a different actin cytoskeleton and FA structure.  
Beside vascular malformations, defects in kidney development are frequently observed, when deleting 
one of the components of integrin mediated adhesion and migration. For integrin β1 and also for the 
parvin binding partner ILK several severe abnormalities in kidney development have been reported, 
including the total absence of one or both kidneys (Wu et al. 2009, Lange et al. 2008). Likewise for αpv 
null mice, problems in proper kidney formation were detected. In αpv fl/fl PDGFRβCre mice kidneys 
formed normally and were of normal morphology and size until P14. At later age, development of cystic 
structures was observed, glomerulus architecture was highly altered and mice developed proteinurea 
together with symptoms of renal inflammation. An explanation for this finding is the αpv deletion in MC 
by PDGFRβCre. MC resemble SMC in morphology, protein expression pattern and contractile abilities. 
According to Schlöndorff, these cells may function like specialized pericytes and are required for 
modulating glomerular hemodynamics by contraction (Schlöndorff et al. 1987). .It was observed in 
various nephrophathies, that MC can transdifferentiate from their mature contractile phenotype into an 
embryonic myofibroblast phenotype along with high proliferation rates and strong expression levels of 
αSMA (El-Nahas et al. 2003). In line with these clinical observations, we detected high levels of αSMA in 
glomeruli of αpv fl/fl PDGFRβCre mice, indicating that MC also switch to a myofibroblast phenotype 
after αpv deletion. According to the literature, this switch is accompanied with upregulated deposition 
of Col I, Col III and FN, instead of the normal ECM consisting of LN and Col IV. This new ECM is negatively 
regulating MC survival, as it was shown for rat MC, thus promoting cell apoptosis and cell depletion 
during progression of the disease (Mooney et al. 1999). This can very well explain our observation in αpv 
fl/fl PDGFRβCre glomeruli of either hypercellularity or areas of cell loss, depending on progression of the 
sclerosis. We additionally observed a tubulo-interstitial sclerosis, which is most likely a secondary effect 
of the glomerular malfunction and proteinurea (Christensen et al. 2008). Interestingly, isolated αpv 
deficient MC showed no phenotype beside a slight spreading defect and mild increase in matrix 
degradation, although not nearly comparable to αpv deficient vSMC. Also no upregulation of 
contractility markers were observed after αpv deletion. We therefore propose a specific role for αpv in 
MC that is well-defined from its function in regulation of contractility in other SMC subtypes and has to 
be revealed in further studies to explain the kidney phenotype in αpv fl/fl PDGFRβCre mice.  
 
We were also asking the question, what function αpv has in adult SMC, where migration, adhesion and 
spreading processes have been already terminated. In our Tamoxifen inducible αpv fl/fl SMMHC-CreERT2 
mice we observed major defects in the SMC layer of the small intestine, leading very rapidly to the death 
of homozygous mice. It is very likely that the loss of αpv in smooth muscle layers of the GI tract is 
disturbing peristalsis and leading to a paralytic ileus. This explains the failure to gain weight and would 
subsequently lead to death, as it is also described in other animal studies (Angstenberger et al. 2007, 
Mericskay et al. 2007). While αpv depleted iSMC behaved comparable to vSMC in αpv fl/fl PDGFRβCre, 
interestingly no phenotype was observed in the vasculature of induced αpv fl/fl SMMHC-CreERT2 mice, 
although it was shown that SMMHC-CreERT2 targets all SMC, including vSMC (Wirth et al. 2008). A 
possible explanation for this might be the severity of the pseudoobstruction and high lethality, which 
prevented prolonged studies of these mice. Another explanation might be a low protein turnover of FAs 
in vSMC. Migration of cells is depending on constant FA assembly and disassembly at the leading and 
lagging edge of the cell and therefore a constant need for FA proteins. Differentiated vSMC are in a 
resting, non-migratory state and not dependent on the formation of new FAs. Thus the loss of αpv 
expression would not become evident until de novo αpv incorporation into FAs would be required.       
This suggests that triggering angiogenesis in adult mice or vSMC migration like in atherosclerosis would 
cause a vascular defect in αpv fl/fl SMMHC-CreERT2 mice. 
αpv is part of the ternary protein complex consisting of ILK, PINCH and parvin. The formation of the IPP 
complex is critically depending on the presence of all three proteins, and with one protein absent the 
other two undergo proteasomal degradation (Fukuda et al. 2003). In case of αpv it was described that 
βpv can rescue ILK and PINCH levels at the FAs, although the ILK-PINCH- βpv complex is unable to rescue 
the hypercontractility phenotype (Montanez et al. 2009). Our in vitro studies could show, that in general 
primary αpv deleted vSMC isolated from aorta phenocopy the vSMC/PC after αpv deletion. They display 
the same round morphology with multiple retraction fibers and elevated pMLC2 levels also confirm the 
regulation of cell contractility by αpv. Unexpectedly in our system βpv expression is not upregulated in 
vSMC, resulting in a loss of the whole IPP complex at FAs and strongly decreased protein levels. Same 
results were obtained for MC and UC, after αpv deletion, suggesting, that βpv expression is absent in 
differentiated contractile SMC found in adult animals. Interestingly the loss of IPP in vSMC is not 
changing the phenotype, compared to vSMC obtained from αpv null mice, where ILK and PINCH levels 
were normal. Additionally no changes in integrin mediated signaling, like FAK and Erk phosphorylation 
were observed in αpv fl/fl PDGFRβCre vSMC upon loss of the IPP complex. Out of these findings we 
conclude, that in SMC especially αpv and the αpv containing IPP complex is of major importance for cell 
morphology and function. Further studies have to concentrate on αpv specific interaction partners to 
explain the regulation of contractility.  
SMC have the ability to switch back and forth between a contractile quiescent state to a proliferative 
synthetic phenotype depending on extracellular stimuli, which goes hand in hand with loss of SMC 
specific proteins like smoothelin and αSMA (Rensen et al. 2007). This switching is necessary is situations, 
where migration and proliferation of SMC is necessary, like the formation of new vessels, or response to 
injury, but an unwanted feature when these cells are cultured for in vitro analysis. We therefore chose 
UC, which keep their contractile abilities also after immortalization and several passages in culture, to 
investigate the biochemical function of αpv on contractility regulation. We show that αpv deletion in UC 
resulted in poorly spread cells, defects in directed migration and adhesion to ECM proteins, especially to 
those present also in the vascular wall like FN and LN. Therefore these cells, unlike MC, seemed to be a 
suitable alternative to primary vSMC for in vitro studies. But in contrast to previous studies on αpv 
deficient vSMC and our results on αpv null vSMC, pMLC2 levels remained unchanged. SMC, even though 
performing similar functions in all organs are a heterogeneous cell type and thus conclusions drawn 
from one SMC subtype must not be true for all SMC. Unlike other cells, which derive from a distinct 
precursor cell like endothelial cells and myocytes, SMC can derive from different embryonic tissues 
(Gittenberger-de Groot et al. 1999). We think that this is the reason for the variability in phenotypes we 
observe in SMC after αpv deletion and we propose that αpv is regulating different signaling pathways 
depending on the origin of the SMC.   
Taken together we confirm with the conditional deletion of αpv in SMC the vascular phenotype 
observed for the constitutive αpv deletion in mice. Although there are differences in lethality and in 
other organs, in both studies αpv regulates cell recruitment and spreading of vSMC and absence of αpv 
results in hypercontractility. We expand these findings to iSMC, which show comparable defects, but 
also show, that αpv is not performing the same function in all SMC related cells and that there might be 
another pathway involved. Further studies are necessary to resolve the critical difference in vSMC/iSMC 
to other SMC to finally present the signaling pathways αpv is regulating.  
  
MATERIAL AND METHODS 
Animal Procedures 
α-parvin fl/fl mice (Altstätter et al., in preparation) were intercrossed with PDGFRβCre transgenic mice 
(Foo et al. 2006) to produce αpv fl/fl PDGFRβCre-mice or with SMMHC-CreERT2 transgenic mice (Wirth 
et a. 2008) to produce αpv fl/fl SMMHC-CreERT2 mice. Deletion of the αpv alleles was induced in 3 
weeks old mice by intraperitoneal injection of 1mg Tamoxifen in peanut oil on 3 consecutive days. For 
experiments αpv fl/fl PDGFRβCre mice were compared to αpv fl/+ PDGFRβCre littermates and 
Tamoxifen induced male αpv fl/fl SMMHC-CreERT2 mice were compared to Tamoxifen induced αpv fl/fl 
female littermates, since the Cre is inherited via the y-Chromosome. All experiments with mice were 
performed in accordance to German guidelines and regulations. 
Antibodies 
The following antibodies were used: rabbit antibody against a-parvin (Cell Signaling); rabbit antibody 
against b-parvin (1453); biotinylated rat antibody agains-Mac-1 (Pharmingen); rat antibody against CD31 
(PharMingen); Cy3-conjugated mouse antibody against aSMA (Sigma); mouse antibody against GAPDH 
(Calbiochem); rabbit antibody against ILK (Cell Signaling Technology); mouse antibody against ILK 
(Transduction Laboratories); mouse antibody against PINCH (Transduction Laboratories); rabbit antibody 
against myosin light chain (MLC2) (Santa Cruz); rabbit antibody against phospho-MLC2 (Cell Signaling); 
mouse antibody against paxillin (Transduction Laboratories); rabbit antibody against FAK (Cell Signaling); 
rabbit antibody against pFAK [Y397] (Invitrogen); rabbit antibody against Akt (Cell Signaling), rabbit 
antibody against pAkt [S473] (Cell Signaling); rabbit antibody against Erk ½ (Cell Signaling), rabbit 
antibody against pErk [T202/ Y204] (Cell Signaling); rabbit antibody against MMP9 (Millipore), goat 
antibody against MT1-MMP (Santa Cruz); rabbit antibody against pSrc [Y416] (Cell Signaling); rabbit 
antibody against pp38MAPK [T180/ Y182] (Cell Signaling); rabbit antibody against p38MAPK (Cell 
Signaling); mouse antibody against vimentin (Sigma), TRITC-conjugated phalloidin was used to detect F-
actin (Molecular Probes; Eugene, OR, USA). Secondary antibodies were purchased from Jackson Immuno 
Research Laboratories, Molecular Probes or Invitrogen. 
 
Histology and Immunohistochemistry 
HE staining on organ sections was performed on tissue which was fixed overnight at 4°C in 4% PFA in 
PBS, dehydrated in a graded alcohol series and embedded in paraffin (Paraplast X-tra; Sigma-Aldrich) 
using a embedding machine (Shandon). For immunohistochemistry cryo-sections were used, therefore 
unfixed organs were embedded in OCT (Shandon Cryomatrix, Thermo) and rapidly frozen. Prior to 
staining, cryo-sections were fixed with PFA or acetone. For immunostaining on cells, primary vSMC, 
Mesangial Cells or Ureteric Cells were plated 4h or over night onto glass-coverslips coated with 2μg/ml 
FN. Cells were fixed in 3% PFA, permeabilized with 0.1% Triton-X100 and blocked with 3% BSA (all in 
PBS). Confocal images were acquired with a Leica TCS SP5 microscope (Leica Microsystems CMS, 
Mannheim, Germany), equipped with 20.0x NA 0.70, 40x NA 1.25, 63x NA 1.4 and 63x NA 1.2 objectives, 
using Leica Application Suite Advanced Fluorescence (LAS AF) software version 1.6.2. build 1110. 
 
Whole mounts 
Aorta and intestine were dissected and longitudinally opened. Ears were cut and the ventral half was 
separated from the dorsal half with the remaining cartilage. Samples were fixed over night in 2% PFA 
and blocked in 1% BSA for 1h at room temperature under constant agitation. Incubation with primary 
antibody was carried out over night at 4°C, incubation with secondary antibody for 1h at room 
temperature. 
 
Micropattern analysis and immunostainings 
Fabrication of FN-coated micropatterns: The micropatterns were generated on PEG-coated glass 
coverslips with deep UV lithography (Azioune et al. 2010). Briefly, glass coverslips were incubated in a 
1mM solution of a linear PEG, CH3-(O-CH2-CH2)43-NH-CO-NH-CH2-CH2-CH2-Si(OEt)3, in dry toluene for 
20 h at 80 °C under a nitrogen atmosphere. The substrates were removed, rinsed intensively with ethyl 
acetate, methanol and water, and dried with nitrogen. A pegylated glass coverslip and a chromium-
coated quartz photomask (ML&C, Jena) were immobilized with vacuum onto a mask holder, which was 
immediately exposed to deep UV light using a low-pressure mercury lamp (Heraeus Noblelight GmbH, 
NIQ 60/35 XL longlife lamp, quartz tube, 60 W) at 5 cm distance for 7 min. The patterned substrates 
were subsequently incubated overnight with 100μL of fibronectin (20 μg/mL in PBS) at 4 °C and washed 
once with PBS before plating cells in culture medium with 0.5% serum. The patters were done by Dr. 
Julien Polleux. 
Immunostaining: The cells were seeded on micropatterns in DMEM (GIBCO by life technologiesTM, 
Paisley, UK) supplemented with 0.5 % FBS at 37°C, 5% CO2 for 3h. Cells were fixed in 3% PFA in PBS and 
blocked with 1% BSA in PBS for 1h under constant agitation. Primary antibodies were incubated in 3% 
BSA, 0.1% TritonX-100 in PBS for 1h at 37°C. Staining intensity was quantified using Metamorph® 
software. 
 
Zymography 
Cells were lysed in buffer (50mM Tris pH 7.5, 100mM NaCl, 10mM CaCl2, 1% Triton-X, 0.01% Brij35) 
without protease inhibitors. Proteins were resolved on 10% SDS-PAA gel, substituted with 0.2% Gelatin 
or 0.2% Casein. After gelelectrophoresis, gels were washed in 0.2% Triton-X and incubated in MMP 
reaction buffer (50mM Tris pH 7.5, 200mM NaCl, 5mM CaCl2, 0.02% Na azide) for 24h – 3days. Gels 
were stained in Coomassie. Areas of degradation appear as white bands on blue background. 
 
In situ zymogram 
Fresh cryosections (8µm) were air dried and covered by a mixture of 1% low gelling agarose, 0.1mg/ml 
DQ-Gelatin and DAPI. After gelling of Agar at 4°C, sections were incubated at RT for minimum 1h. 
Sections were analyzed via confocal microscopy. Areas of degradation are vizualized at 488nm 
wavelength. 
Coverslips were coated with 5% DQ-Gelatin in 10mg/ml Gelatin solution and air dried. After rehydration 
in PBS, Cells were seeded overnight on the Gelatin coated coverslips. After fixation in 3% PFA, coverslips 
were blocked in 3% BSA and incubated in primary antibody ON at 4°C. Cells were analyzed via confocal 
microscopy. Areas of degradation were visualized at 488nm wavelength. 
 Isolation of smooth muscle cells 
Aortas were dissected, cut into smaller pieces and digested with digestion buffer (2 mg/ml collagenase 
type II and 0.5 mg/ml elastase in Dulbecco's modified Eagle medium (DMEM)) for 30 min at 37°C. 
Digestion was terminated with 10% foetal bovine serum (FBS) in DMEM. Released cells were centrifuged 
and re-suspended in DMEM containing 10% FBS and antibiotics, transferred to 6-well dishes and further 
expanded for analysis. 
Small intestines were dissected, longitudinally opened and washed several times with HBSS. The luminal 
side was scratched with a sterile glass slide to remove epithelial layers. The intestine was minced into 
small pieces and digested for 30 min at 37°C in digestion buffer (0.35 mg/ml Papain, 0.35 mg/ml 
Collagenase type II, 0.25 mg/ml soybean trypsin inhibitor and 2 mg/ml BSA in Medium 199). The 
suspension was filtered, centrifuged and re-suspended in culture medium (Medium 199, 20% FBS, 2 mM 
L-Glutamin and antibiotics). 
 
Isolation of Ureteric Cells and immortalization 
Ureters were dissected from E14.5 αpv fl/fl embryos, and digested with digestion buffer (2 mg/ml 
collagenase type II and 0.5 mg/ml elastase in Dulbecco's modified Eagle medium (DMEM)) for 30 min at 
37°C. Digestion was terminated with 10% foetal bovine serum (FBS) in DMEM. Released cells were 
transferred to DMEM containing 10% FBS and antibiotics and cultured in 6-well-dishes. Immortalization 
was achieved by retroviral transduction of SV40 large T antigen and immortalized cells were 
subsequently cloned. αpv null UC were derived from αpv fl/fl UC by adenoviral Cre transduction 
followed by cloning. 
 
SDS–PAGE and immunoblotting 
Cells were lysed in RIPA-Lysis buffer (150 mM NaCl, 1.0% IGEPAL® CA-630, 0.5% sodium deoxycholate, 
0.1% SDS, and 50 mM Tris, pH 8.0, supplemented with protease inhibitors (Roche) and phosphatase 
inhibitors (SIGMA)), homogenized in Laemmli sample buffer and boiled for 5 min. Proteins were 
resolved by SDS–polyacrylamide gel electrophoresis (SDS–PAGE) gels and then electrophoretically 
transferred from the gels onto PVDF membranes, which were subsequently blocked in 5% BSA and 
incubated with antibodies. Bound antibodies were detected using chemiluminescence HRP substrate 
(Millipore Corporation, Billerica, USA). 
 
FACS staining 
UC were trypsinated and resuspended in FACS buffer (TBS; 3%BSA; 0,02%NaN3, 1mM MgCl2, 1mM 
CaCl2). Staining was performed in triplicates using >105 cells/well on 96-well plates. Antibodies used for 
FACS analyzes were FITC conjugated hamster antibody against integrin β1; biotinylated hamster 
antibody against integrin β3 (all from PharMingen, San Diego, CA); mouse antibody against integrin β5; 
rabbit antibody against integrin β8; FITC-conjugated hamster antibody against integrin α1 (Serotec); 
FITC-conjugated hamster antibody against integrin α2; biotinylated rat antibody against integrin α4; 
biotinylated rat antibody against integrin α5; biotinylated rat antibody against integrin αv (all BD 
Biosciences); Cy5-conjugated Streptavidin (Jackson Immunochemicals Laboratories Inc.; West Grove, PA, 
USA); Integrin null cells served as negative control. 
 
In vitro wound healing assay 
After 4h incubation in DMEM complemented with 10%FCS and antibiotics, UC monolayers were gently 
scratched with a pipet tip. Subsequently, images were captured every 10 min for 24h at 37°C and 5% 
CO2 using a Zeiss Axiovert microscope equipped with 10× NA 0.3, 20× NA 0.4, 40× NA 0.6, and 100× NA 
1.3 objectives, a motorized scanning table (Märzhäuser), a stage incubator (EMBL Precision Engineering) 
and a CCD camera (Roper Scientific MicroMAX). MetaMorph (Universal Imaging Corp.) software was 
used for microscope control and data acquisition. For single cell tracking and data analyzes, the ImageJ 
software-plugins “Manual Tracking” (Fabrice P. Cordelières) and “Chemotaxis and Migration Tool” (ibidi) 
were used. At least three independent experiments were performed and more than 10 individual cells 
were tracked for each experiment. 
 
Boyden chamber assay 
Chemotactic and chemokinetic migration assays were performed in 3-mm pore size chamber inserts (BD 
Falcon). For chemotaxis assays, 4x104 cells were plated into the chamber and transferred into 24-well 
plates containing serum-free medium with or medium with 10% FCS. After overnight incubation, the 
cells in the bottom part of the chamber were stained with a crystal violet solution and counted. Five 
microscopic fields per chamber were analyzed. Data are represented as x-fold more cells when FCS was 
present to cell number in serum free medium. 
 
Adhesion assay 
96 well plates were coated with 2, 5, 10 [µg/ml] Fibronectin (Calbiochem, bovine); 2, 5, 10 [µg/ml] 
CollagenI (PureCol, Inamed Materials #5409); 2, 5, 10 [µg/ml] Laminin; 2, 5, 10 [µg/ml] CollagenIV; 1% 
BSA in PBS, or 0.1% PLL for 2h at RT and subsequently blocked with 1% BSA in PBS for 15 min at RT. 
50.000 cells were used per well for 1h of adhesion. Wells were washed with PBS, dried and stained over 
night with 0.1% Crystal violet in 20% Methanol at 4°C. After washing with H2O, permeabilization was 
performed with 0.1% Triton X-100 in dH2O for several hours until the dye left the cells. Absorption was 
measured at absorption at 595nm wavelength in a plate reader. 
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FIGURE LEGEND 
Figure 1: PDGFRβCre induced deletion of αpv leads to vascular and intestinal defects. (A) 
Representative images of αpv fl/+ PDGFRβCre and αpv fl/fl PDGFRβCre mice at the age of 30 days. (B) 
Weight gaining curve of αpv fl/+ PDGFRβCre and αpv fl/fl PDGFRβCre mice. Values are mean weight of 
10 animals per genotype. (C) Kaplan-Meier-survival curve of αpv fl/+ PDGFRβCre and αpv fl/fl 
PDGFRβCre mice. Values are based on 20 mice per genotype. (D) Dissected aorta from αpv fl/+ 
PDGFRβCre and αpv fl/fl PDGFRβCre mice at day 1 and day 30 after birth. αpv fl/fl PDGFRβCre mice 
display large abdominal aortic aneurysms. Star points to atheroma formation. Scale bar: 0.25cm and 
1cm. (E) HE staining of ductus arteriosus sections from αpv fl/+ PDGFRβCre and αpv fl/fl PDGFRβCre 
mice at day 30 after birth. Note the persistent ductus arteriosus in αpv fl/fl PDGFRβCre mice. Scale bar: 
100µm. (F) Dissected digestion tract from αpv fl/+ PDGFRβCre and αpv fl/fl PDGFRβCre mice at day 30 
after birth. Note the enlarged large intestine and caecum. si = small intestine, li = large intestine, c = 
caecum. Scale bar: 1cm  
 
Figure 2: PDGFRβCre deletion of αpv results in impaired cell spreading and cell shape. (A) Whole 
mount immunostaining of the vasculature in the ear and aorta of αpv fl/+ PDGFRβCre and αpv fl/fl 
PDGFRβCre mice Scale bar: 100µm and 75µm. SMCs are labeled with αSMA (red/white) and ECs with 
CD31/PECAM (green). (B) Immunostaining of aorta sections of αpv fl/+ PDGFRβCre and αpv fl/fl 
PDGFRβCre mice. αpv (green) is absent from the smooth muscle cell containing layer in αpv fl/fl 
PDGFRβCre mice. Nuclei are visualized with DAPI. Note the round smooth muscle cells in the aorta of 
αpv fl/fl PDGFRβCre mice. Scale bar: 75µm and 50µm. (C) Brightfield images and immunostainings 
against αpv (green) and αSMA (red) of isolated primary vSMC from αpv fl/+ PDGFRβCre and αpv fl/fl 
PDGFRβCre mice seeded on 2µg/ml FN. Nuclei are visualized with DAPI. Scale bar: 50 and 20µm. (D) 
Protein levels of αpv, β-parvin, ILK and PINCH1 from primary vSMC. Gapdh levels served as loading 
control. (E) Immunostainings for ILK (red), PINCH1 (red) and αpv (green) in primary vSMC from αpv fl/+ 
PDGFRβCre and αpv fl/fl PDGFRβCre mice seeded of 2µg/ml FN. Scale bar: 20µm. 
 
Figure 3: Tamoxifen induced deletion of αpv in SMCs leads to severe intestinal defects. (A) 
Representative images of αpv fl/fl and αpv fl/fl SMMHC-CreERT2 mice at day 35 after Tamoxifen 
treatment. (B) Dissected digestion tract from αpv fl/fl and αpv fl/fl SMMHC-CreERT2 mice at day 35 after 
Tamoxifen treatment. Note the enlargement of the small intestine together with the black discoloration. 
si = small intestine, li = large intestine, c = caecum. Scale bar: 1cm. (C) HE staining of small intestine 
sections of αpv fl/fl and αpv fl/fl SMMHC-CreERT2 mice at day 35 after Tamoxifen treatment. Closeup of 
the SMC layer shows round SMCs in αpv fl/fl SMMHC-CreERT2 mice. Immunostainings against αSMA 
(red) and αpv (green) show absence of αpv in αpv fl/fl SMMHC-CreERT2 mice. Scale bar: 100µm and 
75µm. (D) Brightfield images and immunostainings against αpv (green) and αSMA (red) of isolated 
primary iSMC from αpv fl/fl and αpv fl/fl SMMHC-CreERT2 mice seeded on 2µg/ml FN. Nuclei are 
visualized with DAPI. Scale bar: 50µm and 20µm. (E) Protein levels of αpv, βpv, ILK and PINCH1 from 
primary vSMC. Gapdh levels served as loading control. 
 
Figure 4: Deletion of αpv leads to increased cell contraction of SMC. (A) Immunostainings of primary 
vSMC against pMLC2 (green) and αSMA (red). Nuclei are visualized with DAPI. Scale bar: 20µm. 
(B).Protein levels of pMLC2 and MLC2 in vSMC lysates from αpv fl/+ PDGFRβCre and αpv fl/fl PDGFRβCre 
mice. (C) Immunostainings of immortalized UC against pMLC2 (green) and αSMA (red). Nuclei are 
visualized with DAPI. Scale bar: 20µm (D) Protein levels of pMLC2 and MLC2 from of αpv fl/fl UC, αpv -/- 
361 and αpv -/- 369 UC. (E) Immortalized αpv fl/fl and αpv -/- UC on FN coated umbrella shaped 
micropatterns and immunostained for pMLC2 (green), Phalloidin (red) and Paxillin (white). Nuclei are 
visualized with DAPI. Single channels are shown in black and white. 
 
Figure 5: αpv regulates migration and adhesion of UC (A) In vitro wound healing assay with αpv fl/fl UC, 
αpv -/- 361 and αpv -/- 369 UC. Representative images at t=0 and at t=24h show inability of αpv -/- 361 
and αpv -/- 369 UC to close the scratch after 24h. Graphs display average distance after 13h in µm, 
average velocity in µm/min and directionality of cells. 10 cells were tracked for analysis. Bars represent 
SEM. (B) Protein levels of FAK, pFAK [Y397], Akt, pAkt [S473], Erk1/2, pErk 1/2 [T202/ Y204] of primary 
vSMC from αpv fl/+ PDGFRβCre and αpv fl/fl PDGFRβCre mice. Gapdh levels served as loading control. 
(C) Protein levels of FAK, pFAK [Y397], Akt, pAkt [S473], Erk 1/2, pErk1/2 [T202/ Y204] of αpv fl/fl UC, 
αpv -/- 361 and αpv -/- 369 UC. Gapdh levels served as loading control (D) Adhesion assay using αpv fl/fl 
UC, αpv -/- 361 and αpv -/- 369 UC on Laminin, Collagen I and IV and Fibronectin [numbers represent 
concentrations]. Adhesion was allowed for 1h. Graph shows x-fold increase of adhesion over 
background adhesion and represents data of technical triplicates. Bars represent SD. (E) FACS analysis of 
Integrin surface expression from αpv fl/fl UC, αpv -/- 361 and αpv -/- 369 UC. Integrin null cells were 
used as control 
 
Figure S1: Loss of αpv in the mesangium results in glomerulus breakdown and interstitial fibrosis (A) 
HE staining of kidney sections from αpv fl/+ PDGFRβCre and αpv fl/fl PDGFRβCre mice at embryonic 
stage 17 and 30 days after birth. Note kidney cysts in P30 kidneys from αpv fl/fl PDGFRβCre mice. Scale 
bar: 500µm (B) HE staining and immunostaining against αpv (green) and αSMA (red) of large intestine 
sections of αpv fl/+ PDGFRβCre and αpv fl/fl PDGFRβCre mice. Scale bar: 50µm and 75µm (C) HE 
stainings of glomeruli and closeup of single glomerulus. Arrowhead indicates areas of cell loss, rectangle 
indicates area of matrix accumulation, star indicates hypercellular area. Scale bar: 200µm. 
Immunostaining of kidney sections from αpv fl/+ PDGFRβCre and αpv fl/fl PDGFRβCre mice against αpv 
(green) and αSMA (red) reveal loss of αpv in glomeruli of αpv fl/fl PDGFRβCre mice. Nuclei are visualized 
with DAPI. Scale bar: 75µm. (D) Urine samples taken from αpv fl/+ PDGFRβCre and αpv fl/fl PDGFRβCre 
mice were analysed by coomassie stained 12% SDS-Page. (E) Immunostaining of kidney sections from 
αpv fl/+ PDGFRβCre and αpv fl/fl PDGFRβCre mice against αSMA (red) and Vimentin (green) reveal 
fibrotic areas in αpv fl/fl PDGFRβCre mice. Nuclei are visualized with DAPI. Scale bar: 75µm. (F) Hemavet 
analysis of blood samples of αpv fl/+ PDGFRβCre and αpv fl/fl PDGFRβCre mice. Panel shows average 
white blood cell counts of 5 mice of each genotype. Bars represent standard deviation. (G) Hemavet 
analysis of blood samples of αpv fl/+ PDGFRβCre and αpv fl/fl PDGFRβCre mice. Panel shows average 
red blood cell counts of 5 mice of each genotype. Bars represent standard deviation. 
 
Figure S2: Deletion of αpv in vSMC leads to degradation of laminar fibers in the aorta. (A) HE staining 
and Verhoeff van Gieson staining of abdominal aorta sections of αpv fl/+ PDGFRβCre and αpv fl/fl 
PDGFRβCre mice. Scale bar: 75µm. (B) Immunostaining against Mac1 (white) and in situ zymogram of 
aorta sections of αpv fl/+ PDGFRβCre and αpv fl/fl PDGFRβCre mice. Green staining indicates areas of 
proteolytic activity. Pictures were taken with the same laser intensity. Nuclei are visualized with DAPI. 
Scale bar: 75µm (C) In situ zymogram with DQ-Gelatin (green) and phalloidin (red) in αpv fl/+ PDGFRβCre 
and αpv fl/fl PDGFRβCre vSMC. Green fluorescence marks areas of proteolytic activity. Nuclei are 
visualized with DAPI. Pictures were taken with same the laser intensity. Scale bar: 20µm (D) Zymogram 
of vSMC lysates of αpv fl/+ PDGFRβCre and αpv fl/fl PDGFRβCre mice with Gelatin (2mg/ml) and Casein 
(2mg/ml) as substrate. White bands indicate areas of MMP induced degradation. (E) Protein levels of 
MMP9, MMP1, MT1-MMP and MMP2 in vSMC lysates of αpv fl/+ PDGFRβCre and αpv fl/fl PDGFRβCre 
mice. Gapdh served as loading control. 
 
Figure S3: Tamoxifen induced deletion of αpv in SMCs results in gastrointestinal defects. (A) Whole 
mount immunostaining of small intestine of αpv fl/fl and αpv fl/fl SMMHC-CreERT2 mice against αSMA 
(white). Images are maximum projections of multiple stack images. Scale bar: 75µm. (B) Immunostaining 
against Mac1 (white), in situ zymogram with DQ-Gelatin (green) and Tunel (green) assay for apoptotic 
cells on small intestine sections of αpv fl/fl and αpv fl/fl SMMHC-CreERT2 mice. Nuclei are visualized with 
DAPI. Scale bar: 75µm. (C) HE staining of stomach sections of αpv fl/fl and αpv fl/fl SMMHC-CreERT2 
mice. Closeup shows increased thickness of SMC layer and round SMCs. Scale bar: 100µm. (D) HE 
staining of aorta sections of αpv fl/fl and αpv fl/fl SMMHC-CreERT2 mice. Closeup shows no changes in 
number or shape of SMCs. Scale bar: 100µm. 
 
Figure S4: αpv deletion does not change contractility of MC. (A) Immunostaining against αpv (green) 
and αSMA (red) (upper row)and  ILK (green) and PINCH1 (red) (lower row) of αpv fl/fl UC, αpv -/- 361 
and αpv -/- 369 UC seeded on 2µg/ml FN. Nuclei are visualized with DAPI. Scale bar: 20µm. (B) Protein 
levels of αpv, ILK and PINCH1 of αpv fl/fl UC, αpv -/- 361 and αpv -/- 369 UC. Gapdh levels served as 
loading control. (C) Immunostaining against αpv (green) and αSMA (red) of αpv fl/fl and αpv -/- MC 
seeded on 2µg/ml FN. Nuclei are visualized with DAPI. Immunostaining against pMLC2 (green) and 
αSMA (red) of αpv fl/fl and αpv -/- MC seeded on 2µg/ml FN. Nuclei are visualized with DAPI. Scale bar: 
20µm. (D) Protein levels of αpv, ILK and PINCH1 of αpv fl/fl UC, αpv -/- 361 and αpv -/- 369 UC. Gapdh 
levels served as loading control. (E) Immortalized αpv fl/fl and αpv -/- MC seeded on FN coated umbrella 
shaped micropatterns and immunostained for pMLC2 (green), Phalloidin (red) and Paxillin (white). 
Nuclei are visualized with DAPI. Single channels are shown in black and white. 
 
Figure S5: αpv deletion enhances degradation activity of MC. (A) Representative pictures of a boyden 
chamber assay using αpv fl/fl UC, αpv -/- 361 and αpv -/- 369 UC. Cells were stained by crystal violet 
Pure medium was used as a control. Graph displays fold increase of cell number stimulated by 10% FCS 
against pure medium. (B) Protein levels of FAK, pFAK [Y397], Akt, pAkt [S473], Erk 1/2, pErk1/2 [T202/ 
Y204] of αpv fl/fl and αpv -/- MC. Gapdh levels served as loading control (C) Protein levels of MMP9, 
MT1-MMP and MMP2 in αpv fl/fl UC, αpv -/- 361 and αpv -/- 369 UC and αpv fl/fl and αpv -/- MC. 
Tubulin levels served as loading control. (D) In situ zymogram with DQ-Gelatin (green) using αpv fl/fl UC, 
αpv -/- 361 and αpv -/- 369 UC and αpv fl/fl and αpv -/- MC. Green fluorescence marks areas of 
proteolytic activity. Nuclei are visualized with DAPI. Pictures were taken with the same laser intensity. 
Scale bar: 20µm. 










